10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

Commission file number 001-15925

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware	13-3893191
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)
4000 Meridian Boulevard Franklin, Tennessee	37067
(Address of principal executive offices)	(Zip Code)

615-465-7000

(Registrant’s telephone number)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes   x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of April 19, 2012, there were outstanding 91,888,334 shares of the Registrant’s Common Stock, $0.01 par value.

Community Health Systems, Inc.

Form 10-Q

For the Three Months Ended March 31, 2012

	Page
Part I. Financial Information
Item 1. Financial Statements:
Condensed Consolidated Balance Sheets - March 31, 2012 and December 31, 2011 (Unaudited)		2
Condensed Consolidated Statements of Income - Three Months Ended March 31, 2012 and March 31, 2011 (Unaudited)		3
Condensed Consolidated Statements of Comprehensive Income - Three Months Ended March 31, 2012 and March 31, 2011 (Unaudited)		4
Condensed Consolidated Statements of Cash Flows - Three Months Ended March 31, 2012 and March 31, 2011 (Unaudited)		5
Notes to Condensed Consolidated Financial Statements (Unaudited)		6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		41
Item 3. Quantitative and Qualitative Disclosures about Market Risk		59
Item 4. Controls and Procedures		59
Part II. Other Information
Item 1. Legal Proceedings		60
Item 1A. Risk Factors		65
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		65
Item 3. Defaults Upon Senior Securities		65
Item 4. Mine Safety Disclosures		65
Item 5. Other Information		65
Item 6. Exhibits		66
Signatures		67
Index to Exhibits		68

1

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

	March 31, 2012			December 31, 2011
ASSETS
Current assets
Cash and cash equivalents	$	129,298		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts of $1,996,090 and $1,891,334 at March 31, 2012 and December 31, 2011, respectively		2,019,537			1,834,167
Supplies		354,074			346,611
Prepaid income taxes		49,769			101,389
Deferred income taxes		89,797			89,797
Prepaid expenses and taxes		129,154			112,613
Other current assets		328,847			231,647
Total current assets		3,100,476			2,846,089
Property and equipment		9,640,636			9,369,528
Less accumulated depreciation and amortization		(2,638,773	)		(2,513,552	)
Property and equipment, net		7,001,863			6,855,976
Goodwill		4,367,841			4,264,845
Other assets, net		1,376,236			1,241,930
Total assets	$	15,846,416		$	15,208,840
LIABILITIES AND EQUITY
Current liabilities
Current maturities of long-term debt	$	75,388		$	63,706
Accounts payable		822,247			748,997
Accrued interest		101,156			110,121
Accrued liabilities		997,618			988,315
Total current liabilities		1,996,409			1,911,139
Long-term debt		9,243,616			8,782,798
Deferred income taxes		704,725			704,725
Other long-term liabilities		986,022			949,990
Total liabilities		12,930,772			12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		363,540			395,743
EQUITY
Community Health Systems, Inc. stockholders’ equity
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued		—			—
Common stock, $.01 par value per share, 300,000,000 shares authorized; 91,858,778 shares issued and 90,883,229 shares outstanding at March 31, 2012, and 91,547,079 shares issued and 90,571,530 shares outstanding at December 31, 2011		919			915
Additional paid-in capital		1,089,447			1,086,008
Treasury stock, at cost, 975,549 shares at March 31, 2012 and December 31, 2011		(6,678	)		(6,678	)
Accumulated other comprehensive loss		(170,136	)		(184,479	)
Retained earnings		1,576,804			1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,490,356			2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		61,748			67,349
Total equity		2,552,104			2,464,445
Total liabilities and equity	$	15,846,416		$	15,208,840

See accompanying notes to the condensed consolidated financial statements.

2

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except share and per share data)

(Unaudited)

	Three Months Ended
	March 31,
	2012			2011
Operating revenues (net of contractual allowances and discounts)	$	3,783,491		$	3,354,052
Provision for bad debts		486,456			399,969
Net operating revenues		3,297,035			2,954,083
Operating costs and expenses:
Salaries and benefits		1,524,975			1,379,367
Supplies		498,579			457,817
Other operating expenses		708,943			614,793
Electronic health records incentive reimbursement		(26,168	)		—
Rent		67,224			63,170
Depreciation and amortization		174,354			158,155
Total operating costs and expenses		2,947,907			2,673,302
Income from operations		349,128			280,781
Interest expense, net		152,175			163,218
Loss from early extinguishment of debt		63,429			—
Equity in earnings of unconsolidated affiliates		(12,013	)		(18,134	)
Income from continuing operations before income taxes		145,537			135,697
Provision for income taxes		45,819			44,092
Income from continuing operations		99,718			91,605
Discontinued operations, net of taxes:
Loss from operations of entities sold		(466	)		(1,678	)
Impairment of hospital sold		—			(8,368	)
Loss on sale, net		—			(3,234	)
Loss from discontinued operations, net of taxes		(466	)		(13,280	)
Net income		99,252			78,325
Less: Net income attributable to noncontrolling interests		23,778			17,001
Net income attributable to Community Health Systems, Inc.	$	75,474		$	61,324
Basic earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders:
Continuing operations	$	0.86		$	0.82
Discontinued operations		(0.01	)		(0.15	)
Net income	$	0.85		$	0.67
Diluted earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders (1):
Continuing operations	$	0.85		$	0.81
Discontinued operations		(0.01	)		(0.14	)
Net income	$	0.85		$	0.67
Weighted-average number of shares outstanding:
Basic		88,674,779			91,008,405
Diluted		88,852,704			92,136,819

(1) Total per share amounts may not add due to rounding.

See accompanying notes to the condensed consolidated financial statements.

3

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended
	March 31,
	2012		2011
Net income	$	99,252	$	78,325
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps		10,536		36,446
Net change in fair value of available-for-sale securities		2,667		1,069
Amortization and recognition of unrecognized pension cost components		1,140		772
Other comprehensive income		14,343		38,287
Comprehensive income		113,595		116,612
Less: Comprehensive income attributable to noncontrolling interests		23,778		17,001
Comprehensive income attributable to Community Health Systems, Inc.	$	89,817	$	99,611

See accompanying notes to the condensed consolidated financial statements.

4

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended
	March 31,
	2012			2011
Cash flows from operating activities
Net income	$	99,252		$	78,325
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		174,354			161,318
Stock-based compensation expense		10,495			9,918
Loss on sale, net		—			3,234
Impairment of hospital sold		—			8,368
Loss from early extinguishment of debt		63,429			—
Excess tax benefit relating to stock-based compensation		(1,004	)		(4,675	)
Other non-cash expenses, net		2,569			(11,173	)
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable		(163,484	)		(56,454	)
Supplies, prepaid expenses and other current assets		(125,111	)		14,336
Accounts payable, accrued liabilities and income taxes		96,109			(14,938	)
Other		30,701			(748	)
Net cash provided by operating activities		187,310			187,511
Cash flows from investing activities
Acquisitions of facilities and other related equipment		(248,436	)		(45,422	)
Purchases of property and equipment		(184,903	)		(153,875	)
Proceeds from disposition of ancillary operations		—			14,583
Proceeds from sale of property and equipment		748			7,587
Increase in other investments		(67,708	)		(32,277	)
Net cash used in investing activities		(500,299	)		(209,404	)
Cash flows from financing activities
Proceeds from exercise of stock options		308			18,125
Repurchase of restricted stock shares for payroll tax withholding requirements		(9,032	)		—
Deferred financing costs		(24,787	)		—
Excess tax benefit relating to stock-based compensation		1,004			4,675
Proceeds from noncontrolling investors in joint ventures		—			863
Redemption of noncontrolling investments in joint ventures		(31,096	)		(225	)
Distributions to noncontrolling investors in joint ventures		(27,038	)		(15,333	)
Borrowings under credit agreements		4,315,011			—
Issuance of long-term debt		1,025,000			—
Proceeds from receivables facility		300,000			—
Repayments of long-term indebtedness		(5,236,948	)		(14,665	)
Net cash provided by (used in) financing activities		312,422			(6,560	)
Net change in cash and cash equivalents		(567	)		(28,453	)
Cash and cash equivalents at beginning of period		129,865			299,169
Cash and cash equivalents at end of period	$	129,298		$	270,716
Supplemental disclosure of cash flow information:
Interest payments	$	161,140		$	226,124
Income tax refunds received, net	$	(61	)	$	(677	)

See accompanying notes to the condensed consolidated financial statements.

5

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The unaudited condensed consolidated financial statements of Community Health Systems, Inc. and its subsidiaries (the “Company”) as of March 31, 2012 and December 31, 2011 and for the three-month period ended March 31, 2012 and March 31, 2011, have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, such information contains all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for such periods. All intercompany transactions and balances have been eliminated. The results of operations for the three months ended March 31, 2012, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2012. Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted as permitted by the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company believes the disclosures are adequate to make the information presented not misleading. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2011, contained in the Company’s Annual Report on Form 10-K.

Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the parent are presented as a component of total equity on the condensed consolidated balance sheets to distinguish between the interests of the parent company and the interests of the noncontrolling owners. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the condensed consolidated balance sheets.

Allowance for Doubtful Accounts. In July 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU was adopted by the Company on January 1, 2012. Upon adoption, the Company’s provision for bad debts was presented as a reduction of net operating revenue after contractual adjustments and discounts. The condensed consolidated statement of income for the three months ended March 31, 2011 has been restated to present the provision for bad debts as a reduction of net operating revenue for comparative purposes with the March 31, 2012 presentation.

Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.

The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.

6

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the three months ended March 31, 2012 and 2011, is as follows (in thousands):

	Three Months Ended
	March 31,
	2012		2011
Medicare	$	1,064,157	$	923,864
Medicaid		315,092		321,525
Managed Care and other third-party payors		1,906,487		1,699,860
Self-pay		497,755		408,803
Total	$	3,783,491	$	3,354,052

Electronic Health Records Incentive Reimbursement. The American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act (“HITECH”). These provisions were designed to increase the use of electronic health records (“EHR”) technology and establish the requirements for a Medicare and Medicaid incentive payments program beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. Eligibility for annual Medicare incentive payments is dependent on providers demonstrating meaningful use of EHR technology in each period over a four-year period. Initial Medicaid incentive payments are available to providers that adopt, implement or upgrade certified EHR technology; but providers must demonstrate meaningful use of such technology in subsequent years to qualify for additional incentive payments. Medicaid EHR incentive payments are fully funded by the federal government and administered by the states; however, the states are not required to offer EHR incentive payments to providers.

During the three months ended March 31, 2012, the Company recognized approximately $26.2 million of incentive reimbursement for HITECH incentives from Medicaid related to certain of the Company’s hospitals and from Medicare and Medicaid for certain of the Company’s employed physicians that have demonstrated meaningful use of certified EHR technology or have completed attestations to their adoption or implementation of certified EHR technology. These incentive reimbursements were presented as a reduction of operating expenses on the condensed consolidated statement of income. The Company received approximately $5.8 million of cash related to the incentive reimbursement for HITECH incentives during the three months ended March 31, 2012. No incentive reimbursements were recognized during the three months ended March 31, 2011.

Reimbursement Settlements. Included in net operating revenues on a non-same store basis is approximately $101.8 million of net operating revenue from an industry-wide settlement with the United States Department of Health and Human Services and Centers for Medicare and Medicaid Services, based on a claim that acute-care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system in federal fiscal years 1999 through 2011. The underpayments resulted from calculations related to the rural floor budget neutrality adjustments implemented in connection with the Balanced Budget Act of 1997. Also included is an unfavorable adjustment of approximately $21.0 million related to the newly issued Supplemental Security Income ratios for federal fiscal years 2006 through 2009 utilized for calculating Medicare Disproportionate Share Hospital reimbursements.

Throughout these notes to the condensed consolidated financial statements, Community Health Systems, Inc. (the “Parent”), and its consolidated subsidiaries are referred to on a collective basis as the “Company.” This drafting style is not meant to indicate that the publicly-traded Parent or any subsidiary of the Parent owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

2. ACCOUNTING FOR STOCK-BASED COMPENSATION

Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and Restated 2000 Stock Option and Award Plan, amended and restated as of March 24, 2009 (the “2000 Plan”), and the Community Health Systems, Inc. 2009 Stock Option and Award Plan, amended and restated as of March 18, 2011 (the “2009 Plan”).

7

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The 2000 Plan allows for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code (the “IRC”), as well as stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Prior to being amended in 2009, the 2000 Plan also allowed for the grant of phantom stock. Persons eligible to receive grants under the 2000 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2000 Plan have been “nonqualified” stock options for tax purposes. Generally, vesting of these granted options occurs in one-third increments on each of the first three anniversaries of the award date. Options granted prior to 2005 have a 10-year contractual term, options granted in 2005 through 2007 have an eight-year contractual term and options granted in 2008 or later have a 10-year contractual term. As of March 31, 2012, 446,221 shares of unissued common stock were reserved for future grants under the 2000 Plan.

The 2009 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the IRC and for the grant of stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Persons eligible to receive grants under the 2009 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2009 Plan have been “nonqualified” stock options for tax purposes. Options granted in 2011 have a 10-year contractual term. As of March 31, 2012, 1,529,549 shares of unissued common stock were reserved for future grants under the 2009 Plan.

The exercise price of all options granted is equal to the fair value of the Company’s common stock on the option grant date.

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Effect on income from continuing operations before income taxes	$	(10,495	)	$	(9,918	)
Effect on net income	$	(6,664	)	$	(6,298	)

At March 31, 2012, $64.9 million of unrecognized stock-based compensation expense was expected to be recognized over a weighted-average period of 23 months. Of that amount, $13.1 million related to outstanding unvested stock options was expected to be recognized over a weighted-average period of 23 months and $51.8 million related to outstanding unvested restricted stock, restricted stock units and phantom shares was expected to be recognized over a weighted-average period of 24 months. There were no modifications to awards during the three months ended March 31, 2012.

The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three months ended March 31, 2012 and 2011:

	Three Months Ended
	March 31,
	2012			2011
Expected volatility		57.7	%		31.2	%
Expected dividends		—			—
Expected term		4.1 years			4 years
Risk-free interest rate		0.7	%		1.7	%

8

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

In determining the expected term, the Company examined concentrations of option holdings and historical patterns of option exercises and forfeitures, as well as forward-looking factors, in an effort to determine if there were any discernable employee populations. From this analysis, the Company identified two primary employee populations, one consisting of certain senior executives and the other consisting of substantially all other recipients.

The expected volatility rate was estimated based on historical volatility. In determining expected volatility, the Company also reviewed the market-based implied volatility of actively traded options of its common stock and determined that historical volatility utilized to estimate the expected volatility rate did not differ significantly from the implied volatility.

The expected term computation is based on historical exercise and cancellation patterns and forward-looking factors, where present, for each population identified. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting forfeiture rate is based on historical rates and forward-looking factors for each population identified. The Company adjusts the estimated forfeiture rate to its actual experience.

Options outstanding and exercisable under the 2000 Plan and the 2009 Plan as of March 31, 2012, and changes during the three-month period following December 31, 2011, were as follows (in thousands, except share and per share data):

						Weighted - Average
				Weighted -				Aggregate
				Average		Remaining		Intrinsic
				Exercise		Contractual		Value as of
	Shares			Price		Term		March 31, 2012
Outstanding at December 31, 2011		8,389,142		$	32.83
Granted		246,500			21.07
Exercised		(17,244	)		17.88
Forfeited and cancelled		(130,475	)		32.27
Outstanding at March 31, 2012		8,487,923		$	32.53		5.2 years	$	5,244
Exercisable at March 31, 2012		6,802,639		$	32.56		4.3 years	$	4,329

The weighted-average grant date fair value of stock options granted during the three months ended March 31, 2012 and 2011 was $9.15 and $10.34, respectively. The aggregate intrinsic value (the number of in-the-money stock options multiplied by the difference between the Company’s closing stock price on the last trading day of the reporting period ($22.24) and the exercise price of the respective stock options) in the table above represents the amount that would have been received by the option holders had all option holders exercised their options on March 31, 2012. This amount changes based on the market value of the Company’s common stock. The aggregate intrinsic value of options exercised during the three months ended March 31, 2012 and 2011 was $0.1 million and $5.9 million, respectively. The aggregate intrinsic value of options vested and expected to vest approximates that of the outstanding options.

The Company has also awarded restricted stock under the 2000 Plan and the 2009 Plan to its directors and employees of certain subsidiaries. The restrictions on these shares generally lapse in one-third increments on each of the first three anniversaries of the award date. Certain of the restricted stock awards granted to the Company’s senior executives contain a performance objective that must be met in addition to any vesting requirements. If the performance objective is not attained, the awards will be forfeited in their entirety. Once the performance objective has been attained, restrictions will lapse in one-third increments on each of the first three anniversaries of the award date. Notwithstanding the above-mentioned performance objectives and vesting requirements, the restrictions will lapse earlier in the event of death, disability or termination of employment by the Company for any reason other than for cause of the holder of the restricted stock, or change in control of the Company. Restricted stock awards subject to performance standards are not considered outstanding for purposes of determining earnings per share until the performance objectives have been satisfied.

9

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of March 31, 2012, and changes during the three-month period following December 31, 2011, were as follows:

				Weighted -
				Average
				Grant Date
	Shares			Fair Value
Unvested at December 31, 2011		2,207,612		$	32.95
Granted		660,500			21.07
Vested		(1,082,821	)		29.67
Forfeited		(1,000	)		37.96
Unvested at March 31, 2012		1,784,291			30.54

Phantom stock and restricted stock units (“RSUs”) have been granted to the Company’s outside directors under the 2000 Plan and the 2009 Plan. On February 25, 2009, each of the Company’s outside directors received a grant under the 2000 Plan of 7,151 shares of phantom stock. On May 19, 2009, the newly elected outside director received a grant under the 2000 Plan of 7,151 RSUs. On February 24, 2010, six of the Company’s seven outside directors each received a grant under the 2000 Plan of 4,130 RSUs and one outside director, who did not stand for reelection in 2010, did not receive such a grant. On February 23, 2011, each of the Company’s outside directors received a grant under the 2009 Plan of 3,688 RSUs. On February 16, 2012, each of the Company’s outside directors received a grant under the 2009 Plan of 6,645 RSUs. Vesting of these shares of phantom stock and RSUs occurs in one-third increments on each of the first three anniversaries of the award date.

				Weighted -
				Average
				Grant Date
				Fair
	Shares			Value
Unvested at December 31, 2011		52,956		$	31.67
RSUs Granted February 16, 2012		39,870			21.07
Vested		(27,556	)		28.19
Forfeited		—			—
Unvested at March 31, 2012		65,270			26.67

10

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Under the Directors’ Fees Deferral Plan, the Company’s outside directors may elect to receive share equivalent units in lieu of cash for their directors’ fees. These share equivalent units are held in the plan until the director electing to receive the share equivalent units retires or otherwise terminates his/her directorship with the Company. Share equivalent units are converted to shares of common stock of the Company at the time of distribution based on the closing market price of the Company’s common stock on that date. The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

	Three Months Ended
	March 31,
	2012		2011
Directors’ fees earned and deferred into plan	$	28	$	55
Share equivalent units		1,237		1,375

At March 31, 2012, a total of 30,012 share equivalent units were deferred in the plan with an aggregate fair value of $0.7 million, based on the closing market price of the Company’s common stock at March 31, 2012 of $22.24.

3. COST OF REVENUE

Substantially all of the Company’s operating costs and expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $47.6 million and $41.7 million for the three months ended March 31, 2012 and 2011, respectively. Included in these amounts is stock-based compensation expense of $10.5 million and $9.9 million for the three months ended March 31, 2012 and 2011, respectively.

4. USE OF ESTIMATES

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Actual results could differ from these estimates under different assumptions or conditions.

5. ACQUISITIONS AND DIVESTITURES

Acquisitions

The Company accounts for all transactions that represent business combinations after January 1, 2009 using the acquisition method of accounting, where the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquired entity are recognized and measured at their fair values on the date the Company obtains control in the acquiree. Such fair values that are not finalized for reporting periods following the acquisition date are estimated and recorded as provisional amounts. Adjustments to these provisional amounts during the measurement period (defined as the date through which all information required to identify and measure the consideration transferred, the assets acquired, the liabilities assumed and any noncontrolling interests has been obtained, limited to one year from the acquisition date) are recorded as of the date of acquisition. Any material impact to comparative information for periods after acquisition, but before the period in which adjustments are identified, is reflected in those prior periods as if the adjustments were considered as of the acquisition date. Goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired.

11

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Effective March 5, 2012, one or more subsidiaries of the Company completed a merger with Diagnostic Clinic of Longview, P.A., which is a multi-specialty clinic serving residents of Longview, Texas and surrounding East Texas communities. This merger was accounted for as a purchase business combination. The total cash consideration paid for the business, including net working capital, was approximately $52.3 million, with additional consideration of $12.0 million assumed in liabilities, for a total consideration of $64.3 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, approximately $41.8 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective March 1, 2012, one or more subsidiaries of the Company completed the acquisition of MetroSouth Medical Center (330 licensed beds) located in Blue Island, Illinois. The total cash consideration paid for fixed assets was approximately $39.3 million with additional consideration of $12.1 million assumed in liabilities as well as a credit applied at closing of $0.9 million for negative acquired working capital, for a total consideration of $50.5 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, no goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective January 1, 2012, one or more subsidiaries of the Company completed the acquisition of Moses Taylor Healthcare System based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals and other healthcare providers. This healthcare system includes Moses Taylor Hospital (217 licensed beds) located in Scranton, Pennsylvania, and Mid-Valley Hospital (25 licensed beds) located in Peckville, Pennsylvania. The total cash consideration paid for fixed assets and working capital was approximately $151.1 million and $9.2 million, respectively, with additional consideration of $12.1 million assumed in liabilities, for a total consideration of $172.4 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, approximately $55.2 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective October 1, 2011, one or more subsidiaries of the Company completed the acquisition of Tomball Regional Hospital (358 licensed beds) located in Tomball, Texas. The total cash consideration paid for fixed assets and working capital was approximately $192.0 million and $17.5 million, respectively, with additional consideration of $15.9 million assumed in liabilities, for a total consideration of $225.4 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, approximately $32.4 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective May 1, 2011, one or more subsidiaries of the Company completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.8 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $161.0 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of March 31, 2012, approximately $43.1 million of goodwill has been recorded.

Additionally, during the three months ended March 31, 2012, the Company paid approximately $5.9 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $1.5 million of the consideration paid to property and equipment, $0.3 million to net working capital, and the remainder, approximately $4.1 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

12

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Approximately $4.3 million and $3.3 million of acquisition costs related to prospective and closed acquisitions were expensed during the three months ended March 31, 2012 and 2011, respectively.

Discontinued Operations

Effective February 1, 2011, the Company sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group, located in Springfield, Oregon, to Oregon Healthcare Resources, LLC, for $14.6 million in cash; this business had a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million.

Effective September 1, 2011, the Company sold SouthCrest Hospital, located in Tulsa, Oklahoma, Claremore Regional Hospital, located in Claremore, Oklahoma, and other related healthcare assets affiliated with those hospitals to Hillcrest Healthcare System, part of Ardent Health Services, for approximately $154.2 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $193.0 million.

Effective October 22, 2011, the Company sold Cleveland Regional Medical Center, located in Cleveland, Texas, and other related healthcare assets affiliated with the hospital to New Directions Health Systems, LLC for approximately $0.9 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $14.2 million.

The Company has classified the results of operations for Oregon Medical Group, SouthCrest Hospital, Claremore Regional Hospital and Cleveland Regional Hospital as discontinued operations in the accompanying condensed consolidated statements of income for the three months ended March 31, 2012 and 2011.

Net operating revenues and loss from discontinued operations for the respective periods are as follows (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Net operating revenues	$	—		$	59,126
Loss from operations of entities sold before income taxes		(729	)		(2,673	)
Impairment of hospitals sold		—			(13,095	)
Loss on sale, net		—			(5,061	)
Loss from discontinued operations, before taxes		(729	)		(20,829	)
Income tax benefit		263			7,549
Loss from discontinued operations, net of taxes	$	(466	)	$	(13,280	)

Interest expense was allocated to discontinued operations based on sale proceeds available for debt repayment.

6. INCOME TAXES

The total amount of unrecognized benefit that would affect the effective tax rate, if recognized, was approximately $2.0 million as of March 31, 2012. During the three months ended March 31, 2012, the Company increased liabilities for uncertain tax positions by $1.0 million and increased interest and penalties by approximately $0.2 million. A total of approximately $0.5 million of interest and penalties is included in the amount of the liability for uncertain tax positions at March 31, 2012. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its condensed consolidated statements of income as income tax expense.

It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, the Company does not anticipate the change will have a material impact on its consolidated results of operations or consolidated financial position.

13

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction and various state jurisdictions. The Company has extended the federal statute of limitations for Triad Hospitals, Inc. (“Triad”) for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The Internal Revenue Service (the “IRS”) has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. With few exceptions, the Company is no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. The Company’s federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position. In connection with the Company’s 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of the Company’s malpractice expense deductions. Management believes that the Company’s deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of the Company’s deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.

Cash paid for income taxes, net of refunds received, resulted in a net cash refund of $0.1 million and $0.7 million for the three months ended March 31, 2012 and 2011, respectively.

7. GOODWILL AND OTHER INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for the three months ended March 31, 2012, are as follows (in thousands):

Balance as of December 31, 2011	$	4,264,845
Goodwill acquired as part of acquisitions during 2012		101,097
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		1,899
Balance as of March 31, 2012	$	4,367,841

Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At March 31, 2012, the hospital operations reporting unit, the home care agency operations reporting unit, and the hospital management services reporting unit had approximately $4.3 billion, $40.5 million and $33.3 million, respectively, of goodwill.

Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2011, which evaluation took place during the fourth quarter of 2011. No impairment was indicated by this evaluation.

The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.

The gross carrying amount of the Company’s other intangible assets subject to amortization was $62.6 million at March 31, 2012 and $60.0 million at December 31, 2011, and the net carrying amount was $31.5 million at March 31, 2012 and $30.6 million at December 31, 2011. The carrying amount of the Company’s other intangible assets not subject to amortization was $47.3 million at March 31, 2012 and $46.9 million at December 31, 2011. Other intangible assets are included in other assets, net on the Company’s condensed consolidated balance sheets. Substantially all of the Company’s intangible assets are contract-based intangible assets related to operating licenses, management contracts, or non-compete agreements entered into in connection with prior acquisitions.

14

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The weighted-average amortization period for the intangible assets subject to amortization is approximately eight years. There are no expected residual values related to these intangible assets. Amortization expense on these intangible assets was $1.6 million and $1.9 million during the three months ended March 31, 2012 and 2011, respectively. Amortization expense on intangible assets is estimated to be $6.2 million for the remainder of 2012, $5.4 million in 2013, $3.5 million in 2014, $3.1 million in 2015, $2.4 million in 2016, $2.2 million in 2017 and $8.7 million thereafter.

The gross carrying amount of capitalized software for internal use was approximately $486.3 million and $451.0 million at March 31, 2012 and December 31, 2011, respectively, and the net carrying amount considering accumulated amortization was approximately $256.3 million and $241.3 million at March 31, 2012 and December 31, 2011, respectively. The estimated amortization period for capitalized internal-use software is generally three years, except for capitalized costs related to significant system conversions, which is generally eight years. There is no expected residual value for capitalized internal-use software. At March 31, 2012, there was approximately $152.8 million of capitalized costs for internal-use software that is currently in the development stage and will begin amortization once the software project is complete and ready for its intended use. Amortization expense on capitalized internal-use software was $19.7 million and $17.9 million during the three months ended March 31, 2012 and 2011, respectively. Amortization expense on capitalized internal-use software is estimated to be $68.6 million for the remainder of 2012, $85.6 million in 2013, $41.2 million in 2014, $19.1 million in 2015, $16.4 million in 2016, $12.9 million in 2017 and $12.5 million thereafter.

8. EARNINGS PER SHARE

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Three Months Ended
	March 31,
	2012			2011
Numerator:
Income from continuing operations, net of taxes	$	99,718		$	91,605
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		23,778			17,001
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	75,940		$	74,604
Loss from discontinued operations, net of taxes	$	(466	)	$	(13,280	)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes		—			—
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	(466	)	$	(13,280	)
Denominator:
Weighted-average number of shares outstanding — basic		88,674,779			91,008,405
Effect of dilutive securities:
Restricted stock awards		21,233			253,866
Employee stock options		147,440			865,691
Other equity-based awards		9,252			8,857
Weighted-average number of shares outstanding — diluted		88,852,704			92,136,819
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options		6,869,031			4,395,292

15

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

9. STOCKHOLDERS’ EQUITY

Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of 300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the aforementioned classes of capital stock has a par value of $0.01 per share. Shares of preferred stock, none of which were outstanding as of March 31, 2012, may be issued in one or more series having such rights, preferences and other provisions as determined by the Board of Directors without approval by the holders of common stock.

On December 14, 2011, the Company adopted a new open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. The new repurchase program will conclude at the earliest of three years, when the maximum number of shares has been repurchased, or when the maximum dollar amount of repurchases has been expended. Through March 31, 2012, no shares have been purchased and retired under this program.

On September 15, 2010, the Company commenced an open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount of repurchases has been expended. During the three months ended March 31, 2012 and 2011, the Company did not repurchase any shares under this program. The cumulative number of shares that have been repurchased and retired under this program through March 31, 2012 is 3,921,138 shares at a weighted-average price of $25.39 per share.

The Company’s Credit Facility (as discussed below) limits the Company’s ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate plus the aggregate amount of proceeds from the exercise of stock options. The indentures governing the 8 ⁷/8% Senior Notes due 2015 and the 8% Senior Notes due 2019 (collectively, the “Senior Notes”) also limit the Company’s ability to pay dividends and/or repurchase stock. As of March 31, 2012, under the most restrictive test under these agreements, the Company has approximately $80.4 million remaining available with which to pay permitted dividends and/or repurchase shares of stock or its Senior Notes.

16

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The following schedule presents the reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests for the three-month period ended March 31, 2012 (in thousands):

				Community Health Systems, Inc. Stockholders
													Accumulated
	Redeemable						Additional						Other								Total
	Noncontrolling			Common			Paid-in			Treasury			Comprehensive			Retained		Noncontrolling			Stockholders’
	Interests			Stock			Capital			Stock			Income (Loss)			Earnings		Interests			Equity
Balance, December 31, 2011	$	395,743		$	915		$	1,086,008		$	(6,678	)	$	(184,479	)	$	1,501,330	$	67,349		$	2,464,445
Comprehensive income		17,599			—			—			—			14,343			75,474		6,179			95,996
Distributions to noncontrolling interests, net of contributions		(15,904	)		—			—			—			—			—		(11,019	)		(11,019	)
Purchase of subsidiary shares from noncontrolling interests		(12,285	)		—			(18,673	)		—			—			—		(138	)		(18,811	)
Other reclassifications of noncontrolling interests		623			—			—			—			—			—		(623	)		(623	)
Adjustment to redemption value of redeemable noncontrolling interests		(22,236	)		—			22,236			—			—			—		—			22,236
Repurchase of common stock		—			—			—			—			—			—		—			—
Issuance of common stock in connection with the exercise of stock options		—			—			308			—			—			—		—			308
Cancellation of restricted stock for tax withholdings on vested shares		—			(3	)		(9,032	)		—			—			—		—			(9,035	)
Excess tax benefit from exercise of stock options		—			—			(1,895	)		—			—			—		—			(1,895	)
Share-based compensation		—			7			10,495			—			—			—		—			10,502
Balance, March 31, 2012	$	363,540		$	919		$	1,089,447		$	(6,678	)	$	(170,136	)	$	1,576,804	$	61,748		$	2,552,104

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Three Months Ended March 31, 2012
Net income attributable to Community Health Systems, Inc.	$	75,474
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(18,673	)
Net transfers to the noncontrolling interests		(18,673	)
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	$	56,801

17

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

10. EQUITY INVESTMENTS

As of March 31, 2012, the Company owned equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one hospital in Las Vegas, Nevada, in which Universal Health Systems, Inc. owns the majority interest, and an equity interest of 38.0% in three hospitals in Macon, Georgia, in which HCA Inc. owns the majority interest.

Summarized combined financial information for the three months ended March 31, 2012 and 2011, for these unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	Three Months Ended
	March 31
	2012		2011
Revenues	$	317,317	$	320,840
Operating costs and expenses	$	277,256	$	266,236
Income from continuing operations before taxes	$	40,035	$	54,584

The summarized financial information for the three months ended March 31, 2012 and 2011 was derived from the unaudited financial information provided to the Company by those unconsolidated entities.

The Company’s investment in all of its unconsolidated affiliates was $431.9 million and $422.2 million at March 31, 2012 and December 31, 2011, respectively, and is included in other assets, net in the accompanying condensed consolidated balance sheets. Included in the Company’s results of operations is the Company’s equity in pre-tax earnings from all of its investments in unconsolidated affiliates, which was $12.0 million and $18.1 million for the three months ended March 31, 2012 and 2011, respectively.

11. LONG-TERM DEBT

Long-term debt consists of the following (in thousands):

	March 31,			December 31,
	2012			2011
Credit Facility:
Term loan A	$	750,000		$	—
Term loan B		5,219,062			5,949,383
Revolving credit loans		—			30,000
8 7/8% Senior Notes due 2015		931,016			1,777,617
8% Senior Notes due 2019		2,024,694			1,000,000
Receivables Facility		300,000			—
Capital lease obligations		48,767			48,361
Other		45,465			41,143
Total debt		9,319,004			8,846,504
Less current maturities		(75,388	)		(63,706	)
Total long-term debt	$	9,243,616		$	8,782,798

18

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Credit Facility

In connection with the consummation of the acquisition of Triad in July 2007, the Company’s wholly-owned subsidiary CHS/Community Health Systems, Inc. (“CHS”) obtained approximately $7.2 billion of senior secured financing under a new credit facility (the “Credit Facility”) with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent, and issued approximately $3.0 billion aggregate principal amount of 8 ⁷/8% senior notes due 2015 (the “ 8 ⁷/8% Senior Notes”). The Company used the net proceeds of $3.0 billion from the 8 ⁷/8% Senior Notes offering and the net proceeds of approximately $6.1 billion of term loans under the Credit Facility to acquire the outstanding shares of Triad, to refinance certain of Triad’s indebtedness and the Company’s indebtedness, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. Specifically, the Company repaid its outstanding debt under the previously outstanding credit facility, the 6.50% senior subordinated notes due 2012 and certain of Triad’s existing indebtedness.

The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $400 million delayed draw term loan facility with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million delayed draw term loan facility had been reduced to $300 million at the request of CHS. During the fourth quarter of 2008, $100 million of the delayed draw term loan was drawn by CHS, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, CHS drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans.

On November 5, 2010, CHS entered into an amendment and restatement of the Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of the existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of the 8 ⁷/8% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increased CHS’s ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permitted CHS to issue term loan A loans under the incremental facility, and provided up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which $1.7 billion would be required to be used for repayment of existing term loans. In addition, effective February 2, 2012, the Company completed the second amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

Effective March 6, 2012, the Company obtained a new $750 million senior secured revolving credit facility (the “Replacement Revolver Facility”) and a new $750 million incremental term loan A facility (the “Incremental Term Loan”) subject to the terms and conditions set forth in the Credit Facility. The Replacement Revolver Facility replaced in full the existing revolving credit facility under the Credit Facility. The net proceeds of the Incremental Term Loan were used to repay the same amount of the existing term loans under the Credit Facility. The execution of these agreements resulted in a loss from early extinguishment of debt of $8.5 million with an after-tax impact of $5.3 million recorded in continuing operations for the three months ended March 31, 2012. Both the Replacement Revolver Facility and the Incremental Term Loan have a maturity date of October 25, 2016, subject to customary acceleration events and to the repayment, extension or refinancing with longer maturity debt of substantially all of the Company’s outstanding term loans maturing July 25, 2014, and 8 ⁷/8% Senior Notes due 2015. The pricing on each of the Replacement Revolver Facility and the Incremental Term Loan initially is LIBOR plus a margin of 250 basis points, subject to adjustment based on the Company’s leverage ratio. The Incremental Term Loan amortizes at 5% in year one, 10% in years two and three, 15% in year four and 60% in year five.

The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

19

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The obligor under the Credit Facility is CHS. All of the obligations under the Credit Facility are unconditionally guaranteed by the Company and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of the Company, CHS and each subsidiary guarantor, including equity interests held by the Company, CHS or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for revolving loans is 1.50% for Alternate Base Rate revolving loans and 2.50% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

CHS has agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. CHS is obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon the Company’s leverage ratio) on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, CHS was also obligated to pay commitment fees of 0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum. In each case, the commitment fee was paid on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, CHS no longer pays any commitment fees for the delayed draw term loan facility. CHS paid arrangement fees on the closing of the 2007 Credit Facility and pays an annual administrative agent fee.

The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting the Company’s and its subsidiaries’ ability, subject to certain exceptions, to, among other things (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the Company’s businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the Company’s fiscal year. The Company is also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

Events of default under the Credit Facility include, but are not limited to, (1) CHS’s failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

As of March 31, 2012, the availability for additional borrowings under the Credit Facility was $750 million pursuant to the Replacement Revolver Facility, of which $37.7 million was set aside for outstanding letters of credit. CHS has the ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, which CHS has not yet accessed. As of March 31, 2012, the weighted-average interest rate under the Credit Facility, excluding swaps, was 3.4%.

20

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

8 ⁷/8% Senior Notes due 2015

The 8 ⁷/8% Senior Notes were issued by CHS in connection with the Triad acquisition in the principal amount of approximately $3.0 billion. The 8 ⁷/8% Senior Notes will mature on July 15, 2015. The 8 ⁷/8% Senior Notes bear interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July 15, commencing January 15, 2008. Interest on the 8 ⁷/8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

On December 7, 2011, CHS completed the cash tender offer for $1.0 billion of the then $2.8 billion aggregate outstanding principal amount of 8 ⁷/8% Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $66.0 million with an after-tax impact of $42.0 million recorded in continuing operations for the year ended December 31, 2011.

On March 21, 2012, CHS completed the cash tender offer for $850 million of the then $1.8 billion aggregate outstanding principal amount of 8 ⁷/8% Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $54.9 million with an after-tax impact of $34.3 million recorded in continuing operations for the three months ended March 31, 2012.

After July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the 8 ⁷/8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	Redemption Price
2011		104.438	%
2012		102.219	%
2013 and thereafter		100.000	%

Pursuant to a registration rights agreement entered into at the time of the issuance of the 8 ⁷/8% Senior Notes, as a result of an exchange offer made by CHS, substantially all of the 8 ⁷/8% Senior Notes issued in July 2007 were exchanged in November 2007 for new notes (the “Exchange Notes”) having terms substantially identical in all material respects to the 8 ⁷/8% Senior Notes (except that the Exchange Notes were issued under a registration statement pursuant to the 1933 Act). References to the 8 ⁷/8% Senior Notes shall also be deemed to include the Exchange Notes unless the context provides otherwise.

8% Senior Notes due 2019

On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 (the “8% Senior Notes”), which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of $1.0 billion aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015 and related fees and expenses. On March 21, 2012, CHS completed the secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019, which were issued in a private placement (at a premium of 102.5%). The net proceeds from this issuance were used to finance the purchase of $850 million aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015, to pay related fees and expenses and for general corporate purposes. The 8% Senior Notes bear interest at 8% per annum, payable semiannually in arrears on May 15 and November 15, commencing May 15, 2012. Interest on the 8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

Except as set forth below, CHS is not entitled to redeem the 8% Senior Notes prior to November 15, 2015.

On and after November 15, 2015, CHS is entitled, at its option, to redeem all or a portion of the 8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on November 15 of the years set forth below:

Period	Redemption Price
2015		104.000	%
2016		102.000	%
2017 and thereafter		100.000	%

21

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Receivables Facility

On March 21, 2012, the Company and certain of its subsidiaries entered into an accounts receivables loan agreement (the “Receivables Facility”) with a group of conduit lenders and liquidity banks, Credit Agricolé Corporate and Investment Bank, as a managing agent and as the administrative agent, and The Bank of Nova Scotia, as a managing agent. The existing and future patient-related accounts receivable (the “Receivables”) for certain of the Company’s hospitals serve as collateral for the outstanding borrowings under the Receivables Facility. The interest rate on the borrowings is based on the commercial paper rate plus an applicable interest rate spread. Unless earlier terminated or subsequently extended pursuant to its terms, the Receivables Facility will expire on March 21, 2014, subject to customary termination events that could cause an early termination date. The Company maintains effective control over the Receivables because, pursuant to the terms of the Receivables Facility, the Receivables are sold from certain of the Company’s subsidiaries to the Company, which then sells or contributes the Receivables to a special-purpose entity that is wholly-owned by the Company. The wholly-owned special-purpose entity in turn grants security interests in the Receivables in exchange for borrowings obtained from the group of third-party conduit lenders and liquidity banks of up to $300 million outstanding from time to time based on the availability of eligible Receivables and other customary factors. The group of third-party conduit lenders and liquidity banks do not have recourse to the Company or its subsidiaries beyond the assets of the wholly-owned special-purpose entity that collateralizes the loan. The Receivables and other assets of the wholly-owned special-purpose entity will be available first and foremost to satisfy the claims of the creditors of such entity. The outstanding borrowings pursuant to the Receivables Facility at March 31, 2012 totaled $300.0 million and are classified as long-term debt on the condensed consolidated balance sheet. At March 31, 2012, the carrying amount of Receivables included in the Receivables Facility totaled approximately $881.9 million and are included in patient accounts receivable on the condensed consolidated balance sheet.

The Company paid interest of $161.1 million and $226.1 million on borrowings during the three months ended March 31, 2012 and 2011, respectively.

12. FAIR VALUE OF FINANCIAL INSTRUMENTS

The fair value of financial instruments has been estimated by the Company using available market information as of March 31, 2012 and December 31, 2011, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

	March 31, 2012				December 31, 2011
	Carrying		Estimated Fair		Carrying		Estimated Fair
	Amount		Value		Amount		Value
Assets:
Cash and cash equivalents	$	129,298	$	129,298	$	129,865	$	129,865
Available-for-sale securities		34,354		34,354		31,582		31,582
Trading securities		35,944		35,944		30,486		30,486
Liabilities:
Credit Facility		5,969,062		5,894,354		5,979,383		5,780,877
8 7/8% Senior Notes		931,016		968,200		1,777,617		1,842,322
8% Senior Notes		2,024,694		2,067,500		1,000,000		995,000
Other debt		345,465		345,465		41,143		41,143

The estimated fair value is determined using the methodologies discussed below in accordance with accounting standards related to the determination of fair value based on the U.S. GAAP fair value hierarchy as discussed in Note 13. The estimated fair value for financial instruments with a fair value that does not equal its carrying value is considered a Level 2 valuation. The Company utilizes the market approach and obtains indicative pricing from the administrative agent to our Credit Facility to determine fair values, which are validated through subscription services such as Bloomberg where relevant.

Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

Trading securities. Estimated fair value is based on closing price as quoted in public markets.

22

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

8  ⁷/8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the three months ended March 31, 2012 and 2011, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at March 31, 2012, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

23

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Interest rate swaps consisted of the following at March 31, 2012:

								Fair Value
	Notional Amount		Fixed Interest			Termination		of Liability
Swap #	(in 000’s)		Rate			Date		(in 000’s)
1	$	250,000		5.0185	%		May 30, 2012	$	1,845
2		150,000		5.0250	%		May 30, 2012		1,108
3		200,000		4.6845	%		September 11, 2012		3,750
4		100,000		3.3520	%		October 23, 2012		1,607
5		125,000		4.3745	%		November 23, 2012		3,140
6		75,000		4.3800	%		November 23, 2012		1,886
7		150,000		5.0200	%		November 30, 2012		4,524
8		200,000		2.2420	%		February 28, 2013		3,170
9		100,000		5.0230	%		May 30, 2013		5,218
10		300,000		5.2420	%		August 6, 2013		18,940
11		100,000		5.0380	%		August 30, 2013		6,320
12		50,000		3.5860	%		October 23, 2013		2,350
13		50,000		3.5240	%		October 23, 2013		2,303
14		100,000		5.0500	%		November 30, 2013		7,377
15		200,000		2.0700	%		December 19, 2013		5,130
16		100,000		5.2310	%		July 25, 2014		10,301
17		100,000		5.2310	%		July 25, 2014		10,302
18		200,000		5.1600	%		July 25, 2014		20,287
19		75,000		5.0405	%		July 25, 2014		7,405
20		125,000		5.0215	%		July 25, 2014		12,289
21		100,000		2.6210	%		July 25, 2014		4,453
22		100,000		3.1100	%		July 25, 2014		5,550
23		100,000		3.2580	%		July 25, 2014		5,881
24		200,000		2.6930	%		October 26, 2014		9,962
25		300,000		3.4470	%		August 8, 2016		27,989
26		200,000		3.4285	%		August 19, 2016		18,576
27		100,000		3.4010	%		August 19, 2016		9,185
28		200,000		3.5000	%		August 30, 2016		19,200
29		100,000		3.0050	%		November 30, 2016		7,691

24

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the condensed consolidated statement of financial position. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.

Assuming no change in March 31, 2012 interest rates, approximately $111.0 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings.

The following tabular disclosure provides the amount of pre-tax (loss) gain recognized in the condensed consolidated balance sheets as a component of OCI during the three months ended March 31, 2012 and 2011 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Amount of Pre-Tax (Loss) Gain Recognized in OCI on Derivative (Effective Portion)
	Three Months Ended March 31,
	2012			2011
Interest rate swaps	$	(23,122	)	$	4,113

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the condensed consolidated statements of income during the three months ended March 31, 2012 and 2011 (in thousands):

Location of Loss Reclassified from AOCL into Income (Effective Portion)	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)
	Three Months Ended March 31,
	2012		2011
Interest expense, net	$	39,610	$	52,923

The fair values of derivative instruments in the condensed consolidated balance sheets as of March 31, 2012 and December 31, 2011 were as follows (in thousands):

	0000000		0000000	0000000		0000000	0000000		0000000	0000000		0000000
	Asset Derivatives						Liability Derivatives
	March 31, 2012			December 31, 2011			March 31, 2012			December 31, 2011
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments	Other assets, net	$	—	Other assets, net	$	—	Other long- term liabilities	$	237,739	Other long- term liabilities	$	254,228

25

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

13. FAIR VALUE

Fair Value Hierarchy

Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, the Company utilizes the U.S. GAAP fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumption about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The inputs used to measure fair value are classified into the following fair value hierarchy:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes values determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions.

In instances where the determination of the fair value hierarchy measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment of factors specific to the asset or liability.

The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of March 31, 2012 and December 31, 2011 (in thousands):

		000000000		000000000		000000000		000000000
	March 31,
	2012		Level 1		Level 2		Level 3
Available-for-sale securities	$	34,354	$	34,354	$	—	$	—
Trading securities		35,944		35,944		—		—
Total assets	$	70,298	$	70,298	$	—	$	—
Fair value of interest rate swap agreements	$	237,739	$	—	$	237,739	$	—
Total liabilities	$	237,739	$	—	$	237,739	$	—
	December 31, 2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,582	$	31,582	$	—	$	—
Trading securities		30,486		30,486		—		—
Total assets	$	62,068	$	62,068	$	—	$	—
Fair value of interest rate swap agreements	$	254,228	$	—	$	254,228	$	—
Total liabilities	$	254,228	$	—	$	254,228	$	—

26

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices.

The valuation of the Company’s interest rate swap agreements is determined using market valuation techniques, including discounted cash flow analysis on the expected cash flows of each agreement. This analysis reflects the contractual terms of the agreement, including the period to maturity, and uses observable market-based inputs, including forward interest rate curves. The fair value of interest rate swap agreements are determined by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates based on observable market forward interest rate curves and the notional amount being hedged.

The Company incorporates CVAs to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. The CVA on the Company’s interest rate swap agreements at March 31, 2012 resulted in a decrease in the fair value of the related liability of $12.6 million and an after-tax adjustment of $8.1 million to OCI. The CVA on the Company’s interest rate swap agreements at December 31, 2011 resulted in a decrease in the fair value of the related liability of $21.7 million and an after-tax adjustment of $13.9 million to OCI.

The majority of the inputs used to value its interest rate swap agreements, including the forward interest rate curves and market perceptions of the Company’s credit risk used in the CVAs, are observable inputs available to a market participant. As a result, the Company has determined that the interest rate swap valuations are classified in Level 2 of the fair value hierarchy.

14. RECENT ACCOUNTING PRONOUNCEMENTS

In September 2011, the FASB issued ASU 2011-08, which modifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. This ASU is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and was adopted by the Company on January 1, 2012. The adoption of this ASU did not impact the Company’s consolidated financial position, results of operations or cash flows.

15. SEGMENT INFORMATION

The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.

27

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The distribution between reportable segments of the Company’s revenues and income from continuing operations before income taxes is summarized in the following tables (in thousands):

	Three Months Ended March 31,
	2012			2011
Revenues:
Hospital operations	$	3,223,098		$	2,884,330
Corporate and all other		73,937			69,753
Total	$	3,297,035		$	2,954,083
Income from continuing operations before income taxes:
Hospital operations	$	200,308		$	178,113
Corporate and all other		(54,771	)		(42,416	)
Total	$	145,537		$	135,697

16. CONTINGENCIES

The Company is a party to various legal proceedings incidental to its business. In the opinion of management, any ultimate liability with respect to these actions will not have a material adverse effect on the Company’s consolidated financial position, cash flows or results of operations. With respect to all litigation matters, the Company considers the likelihood of a negative outcome. If the Company determines the likelihood of a negative outcome is probable and the amount of the loss can be reasonably estimated, the Company records an estimated loss for the expected outcome of the litigation and discloses that fact together with the amount accrued, if it was estimable. If the likelihood of a negative outcome is reasonably possible and the Company is able to determine an estimate of the possible loss or a range of loss, the Company discloses that fact together with the estimate of the possible loss or range of loss. However, it is difficult to predict the outcome or estimate a possible loss or range of loss in some instances because litigation is subject to significant uncertainties.

Reasonably Possible Contingencies

For all of the legal matters below, the Company believes that a negative outcome is reasonably possible, but the Company is unable to determine an estimate of the possible loss or a range of loss.

On February 10, 2006, the Company received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on the Company’s hospitals in three states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, the Company received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to the Company’s three hospitals in that state. Through the beginning of 2009, the Company provided the Department of Justice with requested documents, met with its personnel on numerous occasions, and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified the Company that it believed that the Company and its three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged

28

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

improper payments were made. The Company filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part the Company’s motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied the Company’s motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, the Company filed its answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. Motions for Summary Judgment were filed on March 27, 2012 and there is currently no trial date set. On March 30, 2012, the court denied the Company’s motion to exclude Plaintiffs’ expert witness testimony, which the Company believes fails to follow the controlling Medicaid statute and regulations and results in an exaggeration of the damages estimate by fourfold. The Company has the opportunity to challenge the methodology employed at trial. The Company is vigorously defending this action.

Matters for which an Outcome Cannot be Assessed

For all of the legal matters below, the Company cannot at this time assess what the outcome may be and is further unable to determine any estimate of loss or range of loss. Because the investigations are at a very preliminary stage, there are not sufficient facts available to make these assessments.

On April 8, 2011, the Company received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, Office of Inspector General (the “OIG”), in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of the Company’s hospitals and appears to concern emergency department processes and procedures, including the Company’s hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about the Company’s relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by the Company’s Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010. This investigation is being led by the Department of Justice. The Company is continuing to cooperate with the government including detailing a process for a medical necessity review by clinical reviewers and physicians of a sampling of medical records at a small number of hospitals.

On April 11, 2011, Tenet Healthcare Corporation (“Tenet”) filed suit against the Company, Wayne T. Smith and W. Larry Cash in the United States District Court for the Northern District of Texas. The suit alleged the Company committed violations of certain federal securities laws by making certain statements in various proxy materials filed with the SEC in connection with the Company’s offer to purchase Tenet. Tenet alleged that the Company engaged in a practice to under-utilize observation status and over-utilize inpatient admission status and asserts that by doing so, the Company created undisclosed financial and legal liability to federal, state and private payors. The suit seeks declaratory and injunctive relief and Tenet’s costs. On April 19, 2011, the Company filed a motion to dismiss the complaint. On April 28, 2011, the Company responded to the allegations during its earnings release conference call as discussed in the Company’s Form 8-K furnished on April 28, 2011. On May 16, 2011, Tenet filed an amended complaint. On June 29, 2011, the Company filed a motion to dismiss the amended complaint. A hearing on the Company’s motion to dismiss occurred on September 8, 2011. On March 21, 2012, the court dismissed this case in its entirety, with prejudice.

On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another department in the fall of 2006. This facility was acquired by the Company as part of the July 25, 2007 merger transaction with Triad. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. The Company had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The motion contained additional information about how the government intended to

29

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services (the “HHS”) are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of the Company’s Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. (Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, the Company may learn of additional qui tam suits filed against the Company or its affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests the Company has received in the past from various governmental agencies are generated from qui tam cases filed under seal.) The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. The Company’s management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. The Company agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. The Company’s response setting forth the Company’s legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. On April 26, 2012, the Company joined the government and the relator in a motion to extend the stay in this case for an additional 180 days. As noted in that filing, the Company is working with the government on a probe audit of medical records (described above with respect to the April 2011 subpoena). The Company is cooperating fully with the government in its investigations.

Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of the Company’s common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for the Company’s common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties are in the process of negotiating operative dates for these consolidated shareholder federal securities actions, including dates for the filing of an operative consolidated complaint and related briefing.

Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. The Plaintiffs filed an operative amended derivative complaint in these three consolidated actions on March 15, 2012. A responsive pleading is due May 14, 2012. The Company believes all of these matters are without merit and will vigorously defend them.

30

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits of possible improper claims submitted to Medicare and Medicaid during the three months ending March 31, 2012 and 2011 (in thousands):

	Three Months Ended March  31,
	2012		2011
Professional fees and other related costs	$	1,903	$	—

Probable Contingencies

In addition to the cases described above, there are a number of legal matters for which, based on information currently available, the Company believes that a negative outcome is known or is probable. In the aggregate, an estimate of these losses has been accrued in the amount of $21.3 million at March 31, 2012. Due to the uncertainties and difficulty in predicting the ultimate resolution of these contingencies, the actual amount could differ from the estimated amount; however, the Company does not believe the ultimate outcome of any of these matters would be material.

17. SUBSEQUENT EVENTS

The Company evaluated all material events occurring subsequent to the balance sheet date for events requiring disclosure or recognition in the condensed consolidated financial statements.

18. SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

In 2007, CHS issued the 8 ⁷/8% Senior Notes in the aggregate principal amount of approximately $3.0 billion. In 2011, CHS issued the 8% Senior Notes in the aggregate principal amount of $1.0 billion, the proceeds from which were used to purchase $1.0 billion of the 8 ⁷/8% Senior Notes. In addition, CHS issued an additional $1.0 billion of 8% Senior Notes in March 2012, which were used to purchase $850 million of 8 ⁷/8% Senior Notes. These 8 ⁷/8% Senior Notes and 8% Senior Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.

Both the 8 ⁷/8% Senior Notes and the 8% Senior Notes are guaranteed on a joint and several basis, with limited exceptions considered customary for such guarantees, including the release of the guarantee when a subsidiary’s assets used in operations are sold. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental condensed consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

31

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. This activity also includes the intercompany transactions between consolidated entities as part of the Receivables Facility that is further discussed in Note 11. The Company’s subsidiaries generally do not purchase services from one another; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of March 31, 2012.

32

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Balance Sheet

March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	18,404		$	110,894	$	—		$	129,298
Patient accounts receivable, net of allowance for doubtful accounts		—			—			585,904			1,433,633		—			2,019,537
Supplies		—			—			228,702			125,372		—			354,074
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		49,769			67			96,916			32,171		—			178,923
Other current assets		—			—			247,017			81,830		—			328,847
Total current assets		139,566			67			1,176,943			1,783,900		—			3,100,476
Intercompany receivable		1,217,652			9,144,874			2,309,599			1,997,851		(14,669,976	)		—
Property and equipment, net		—			—			4,612,206			2,389,657		—			7,001,863
Goodwill		—			—			2,511,418			1,856,423		—			4,367,841
Other assets, net of accumulated amortization		—			133,393			606,887			635,956		—			1,376,236
Net investment in subsidiaries		1,848,287			7,131,830			3,469,179			—		(12,449,296	)		—
Total assets	$	3,205,505		$	16,410,164		$	14,686,232		$	8,663,787	$	(27,119,272	)	$	15,846,416
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	56,329		$	15,032		$	4,027	$	—		$	75,388
Accounts payable		—			1,982			569,299			250,966		—			822,247
Accrued interest		—			100,941			129			86		—			101,156
Accrued liabilities		7,580			—			673,039			316,999		—			997,618
Total current liabilities		7,580			159,252			1,257,499			572,078		—			1,996,409
Long-term debt		—			8,869,202			49,271			325,143		—			9,243,616
Intercompany payable		—			5,295,699			10,670,064			6,290,045		(22,255,808	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		2,844			237,739			482,689			262,750		—			986,022
Total liabilities		715,149			14,561,892			12,459,523			7,450,016		(22,255,808	)		12,930,772
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			363,540		—			363,540
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		919			—			1			2		(3	)		919
Additional paid-in capital		1,089,447			760,940			846,210			658,685		(2,265,835	)		1,089,447
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(170,136	)		(170,136	)		(17,880	)		—		188,016			(170,136	)
Retained earnings		1,576,804			1,257,468			1,398,378			129,796		(2,785,642	)		1,576,804
Total Community Health Systems, Inc. stockholders’ equity		2,490,356			1,848,272			2,226,709			788,483		(4,863,464	)		2,490,356
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			61,748		—			61,748
Total equity		2,490,356			1,848,272			2,226,709			850,231		(4,863,464	)		2,552,104
Total liabilities and equity	$	3,205,505		$	16,410,164		$	14,686,232		$	8,663,787	$	(27,119,272	)	$	15,846,416

33

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Balance Sheet

December 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

34

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Statement of Income

Three Months Ended March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	(1,764	)	$	2,297,493		$	1,487,762		$	—		$	3,783,491
Provision for bad debts		—			—			323,543			162,913			—			486,456
Net operating revenues		—			(1,764	)		1,973,950			1,324,849			—			3,297,035
Operating costs and expenses:
Salaries and benefits		—			—			851,412			673,563			—			1,524,975
Supplies		—			—			301,328			197,251			—			498,579
Other operating expenses		—			315			445,871			262,757			—			708,943
Electronic health records incentive reimbursement		—			—			(18,079	)		(8,089	)		—			(26,168	)
Rent		—			—			34,805			32,419			—			67,224
Depreciation and amortization		—			—			111,133			63,221			—			174,354
Total operating costs and expenses		—			315			1,726,470			1,221,122			—			2,947,907
Income from operations		—			(2,079	)		247,480			103,727			—			349,128
Interest expense, net		—			15,737			123,418			13,020			—			152,175
Loss from early extinguishment of debt		—			63,429			—			—			—			63,429
Equity in earnings of unconsolidated affiliates		(75,474	)		(115,064	)		(51,314	)		—			229,839			(12,013	)
Income from continuing operations before income taxes		75,474			33,819			175,376			90,707			(229,839	)		145,537
Provision for (benefit from) income taxes		—			(41,655	)		63,311			24,163			—			45,819
Income from continuing operations		75,474			75,474			112,065			66,544			(229,839	)		99,718
Discontinued operations, net of taxes:
Loss from operations of entities sold		—			—			—			(466	)		—			(466	)
Impairment of hospital sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			—			(466	)		—			(466	)
Net income		75,474			75,474			112,065			66,078			(229,839	)		99,252
Less: Net income attributable to noncontrolling interests		—			—			—			23,778			—			23,778
Net income attributable to Community Health Systems, Inc.	$	75,474		$	75,474		$	112,065		$	42,300		$	(229,839	)	$	75,474

35

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Statement of Income

Three Months Ended March 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	1,965,090		$	1,388,962		$	—		$	3,354,052
Provision for bad debts		—			—			245,533			154,436			—			399,969
Net operating revenues		—			—			1,719,557			1,234,526			—			2,954,083
Operating costs and expenses:
Salaries and benefits		—			—			753,989			625,378			—			1,379,367
Supplies		—			—			268,603			189,214			—			457,817
Other operating expenses		—			—			350,667			264,126			—			614,793
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			31,489			31,681			—			63,170
Depreciation and amortization		—			—			95,556			62,599			—			158,155
Total operating costs and expenses		—			—			1,500,304			1,172,998			—			2,673,302
Income from operations		—			—			219,253			61,528			—			280,781
Interest expense, net		—			28,103			119,358			15,757			—			163,218
Loss from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(61,324	)		(79,436	)		(21,096	)		—			143,722			(18,134	)
Income from continuing operations before income taxes		61,324			51,333			120,991			45,771			(143,722	)		135,697
Provision for (benefit from) income taxes		—			(9,991	)		43,678			10,405			—			44,092
Income from continuing operations		61,324			61,324			77,313			35,366			(143,722	)		91,605
Discontinued operations, net of taxes:
Loss from operations of entities sold		—			—			—			(1,678	)		—			(1,678	)
Impairment of hospital sold		—			—			—			(8,368	)		—			(8,368	)
Loss on sale, net		—			—			—			(3,234	)		—			(3,234	)
Loss from discontinued operations, net of taxes		—			—			—			(13,280	)		—			(13,280	)
Net income		61,324			61,324			77,313			22,086			(143,722	)		78,325
Less: Net income attributable to noncontrolling interests		—			—			—			17,001			—			17,001
Net income attributable to Community Health Systems, Inc.	$	61,324		$	61,324		$	77,313		$	5,085		$	(143,722	)	$	61,324

36

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Statement of Comprehensive Income

Three Months Ended March 31, 2012

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	75,474	$	75,474	$	112,065	$	66,078	$	(229,839	)	$	99,252
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		10,536		10,536		—		—		(10,536	)		10,536
Net change in fair value of available-for-sale securities		2,667		2,667		2,667		—		(5,334	)		2,667
Amortization and recognition of unrecognized pension cost components		1,140		1,140		1,140		—		(2,280	)		1,140
Other comprehensive income		14,343		14,343		3,807		—		(18,150	)		14,343
Comprehensive income		89,817		89,817		115,872		66,078		(247,989	)		113,595
Less: Comprehensive income attributable to noncontrolling interests		—		—		—		23,778		—			23,778
Comprehensive income attributable to Community Health Systems, Inc.	$	89,817	$	89,817	$	115,872	$	42,300	$	(247,989	)	$	89,817

37

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Statement of Comprehensive Income

Three Months Ended March 31, 2011

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	61,324	$	61,324	$	77,313	$	22,086	$	(143,722	)	$	78,325
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		36,446		36,446		—		—		(36,446	)		36,446
Net change in fair value of available-for-sale securities		1,069		1,069		1,069		—		(2,138	)		1,069
Amortization and recognition of unrecognized pension cost components		772		772		772		—		(1,544	)		772
Other comprehensive income		38,287		38,287		1,841		—		(40,128	)		38,287
Comprehensive income		99,611		99,611		79,154		22,086		(183,850	)		116,612
Less: Comprehensive income attributable to noncontrolling interests		—		—		—		17,001		—			17,001
Comprehensive income attributable to Community Health Systems, Inc.	$	99,611	$	99,611	$	79,154	$	5,085	$	(183,850	)	$	99,611

38

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(1,230	)	$	(26,237	)	$	(64,108	)	$	278,885		$	—	$	187,310
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(242,977	)		(5,459	)		—		(248,436	)
Purchases of property and equipment		—			—			(127,796	)		(57,107	)		—		(184,903	)
Proceeds from disposition of ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			688			60			—		748
Increase in other investments		—			10,000			(45,612	)		(32,096	)		—		(67,708	)
Net cash used in investing activities		—			10,000			(415,697	)		(94,602	)		—		(500,299	)
Cash flows from financing activities:
Proceeds from exercise of stock options		308			—			—			—			—		308
Repurchase of restricted stock shares for payroll tax withholding requirements		(9,032	)		—			—			—			—		(9,032	)
Deferred financing costs		—			(24,787	)		—			—			—		(24,787	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		1,004			—			—			—			—		1,004
Proceeds from noncontrolling investors in joint ventures		—			—			—			—			—		—
Redemption of noncontrolling investments in joint ventures		—			—			—			(31,096	)		—		(31,096	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(27,038	)		—		(27,038	)
Changes in intercompany balances with affiliates, net		8,950			(58,772	)		479,643			(429,821	)		—		—
Borrowings under credit agreement		—			4,305,674			9,337			—			—		4,315,011
Issuance of long-term debt		—			1,025,000			—			—			—		1,025,000
Proceeds from receivables facility		—			—			—			300,000			—		300,000
Repayments of long-term indebtedness		—			(5,230,878	)		(5,307	)		(763	)		—		(5,236,948	)
Net cash provided by (used in) financing activities		1,230			16,237			483,673			(188,718	)		—		312,422
Net change in cash and cash equivalents		—			—			3,868			(4,435	)		—		(567	)
Cash and cash equivalents at beginning of period		—			—			14,536			115,329			—		129,865
Cash and cash equivalents at end of period	$	—		$	—		$	18,404		$	110,894		$	—	$	129,298

39

COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(22,195	)	$	(83,202	)	$	331,077		$	(38,169	)	$	—	$	187,511
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(10,727	)		(34,695	)		—		(45,422	)
Purchases of property and equipment		—			—			(64,312	)		(89,563	)		—		(153,875	)
Proceeds from disposition of ancillary operations		—			—			—			14,583			—		14,583
Proceeds from sale of property and equipment		—			—			473			7,114			—		7,587
Increase in other investments		—			—			(36,201	)		3,924			—		(32,277	)
Net cash used in investing activities		—			—			(110,767	)		(98,637	)		—		(209,404	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,125			—			—			—			—		18,125
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			—			—			—			—		—
Excess tax benefit (income tax payable increase) relating to stock-based compensation		4,675			—			—			—			—		4,675
Proceeds from noncontrolling investors in joint ventures		—			—			—			863			—		863
Redemption of noncontrolling investments in joint ventures		—			—			—			(225	)		—		(225	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(15,333	)		—		(15,333	)
Changes in intercompany balances with affiliates, net		(605	)		95,750			(191,179	)		96,034			—		—
Borrowings under credit agreement		—			—			—			—			—		—
Proceeds from receivables facility		—			—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(12,548	)		(1,472	)		(645	)		—		(14,665	)
Net cash provided by (used in) financing activities		22,195			83,202			(192,651	)		80,694			—		(6,560	)
Net change in cash and cash equivalents		—			—			27,659			(56,112	)		—		(28,453	)
Cash and cash equivalents at beginning of period		—			—			212,035			87,134			—		299,169
Cash and cash equivalents at end of period	$	—		$	—		$	239,694		$	31,022		$	—	$	270,716

40

Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read this discussion together with our unaudited condensed consolidated financial statements and accompanying notes included herein.

Throughout this Quarterly Report on Form 10-Q, Community Health Systems, Inc., the parent company, and its consolidated subsidiaries are referred to on a collective basis using words like “we,” “our,” “us” and the “Company”. This drafting style is not meant to indicate that the publicly-traded parent company or any subsidiary of the parent company owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

Executive Overview

We are one of the largest publicly-traded operators of hospitals in the United States in terms of number of facilities and net operating revenues. We provide healthcare services through the hospitals that we own and operate in non-urban and selected urban markets. We generate revenues by providing a broad range of general and specialized hospital healthcare services to patients in the communities in which we are located. As of March 31, 2012, we owned or leased 134 hospitals comprised of 130 general acute care hospitals and four stand-alone rehabilitation or psychiatric hospitals. In addition, we own and operate home care agencies, located primarily in markets where we also operate a hospital, and through our wholly-owned subsidiary, Quorum Health Resources, LLC, or QHR, we provide management and consulting services to non-affiliated general acute care hospitals located throughout the United States. For the hospitals and home care agencies that we own and operate, we are paid for our services by governmental agencies, private insurers and directly by the patients we serve. For our management and consulting services, we are paid by the non-affiliated hospitals utilizing our services.

As further discussed in Recent Accounting Pronouncements, during the first quarter of 2012 we adopted the provisions of Accounting Standards Update, or ASU, No. 2011-07 of the Financial Accounting Standards Board, or FASB, which requires us to present revenues net of the provision for bad debts. Prior to the adoption of this ASU, our provision for bad debts was presented as a component of operating expenses. For all periods presented in this quarterly report, revenues and any related financial ratios or metrics have been updated to reflect the change in the presentation of net operating revenues. The adoption of this standard did not impact our financial position, results of operations or cash flows.

During the three months ended March 31, 2012, we continued the execution of our acquisition strategy by acquiring three hospitals located in Scranton, Pennsylvania; Peckville, Pennsylvania; and Blue Island, Illinois and a large physician practice located in Longview, Texas.

During the three months ended March 31, 2012, we also entered into several agreements that extend the maturity date of a significant portion of our outstanding indebtedness. As further discussed in the Liquidity and Capital Resources section, we entered into an additional amendment and restatement of our Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of $1.6 billion of our existing term loans. Additionally, we obtained a new $750 million senior secured revolving credit facility and a new $750 million incremental term loan A facility, both with a maturity date of October 25, 2016, subject to certain acceleration clauses, the net proceeds of which were used to repay the same amount of existing borrowings under the previous revolving credit facility and term loans under the Credit Facility. Finally, we completed a secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 sold at a premium of 102.5%, the net proceeds of which were used to finance the purchase of $850 million aggregate principal amount of our outstanding 8 ⁷/8% Senior Notes due 2015, to pay fees and expenses and for general corporate purposes.

Our net operating revenues for the three months ended March 31, 2012 increased to approximately $3.3 billion, as compared to approximately $3.0 billion for the three months ended March 31, 2011. Income from continuing operations, before noncontrolling interests, for the three months ended March 31, 2012 increased 8.9% over the three months ended March 31, 2011 to $99.7 million compared to $91.6 million. Included in income from continuing operations for the three months ended March 31, 2012, is a $42.8 million after-tax benefit from the resolution of an industry-wide governmental settlement and a payment update related to prior periods, an $8.7 million after-tax charge to establish reserves for certain legal matters and a $39.5 million after-tax loss from the early extinguishment of debt. Excluding these one-time items, income from continuing operations, before noncontrolling interests, for the three months ended March 31, 2012 increased 14.8% over the three months ended March 31, 2011 to $105.1 million compared to $91.6 million. This increase in income from continuing operations during the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, is due primarily to increased revenues at our same-store hospitals, offset by increases in the provision for bad debts, income from HITECH incentive reimbursements, offset by expenses incurred while deploying the electronic health records technology, and reductions in interest expense. Total inpatient admissions for the three months ended March 31, 2012

41

increased 3.2%, compared to the three months ended March 31, 2011, and adjusted admissions for the three months ended March 31, 2012 increased 8.1%, compared to the three months ended March 31, 2011. On a same-store basis, admissions decreased 2.3% and adjusted admissions increased 2.5%, compared with the three months ended March 31, 2011.

Self-pay revenues represented approximately 13.4% and 12.2% of our net operating revenues for the three months ended March 31, 2012 and 2011, respectively. The amount of foregone revenue related to providing charity care services as a percentage of net operating revenues was approximately 4.2% and 4.4% for the three months ended March 31, 2012 and 2011, respectively. Direct and indirect costs incurred by us in providing charity care services were approximately 0.9% of net operating revenues for both of the three-month periods ended March 31, 2012 and 2011.

The Patient Protection and Affordable Care Act, or PPACA, was signed into law on March 23, 2010. In addition, the Health Care and Education Affordability Reconciliation Act of 2010, or Reconciliation Act, which contains a number of amendments to PPACA, was signed into law on March 30, 2010. These two healthcare acts, referred to collectively as the Reform Legislation, include a mandate that requires substantially all U.S. citizens to maintain medical insurance coverage which will ultimately increase the number of persons with access to health insurance in the United States. The Reform Legislation should result in a reduction in uninsured patients, which should reduce our expense from uncollectible accounts receivable; however, this legislation makes a number of other changes to Medicare and Medicaid, such as reductions to the Medicare annual market basket update for federal fiscal years 2010 through 2019, a productivity offset to the Medicare market basket update which began October 1, 2011, and a reduction to the Medicare and Medicaid disproportionate share payments, that could adversely impact the reimbursement received under these programs. The various provisions in the Reform Legislation that directly or indirectly affect reimbursement are scheduled to take effect over a number of years, and we cannot predict their impact at this time. Other provisions of the Reform Legislation, such as requirements related to employee health insurance coverage, should increase our operating costs.

Also included in the Reform Legislation are provisions aimed at reducing fraud, waste and abuse in the healthcare industry. These provisions allocate significant additional resources to federal enforcement agencies and expand the use of private contractors to recover potentially inappropriate Medicare and Medicaid payments. The Reform Legislation amends several existing federal laws, including the Medicare Anti-Kickback Statute and the False Claims Act, making it easier for government agencies and private plaintiffs to prevail in lawsuits brought against healthcare providers. These amendments also make it easier for potentially severe fines and penalties to be imposed on healthcare providers accused of violating applicable laws and regulations.

In a number of markets, we have partnered with local physicians in the ownership of our facilities. Such investments have been permitted under an exception to the physician self-referral law, or Stark Law, that allows physicians to invest in an entire hospital (as opposed to individual hospital departments). The Reform Legislation changes the “whole hospital” exception to the Stark Law. The Reform Legislation permits existing physician investments in a whole hospital to continue under a “grandfather” clause if the arrangement satisfies certain requirements and restrictions, but physicians are now prohibited, from the time the Reform Legislation became effective, from increasing the aggregate percentage of their ownership in the hospital. The Reform Legislation also restricts the ability of existing physician-owned hospitals to expand the capacity of their facilities.

The impact of the Reform Legislation on each of our hospitals will vary depending on payor mix and a variety of other factors. We anticipate that many of the provisions in the Reform Legislation will be subject to further clarification and modification through the rule-making process, the development of agency guidance and judicial interpretations. Moreover, twenty-six state attorneys general have jointly filed a challenge to certain aspects of the Reform Legislation. Currently, rulings in four separate federal Courts of Appeals have led to a split among the federal Circuit Courts regarding the constitutionality of the Reform Legislation. The Fourth Circuit, Sixth Circuit and the Court of Appeals for the D.C. Circuit have ruled in favor of the Reform Legislation while the Eleventh Circuit ruled the individual mandate within the Reform Legislation unconstitutional. The United States Supreme Court granted certiorari on or about November 14, 2011 to hear the appeal of the Eleventh Circuit’s ruling. The Supreme Court heard oral argument from March 26 through March 28, 2012 on four issues: (1) does the Anti-Injunction Act bar a legal challenge to the individual mandate aspect of the Reform Legislation until that mandate takes effect in 2014; (2) is the individual mandate aspect of the Reform Legislation constitutional; (3) if not, is the individual mandate aspect of the Reform Legislation severable from the Reform Legislation as a whole such that it may be stricken without nullifying the Reform Legislation in its entirety and (4) can the states be compelled by the federal government to expand their Medicaid expenditures or risk losing federal funding if they refuse. The Supreme Court is expected to issue a decision before its session ends in June 2012. We cannot predict the impact the Reform Legislation may have on our business, results of operations, cash flow, capital resources and liquidity or the ultimate outcome of the Supreme Court case. Furthermore, we cannot predict whether we will be able to modify certain aspects of our operations to offset any potential adverse consequences from the Reform Legislation.

42

In addition to the Reform Legislation, the American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act, or HITECH. These provisions were designed to increase the use of electronic health records, or EHR, technology and establish the requirements for a Medicare and Medicaid incentive payments program beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. These incentive payments are intended to offset a portion of the costs incurred to implement and qualify as a meaningful user of EHR. Rules adopted in July 2010 by the Department of Health and Human Services established an initial set of standards and certification criteria. Our hospital facilities have begun to implement EHR technology on a facility-by-facility basis beginning in 2011. We anticipate recognizing incentive reimbursement related to the Medicare or Medicaid incentives as we are able to implement the certified EHR technology, meet the defined “meaningful use criteria,” and information from completed cost report periods is available from which to calculate the incentive reimbursement. The timing of recognizing incentive reimbursement will not correlate with the timing of recognizing operating expenses and incurring capital costs in connection with the implementation of EHR technology which may result in material period-to-period changes in our future results of operations. Hospitals that do not qualify as a meaningful user of EHR technology by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. Although we believe that our hospital facilities will be in compliance with the EHR standards by 2015, there can be no assurance that all of our facilities will be in compliance and therefore not subject to the penalty provisions of HITECH. During the three months ended March 31, 2012, we recognized approximately $26.2 million of HITECH incentive reimbursements from Medicaid related to certain of our hospitals and from Medicare and Medicaid for certain of our employed physicians, which are presented as a reduction of operating expenses. No incentive reimbursements were recognized during the three months ended March 31, 2011.

As a result of our current levels of cash, available borrowing capacity, long-term outlook on our debt repayments, the refinancing of our term loans and senior notes and our continued projection of our ability to generate cash flows, we do not anticipate a significant impact on our ability to invest the necessary capital in our business over the next twelve months and into the foreseeable future. We believe there continues to be ample opportunity for growth in substantially all of our markets by decreasing the need for patients to travel outside their communities for healthcare services. Furthermore, we continue to benefit from synergies from our acquisitions and continue to strive to improve operating efficiencies and procedures in order to improve our profitability at all of our hospitals.

Sources of Consolidated Net Operating Revenues

The following table presents the approximate percentages of operating revenues, net of contractual allowances and discounts (but before provision for bad debts) by payor source for the periods indicated. The data for the periods presented are not strictly comparable due to the effect that hospital acquisitions have had on these statistics.

	Three Months Ended March 31,
	2012			2011
Medicare		26.6	%(1)		27.5	%
Medicaid		8.5	%		9.6	%
Managed Care and other third-party payors		51.5	%		50.7	%
Self-pay		13.4	%		12.2	%
Total		100.0	%		100.0	%

(1) Excludes the $80.8 million reimbursement settlement and payment update as discussed below.

As shown above, we receive a substantial portion of our revenues from the Medicare and Medicaid programs. Included in Managed Care and other third-party payors is net operating revenues from insurance companies with which we have insurance provider contracts, Medicare managed care, insurance companies for which we do not have insurance provider contracts, workers’ compensation carriers and non-patient service revenue, such as rental income and cafeteria sales. In the future, we generally expect revenues received from the Medicare and Medicaid programs to increase due to the general aging of the population. In addition, the Reform Legislation, currently in effect, should increase the number of insured patients, which, in turn, should reduce revenues from self-pay patients and reduce our provision for bad debts. The Reform Legislation, however, imposes significant reductions in amounts the government pays Medicare managed care plans. Other provisions in the Reform Legislation impose minimum medical-loss ratios and require insurers to meet specific benefit requirements. In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth. There can be no assurance that we will retain our existing reimbursement arrangements or that these third-party payors will not attempt to further reduce the rates they pay for our services.

43

Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-based reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive for treatment of patients covered by these programs are generally less than the standard billing rates. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual allowance adjustments, which we deduct from gross revenues to arrive at net operating revenues. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous program reimbursement estimates as contractual allowance adjustments and report them in the periods that such adjustments become known. During the three months ended March 31, 2012, we recognized a net after-tax benefit of $42.8 million from the resolution of an industry-wide governmental settlement and a payment update related to prior periods. Other than this adjustment, contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in both of the three-month periods ended March 31, 2012 and 2011. In the future, we expect the percentage of revenues received from the Medicare program to increase due to the general aging of the population.

Currently, several states utilize supplemental reimbursement programs for the purpose of providing reimbursement to providers to offset a portion of the cost of providing care to Medicaid and indigent patients. These programs are designed with input from Centers for Medicare and Medicaid Services, or CMS, and are funded with a combination of state and federal resources, including, in certain instances, fees or taxes levied on the providers. Similar programs are also being considered by other states. After these supplemental programs are signed into law, we recognize revenue and related expenses in the period in which amounts are estimable and collection is reasonably assured. Reimbursement under these programs is reflected in net operating revenues and included as Medicaid revenue in the table above, and fees, taxes or other program related costs are reflected in other operating costs and expenses.

The payment rates under the Medicare program for hospital inpatient and outpatient acute care services are based on a prospective payment system, depending upon the diagnosis of a patient’s condition. These rates are indexed for inflation annually, although increases have historically been less than actual inflation. On August 18, 2011, CMS issued the final rule to adjust this index by 3.0% for hospital inpatient acute care services that are reimbursed under the prospective payment system. The final rule also made other payment adjustments that, coupled with the 0.1% reduction to hospital inpatient rates implemented pursuant to the Reform Legislation, yielded a net 1.1% increase in reimbursement for hospital inpatient acute care services beginning October 1, 2011. Reductions in the rate of increase or overall reductions in Medicare reimbursement may cause a decline in the growth of our net operating revenues. In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth.

In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth.

Results of Operations

Our hospitals offer a variety of services involving a broad range of inpatient and outpatient medical and surgical services. These include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic services, psychiatric and rehabilitation services. The strongest demand for hospital services generally occurs during January through April and the weakest demand for these services occurs during the summer months. Accordingly, eliminating the effect of new acquisitions, our net operating revenues and earnings are historically highest during the first quarter and lowest during the third quarter.

44

The following tables summarize, for the periods indicated, selected operating data.

	Three Months Ended March 31,
	2012			2011
	(Expressed as a percentage of net operating revenues)
Consolidated
Net operating revenues		100.0	%		100.0	%
Operating expenses (a)		(84.1	)		(85.1	)
Depreciation and amortization		(5.3	)		(5.4	)
Income from operations		10.6			9.5
Interest expense, net		(4.7	)		(5.5	)
Loss from early extinguishment of debt		(1.9	)		—
Equity in earnings of unconsolidated affiliates		0.4			0.6
Income from continuing operations before income taxes		4.4			4.6
Provision for income taxes		(1.4	)		(1.5	)
Income from continuing operations		3.0			3.1
Loss from discontinued operations, net of taxes		—			(0.4	)
Net income		3.0			2.7
Less: Net income attributable to noncontrolling interests		(0.7	)		(0.6	)
Net income attributable to Community Health Systems, Inc.		2.3	%		2.1	%

	Three Months Ended March 31, 2012
Percentage increase from same period prior year:
Net operating revenues		11.6	%
Admissions		3.2
Adjusted admissions (b)		8.1
Average length of stay		—
Net income attributable to Community
Health Systems, Inc. (c)		23.1
Same-store percentage increase (decrease) from same period prior year (d):
Net operating revenues		4.3	%
Admissions		(2.3	)
Adjusted admissions (b)		2.5

(a) Operating expenses include salaries and benefits, supplies, other operating expenses, electronic health records incentive reimbursement and rent.

(b) Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by multiplying admissions by gross patient revenues and then dividing that number by gross inpatient revenues.

(c) Includes loss from discontinued operations.

(d) Includes acquired hospitals to the extent we operated them in both periods.

45

Three Months Ended March 31, 2012 Compared to Three Months Ended March 31, 2011

Net operating revenues increased $343.0 million to approximately $3.3 billion for the three months ended March 31, 2012, from approximately $3.0 billion for the three months ended March 31, 2011. Hospitals owned throughout both periods contributed $127.8 million of that increase and hospitals acquired in 2012 and 2011 contributed $134.4 million. On a same-store basis, net operating revenues increased 4.3%. The increased net operating revenues contributed by hospitals that we owned throughout both periods were primarily attributable to general rate and reimbursement increases including revenues from states with provider assessment programs. Included in net operating revenues on a non-same store basis is approximately $101.8 million of net operating revenue from an industry-wide settlement with the United States Department of Health and Human Services and CMS, based on a claim that acute-care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system in federal fiscal years 1999 through 2011. The underpayments resulted from calculations related to the rural floor budget neutrality adjustments implemented in connection with the Balanced Budget Act of 1997. Also included is an unfavorable adjustment of approximately $21.0 million, related to the newly issued Supplemental Security Income ratios for federal fiscal years 2006 through 2009 utilized for calculating Medicare Disproportionate Share Hospital reimbursements.

On a consolidated basis, inpatient admissions increased by 3.2% and adjusted admissions increased by 8.1% during the three months ended March 31, 2012. On a same-store basis, inpatient admissions decreased by 2.3% during the three months ended March 31, 2012. This decrease in same-store inpatient admissions was due primarily to a decrease in admissions from women’s services including obstetrics and gynecology, fewer flu and respiratory-related admissions and reductions due to competition and certain service closures in a few of our hospitals during the three months ended March 31, 2012, as compared to the three months ended March 31, 2011.

Operating expenses, excluding depreciation and amortization, as a percentage of net operating revenues, decreased 1.0% to 84.1% for the three months ended March 31, 2012, compared to 85.1% for the three months ended March 31, 2011. Salaries and benefits, as a percentage of net operating revenues, decreased 0.4% to 46.3% for the three months ended March 31, 2012, compared to 46.7% for the three months ended March 31, 2011. This decrease in salaries and benefits, as a percentage of net operating revenues, is due primarily to the increase in non-same store net operating revenues described above. Same-store salaries and benefits, as a percentage of net operating revenues, increased for the three months ended March 31, 2012, primarily due to an increase in the number of employed physicians along with higher health benefit costs, compared to the three months ended March 31, 2011. Supplies, as a percentage of net operating revenues, decreased 0.4% to 15.1% for the three months ended March 31, 2012, as compared to 15.5% for the three months ended March 31, 2011. This decrease is due primarily to lower implant and drug costs. Other operating expenses, as a percentage of net operating revenues, increased 0.7% to 21.5% for the three months ended March 31, 2012, as compared to 20.8% for the three months ended March 31, 2011. This increase is due primarily to increased legal expenses for the establishment of reserves for certain legal matters, legal expenses related to the industry-wide settlement with the United States Department of Health and Human Services and CMS discussed above, and legal expenses and other costs relating to the Tenet lawsuit, shareholder lawsuits and the governmental investigations discussed in more detail in “Legal Proceedings” in Part II, Item 1 of this Form 10-Q. Rent, as a percentage of net operating revenues, decreased 0.1% to 2.0% for the three months ended March 31, 2012, as compared to 2.1% for the three months ended March 31, 2011. Equity in earnings of unconsolidated affiliates, as a percentage of net operating revenues, decreased 0.2% to 0.4% for the three months ended March 31, 2012, compared to 0.6% for the three months ended March 31, 2011.

Electronic health records incentive reimbursements represent those incentives under the HITECH Act for which the recognition criterion has been met. For the three months ended March 31, 2012, we have recognized approximately $26.2 million of incentive reimbursements, or 0.8% of net operating revenues. We received payments of $5.8 million during the three months ended March 31, 2012. Operating expenses incurred related to the installation and adoption of electronic health records, including depreciation and amortization, totaled approximately 0.4% of net operating revenues for the three months ended March 31, 2012, of which depreciation and amortization represented 0.2% of net operating revenues.

Depreciation and amortization, as a percentage of net operating revenues, decreased 0.1% to 5.3% for the three months ended March 31, 2012, compared to 5.4% for the three months ended March 31, 2011.

Interest expense, net, decreased by $11.0 million from $163.2 million for the three months ended March 31, 2011 to $152.2 million for the three months ended March 31, 2012. A decrease in interest rates during the three months ended March 31, 2012, compared to March 31, 2011, resulted in a decrease in interest expense of $14.3 million. Additionally, interest expense decreased by $3.5 million as a result of more interest being capitalized during the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, as the current year period had more major construction projects. These decreases were partially offset by an increase in our average outstanding debt during the three months ended March 31, 2012, compared to the three months ended March 31, 2011, and one additional day of interest expense since 2012 is a leap year, which resulted in an increase in interest expense of $4.9 million and $1.9 million, respectively.

46

The loss from early extinguishment of debt was recognized after the purchase of $850 million of the 8 ⁷/8% Senior Notes due 2015 and the repayment of existing term loans and revolving credit facility under the Credit Facility.

The net of the above mentioned changes resulted in income from continuing operations before income taxes increasing $9.8 million from $135.7 million for the three months ended March 31, 2011 to $145.5 million for the three months ended March 31, 2012.

Provision for income taxes increased from $44.1 million for the three months ended March 31, 2011 to $45.8 million for the three months ended March 31, 2012, due primarily to the increase in income from continuing operations before income taxes in the comparable period in 2011, as discussed above. Our effective tax rate decreased from 32.5% for the three months ended March 31, 2011 to 31.5% for the three months ended March 31, 2012 due to a one-time favorable adjustment related to an amended state tax return.

Income from continuing operations, as a percentage of net operating revenues, decreased 0.1% to 3.0% for the three months ended March 31, 2012, compared to 3.1% for the three months ended March 31, 2011. Net income, as a percentage of net operating revenues, increased 0.3% to 3.0% for the three months ended March 31, 2012, compared to 2.7% for the three months ended March 31, 2011.

Net income attributable to noncontrolling interests as a percentage of net operating revenues, increased 0.1% to 0.7% for the three months ended March 31, 2012, compared to 0.6% for the three months ended March 31, 2011.

Net income attributable to Community Health Systems, Inc. was $75.5 million for the three months ended March 31, 2012, compared to $61.3 million for the three months ended March 31, 2011, representing an increase of 23.1%. The increase in net income is primarily due to the increase in net operating revenues, increase in electronic health records incentive reimbursement and decrease in interest expense, offset by increased legal expenses and the loss from early extinguishment of debt, discussed above.

Liquidity and Capital Resources

Net cash provided by operating activities decreased $0.2 million, from $187.5 million for the three months ended March 31, 2011 to $187.3 million for the three months ended March 31, 2012. The decrease in cash provided by operating activities, in comparison to the prior year period, is primarily due to a decrease in cash flow from the change in accounts receivable of $107.0 million and from the change in supplies, prepaid expenses and other current assets of $139.4 million. These decreases in cash flows were partially offset by an increase in net income of $20.9 million, an increase in depreciation and amortization expense of $13.0 million, loss from early extinguishment of debt of $63.4 million, an increase in all other non-cash expenses of $6.5 million, an increase in cash flow from the change in accounts payable, accrued liabilities and income taxes of $111.0 million and an increase in cash flow from the change in other assets and liabilities of $31.4 million. Included in net cash provided by operating activities for the three months ended March 31, 2012 is $5.8 million of cash received for HITECH incentive reimbursements.

The cash used in investing activities was $500.3 million for the three months ended March 31, 2012, compared to $209.4 million for the three months ended March 31, 2011. The increase in cash used in investing activities, in comparison to the prior year period, is primarily due to an increase in cash used for acquisition of facilities and other related equipment of $203.0 million, an increase in cash used for purchasing property and equipment of $31.0 million and an increase in cash used for other investments of $35.5 million. Included in cash outflows for other investments for the three months ended March 31, 2012 is approximately $30.9 million of capital expenditures related to the purchase and implementation of certified EHR technology. The remaining cash outflows for other investments consists primarily of purchases and development of other internal-use software and payments made under non-employee physician recruiting agreements, of $36.8 million. Other reasons for the increase in cash used in investing activities were the decrease in proceeds from the disposition of ancillary operations of $14.6 million and the decrease in proceeds received from the sale of property and equipment of $6.8 million.

The cash provided by financing activities was $312.4 million for the three months ended March 31, 2012, compared to $6.6 million used in financing activities for the three months ended March 31, 2011. The increase in cash provided by financing activities is due primarily to the increase in borrowings under the credit agreement, proceeds from the Receivables Facility and the issuance of long-term debt, offset partially by repayments of long-term debt during the three months ended March 31, 2012, in comparison to the prior year period.

47

Capital Expenditures

Cash expenditures related to purchases of facilities were $248.4 million for the three months ended March 31, 2012, compared to $45.4 million for the three months ended March 31, 2011. The expenditures during the three months ended March 31, 2012 were for the purchase of two hospitals in Pennsylvania, one hospital in Illinois, a physician practice in Texas, surgery centers and other physician practices and the settlement of working capital items from 2011 acquisitions. The expenditures during the three months ended March 31, 2011 were for the purchase of surgery centers and physician practices and the settlement of working capital items from 2010 acquisitions.

Excluding the cost to construct replacement hospitals, our cash expenditures for routine capital for the three months ended March 31, 2012 totaled $144.4 million, compared to $119.4 million for the three months ended March 31, 2011. These capital expenditures related primarily to the purchase of additional equipment, minor renovations and information systems infrastructure. Costs to construct replacement hospitals for the three months ended March 31, 2012 totaled $40.5 million, compared to $34.5 million for the three months ended March 31, 2011. The costs to construct replacement hospitals for both of the three-month periods ended March 31, 2012 and 2011 represented both planning and construction costs for the four replacement hospitals discussed below.

Pursuant to hospital purchase agreements in effect as of March 31, 2012, and where final certificate of need approval has been obtained, we have commitments to build the following three replacement facilities: As required by an amendment to our lease agreement entered into in 2005, we agreed to build a replacement hospital at our Barstow, California location by November 2012. As part of an acquisition in 2007, we agreed to build a replacement hospital in Valparaiso, Indiana by April 2011; however, due to delays in receiving government approved building and zoning permits, completion is not expected until the fourth quarter of 2012. These delays did not result in any penalties under the terms of the applicable purchase agreement and we do not expect such delays to result in any significant increase in the costs to construct the replacement facility. As part of an acquisition in 2009, we agreed to build a replacement hospital in Siloam Springs, Arkansas by February 2013. Construction costs, including equipment costs, for these three replacement facilities are currently estimated to be approximately $318.5 million, of which approximately $251.0 million has been incurred to date. In addition, in October 2008, after the purchase of the noncontrolling owner’s interest in our Birmingham, Alabama facility, we initiated the purchase of a site, which includes a partially constructed hospital structure, for a potential replacement to our existing Birmingham facility. In September 2010, we received approval of our request for a certificate of need from the Alabama Certificate of Need Review Board; however, this certificate of need remains subject to the final resolution of an appeal process. Our estimated construction costs, including the acquisition of the site and equipment costs, are approximately $280.0 million for the Birmingham replacement facility.

Capital Resources

Net working capital was approximately $1.1 billion at March 31, 2012, compared to approximately $935.0 million at December 31, 2011. The increase in net working capital is primarily attributable to an increase in working capital due to the acquisition of three hospitals and a large physician practice.

In connection with the consummation of the Triad acquisition in July 2007, we obtained approximately $7.2 billion of senior secured financing under the Credit Facility with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent. The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $300 million delayed draw term loan facility (subsequently reduced by us from $400 million) with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. During the fourth quarter of 2008, $100 million of the delayed draw term loan had been drawn down by us, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, we drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans. On November 5, 2010, we entered into an amendment and restatement of our existing Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of our existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of our 8 ⁷/8% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increased our ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permitted us to issue term loan A loans under the incremental facility and provided up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which approximately $1.7 billion would be required to be used for repayment of our existing term loans. In addition, effective February 2, 2012, we completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of our existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

48

Effective March 6, 2012, we obtained a new $750 million senior secured revolving credit facility, or the Replacement Revolver Facility, and a new $750 million incremental term loan A facility, or the Incremental Term Loan. The Replacement Revolver Facility replaced in full the existing revolving credit facility under the Credit Facility. The net proceeds of the Incremental Term Loan were used to repay the same amount of the existing term loans under the Credit Facility. The execution of these agreements resulted in a loss from early extinguishment of debt of $8.5 million with an after-tax impact of $5.3 million recorded in continuing operations for the three months ended March 31, 2012. Both the Replacement Revolver Facility and the Incremental Term Loan have a maturity date of October 25, 2016, subject to customary acceleration events and to the repayment, extension or refinancing with longer maturity debt of substantially all of the outstanding term loans maturing July 25, 2014, and 8 ⁷/8% Senior Notes due 2015. The pricing on each of the Replacement Revolver Facility and the Incremental Term Loan is initially LIBOR plus a margin of 250 basis points, subject to adjustment based on our leverage ratio. The Incremental Term Loan amortizes at 5% in year one, 10% in years two and three, 15% in year four and 60% in year five.

The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by us and our subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by us and our subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on our leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to our EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

The obligor under the Credit Facility is CHS. All of our obligations under the Credit Facility are unconditionally guaranteed by Community Health Systems, Inc. and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of Community Health Systems, Inc., CHS and each subsidiary guarantor, including equity interests held by us or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at our option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted LIBOR rate on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans was initially 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on our leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

We have agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. We are obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon our leverage ratio), on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, we were also obligated to pay commitment fees of 0.50% per annum for the first nine months after the close of the Credit Facility and 0.75% per annum for the next three months after such nine-month period and thereafter 1.0% per annum. In each case, the commitment fee was based on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, we no longer pay any commitment fees for the delayed draw term loan facility. We also paid arrangement fees on the closing of the Credit Facility and pay an annual administrative agent fee.

49

The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting our and our subsidiaries’ ability, subject to certain exception, to, among other things, (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of our businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change our fiscal year. We and our subsidiaries are also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

Events of default under the Credit Facility include, but are not limited to, (1) our failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

As of March 31, 2012, the availability for additional borrowings under our Credit Facility was approximately $750 million pursuant to the revolving credit facility, of which $37.7 million was set aside for outstanding letters of credit. We believe that these funds, along with internally generated cash and continued access to the bank credit and capital markets, will be sufficient to finance future acquisitions, capital expenditures and working capital requirements through the next 12 months and into the foreseeable future.

On March 21, 2012, CHS completed the secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019, which were issued in a private placement (at a premium of 102.5%). The net proceeds from this issuance were used to finance the purchase of $850 million aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015, to pay related fees and expenses and for general corporate purposes. On March 21, 2012, CHS completed the cash tender offer for $850 million of the $1.8 billion aggregate outstanding principal amount of 8 ⁷/8% Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $54.9 million with an after-tax impact of $34.3 million recorded in continuing operations for the three months ended March 31, 2012.

On March 21, 2012, through certain of our subsidiaries, we entered into an accounts receivables loan agreement, or the Receivables Facility, with a group of conduit lenders and liquidity banks, Credit Agricolé Corporate and Investment Bank, as a managing agent and as the administrative agent, and The Bank of Nova Scotia, as a managing agent. The existing and future patient-related accounts receivable, or the Receivables, for certain of our hospitals serve as collateral for the outstanding borrowings under the Receivables Facility. The interest rate on the borrowings is based on the commercial paper rate plus an applicable interest rate spread. Unless earlier terminated or subsequently extended pursuant to its terms, the Receivables Facility will expire on March 21, 2014, subject to customary termination events that could cause an early termination date. We maintain effective control over the Receivables because, pursuant to the terms of the Receivables Facility, the Receivables are sold from certain of our subsidiaries to us, and we then sell or contribute the Receivables to a special-purpose entity that is wholly-owned by us. The wholly-owned special-purpose entity in turn grants security interests in the Receivables in exchange for borrowings obtained from the group of third-party conduit lenders and liquidity banks of up to $300 million outstanding from time to time based on the availability of eligible Receivables and other customary factors. The group of third-party conduit lenders and liquidity banks do not have recourse to us or our subsidiaries beyond the assets of the wholly-owned special-purpose entity that collateralizes the loan. The Receivables and other assets of the wholly-owned special-purpose entity will be available first and foremost to satisfy the claims of the creditors of such entity. The outstanding borrowings pursuant to the Receivables Facility at March 31, 2012 totaled $300.0 million and are classified as long-term debt on the condensed consolidated balance sheet. At March 31, 2012, the carrying amount of Receivables included in the Receivables Facility totaled approximately $881.9 million and are included in patient accounts receivable on the condensed consolidated balance sheet.

As of March 31, 2012, we are a party to the following interest rate swap agreements to limit the effect of changes in interest rates on approximately 66% of our variable rate debt. On each of these swaps, we receive a variable rate of interest based on the three-month LIBOR in exchange for the payment by us of a fixed rate of interest. We currently pay, on a quarterly basis, a margin above LIBOR of 225 basis points for revolving credit and term loans due 2014 and 350 basis points for term loans due 2017 under the Credit Facility.

50

Swap #	Notional Amount (in 000’s)		Fixed Interest Rate			Termination Date		Fair Value of Liability (in 000’s)
1	$	250,000		5.0185	%		May 30, 2012	$	1,845
2		150,000		5.0250	%		May 30, 2012		1,108
3		200,000		4.6845	%		September 11, 2012		3,750
4		100,000		3.3520	%		October 23, 2012		1,607
5		125,000		4.3745	%		November 23, 2012		3,140
6		75,000		4.3800	%		November 23, 2012		1,886
7		150,000		5.0200	%		November 30, 2012		4,524
8		200,000		2.2420	%		February 28, 2013		3,170
9		100,000		5.0230	%		May 30, 2013		5,218
10		300,000		5.2420	%		August 6, 2013		18,940
11		100,000		5.0380	%		August 30, 2013		6,320
12		50,000		3.5860	%		October 23, 2013		2,350
13		50,000		3.5240	%		October 23, 2013		2,303
14		100,000		5.0500	%		November 30, 2013		7,377
15		200,000		2.0700	%		December 19, 2013		5,130
16		100,000		5.2310	%		July 25, 2014		10,301
17		100,000		5.2310	%		July 25, 2014		10,302
18		200,000		5.1600	%		July 25, 2014		20,287
19		75,000		5.0405	%		July 25, 2014		7,405
20		125,000		5.0215	%		July 25, 2014		12,289
21		100,000		2.6210	%		July 25, 2014		4,453
22		100,000		3.1100	%		July 25, 2014		5,550
23		100,000		3.2580	%		July 25, 2014		5,881
24		200,000		2.6930	%		October 26, 2014		9,962
25		300,000		3.4470	%		August 8, 2016		27,989
26		200,000		3.4285	%		August 19, 2016		18,576
27		100,000		3.4010	%		August 19, 2016		9,185
28		200,000		3.5000	%		August 30, 2016		19,200
29		100,000		3.0050	%		November 30, 2016		7,691

The Credit Facility and/or the Notes contain various covenants that limit our ability to take certain actions including, among other things, our ability to:

• incur, assume or guarantee additional indebtedness;

• issue redeemable stock and preferred stock;

• repurchase capital stock;

• make restricted payments, including paying dividends and making investments;

• redeem debt that is junior in right of payment to the notes;

51

• create liens without securing the notes;

• sell or otherwise dispose of assets, including capital stock of subsidiaries;

• enter into agreements that restrict dividends from subsidiaries;

• merge, consolidate, sell or otherwise dispose of substantial portions of our assets;

• enter into transactions with affiliates; and

• guarantee certain obligations.

In addition, our Credit Facility contains restrictive covenants and requires us to maintain specified financial ratios and satisfy other financial condition tests. We were in compliance with all financial ratios and other financial condition tests at March 31, 2012, and expect to remain in compliance in the future. Our ability to meet these restrictive covenants and financial ratios and tests can be affected by events beyond our control, and we cannot assure you that we will meet those tests. A breach of any of these covenants could result in a default under our Credit Facility and/or the Notes. Upon the occurrence of an event of default under our Credit Facility or the Notes, all amounts outstanding under our Credit Facility and the Notes may become due and payable and all commitments under the Credit Facility to extend further credit may be terminated.

We believe that internally generated cash, availability for additional borrowings under our Credit Facility of $750 million (consisting of a $750 million revolving credit facility, of which $37.7 million is set aside for outstanding letters of credit as of March 31, 2012) and our ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion and our continued access to the bank credit and capital markets will be sufficient to finance acquisitions, capital expenditures and working capital requirements through the next 12 months. We believe these same sources of cash, borrowings under our Credit Facility as well as access to bank credit and capital markets will be available to us beyond the next 12 months and into the foreseeable future.

On December 22, 2008, we filed a universal automatic shelf registration statement on Form S-3ASR that will permit us, from time to time, in one or more public offerings, to offer debt securities, common stock, preferred stock, warrants, depositary shares, or any combination of such securities. The shelf registration statement will also permit our subsidiary, CHS, to offer debt securities that would be guaranteed by us, from time to time in one or more public offerings. The terms of any such future offerings would be established at the time of the offering.

The ratio of earnings to fixed charges is a measure of our ability to meet our fixed obligations related to our indebtedness. The following table shows the ratio of earnings to fixed charges for the three months ended March 31, 2012:

	Three Months Ended March 31, 2012
Ratio of earnings to fixed charges (1)		1.75x

(1) Fixed charges include interest expensed and capitalized during the year plus an estimate of the interest component of rent expense. There are no shares of preferred stock outstanding. See exhibit 12 filed as part of this Report for the calculation of this ratio.

Off-balance Sheet Arrangements

Our consolidated operating results for the three months ended March 31, 2012 and 2011, included $57.1 million and $53.0 million, respectively, of net operating revenues and $8.7 million and $5.6 million, respectively, of income from operations generated from five hospitals operated by us under operating lease arrangements. In accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP, the respective assets and the future lease obligations under these arrangements are not recorded on our condensed consolidated balance sheet. Lease costs under these arrangements are included in rent expense and totaled approximately $2.9 million and $3.1 million for the three months ended March 31, 2012 and 2011, respectively. The current terms of these operating leases expire between January 2013 and June 2022, not including lease extension options. If we allow these leases to expire, we would no longer generate revenue nor incur expenses from these hospitals.

52

In the past, we have utilized operating leases as a financing tool for obtaining the operations of specified hospitals without acquiring, through ownership, the related assets of the hospital and without a significant outlay of cash at the front end of the lease. We utilize the same operating strategies to improve operations at those hospitals held under operating leases as we do at those hospitals that we own. We have not entered into any operating leases for hospital operations since December 2000.

Noncontrolling Interests

We have sold noncontrolling interests in certain of our subsidiaries or acquired subsidiaries with existing noncontrolling interest ownership positions. As of March 31, 2012, we have hospitals in 23 of the markets we serve, with noncontrolling physician ownership interests ranging from less than 1% to 40%, including one hospital that also has a non-profit entity as a partner. In addition, we have three other hospitals with noncontrolling interests owned by non-profit entities. During the three months ended March 31, 2012, one of our subsidiaries purchased the outstanding partnership interests not already owned by us that were held by physician investors in the limited partnership that owns and operates Longview Regional Medical Center in Longview, Texas. The purchase price for these partnership interests was $28.8 million. After acquiring these partnership interests, one or more of our subsidiaries collectively own 100% of the outstanding equity of this hospital. Redeemable noncontrolling interests in equity of consolidated subsidiaries was $363.5 million and $395.7 million as of March 31, 2012 and December 31, 2011, respectively. Noncontrolling interests in equity of consolidated subsidiaries was $61.7 million and $67.3 million as of March 31, 2012 and December 31, 2011, respectively. The amount of net income attributable to noncontrolling interests was $23.8 million and $17.0 million for the three months ended March 31, 2012 and 2011, respectively. As a result of the change in the Stark Law “whole hospital” exception included in the Reform Legislation, we are not permitted to introduce physician ownership at any of our wholly-owned facilities or increase the aggregate percentage of physician ownership in any of our existing joint ventures.

Reimbursement, Legislative and Regulatory Changes

The Reform Legislation was enacted in the context of other ongoing legislative and regulatory efforts, which would reduce or otherwise adversely affect the payments we receive from Medicare and Medicaid. Within the statutory framework of the Medicare and Medicaid programs, including programs currently unaffected by the Reform Legislation, there are substantial areas subject to administrative rulings, interpretations, and discretion which may further affect payments made under those programs, and the federal and state governments might, in the future, reduce the funds available under those programs or require more stringent utilization and quality reviews of hospital facilities. Additionally, there may be a continued rise in managed care programs and additional restructuring of the financing and delivery of healthcare in the United States. These events could cause our future financial results to decline. We cannot estimate the impact of Medicare and Medicaid reimbursement changes that have been enacted or are under consideration. We cannot predict whether additional reimbursement reductions will be made or whether any such changes would have a material adverse effect on our business, financial conditions, results of operations, cash flow, capital resources and liquidity.

Inflation

The healthcare industry is labor intensive. Wages and other expenses increase during periods of inflation and when labor shortages occur in the marketplace. In addition, our suppliers pass along rising costs to us in the form of higher prices. We have implemented cost control measures, including our case and resource management program, to curb increases in operating costs and expenses. We have generally offset increases in operating costs by increasing reimbursement for services, expanding services and reducing costs in other areas. However, we cannot predict our ability to cover or offset future cost increases, particularly any increases in our cost of providing health insurance benefits to our employees as a result of the Reform Legislation.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements. Actual results may differ from these estimates under different assumptions or conditions.

Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and potentially result in materially different results under different assumptions and conditions. We believe that our critical accounting policies are limited to those described below.

53

Third-Party Reimbursement

Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive for treatment of patients covered by these programs are generally less than the standard billing rates. Contractual allowances are automatically calculated and recorded through our internally developed “automated contractual allowance system.” Within the automated system, actual Medicare DRG data and payors’ historical paid claims data are utilized to calculate the contractual allowances. This data is automatically updated on a monthly basis. All hospital contractual allowance calculations are subjected to monthly review by management to ensure reasonableness and accuracy. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual allowance adjustments, which we deduct from gross revenues to arrive at net operating revenues. The process of estimating contractual allowances requires us to estimate the amount expected to be received based on payor contract provisions. The key assumption in this process is the estimated contractual reimbursement percentage, which is based on payor classification and historical paid claims data. Due to the complexities involved in these estimates, actual payments we receive could be different from the amounts we estimate and record. If the actual contractual reimbursement percentage under government programs and managed care contracts differed by 1% at March 31, 2012 from our estimated reimbursement percentage, net income for the three months ended March 31, 2012 would have changed by approximately $39.8 million, and net accounts receivable at March 31, 2012 would have changed by $63.9 million. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous program reimbursement estimates as contractual allowance adjustments and report them in the periods that such adjustments become known. During the three months ended March 31, 2012, we recognized a net after-tax benefit of $42.8 million from the resolution of two industry-wide governmental payment updates related to prior periods. Other than this adjustment, contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in both of the three-month periods ended March 31, 2012 and 2011.

Allowance for Doubtful Accounts

Substantially all of our accounts receivable are related to providing healthcare services to our hospitals’ patients. Collection of these accounts receivable is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and outstanding patient balances for which the primary insurance payor has paid some but not all of the outstanding balance, with the remaining outstanding balance (generally deductibles and co-payments) owed by the patient. At the point of service, for patients required to make a co-payment, we generally collect less than 15% of the related revenue. For all procedures scheduled in advance, our policy is to verify insurance coverage prior to the date of the procedure. Insurance coverage is not verified in advance of procedures for walk-in and emergency room patients.

We estimate the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, we reserve 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on our collection history. We believe that we collect substantially all of our third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of our collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect our collection of accounts receivable. The process of estimating the allowance for doubtful accounts requires us to estimate the collectability of self-pay accounts receivable, which is primarily based on our collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. Significant change in payor mix, business office operations, economic conditions, trends in federal and state governmental healthcare coverage or other third-party payors could affect our estimates of accounts receivable collectability. If the actual collection percentage differed by 1% at March 31, 2012 from our estimated collection percentage as a result of a change in expected recoveries, net income for the three months ended March 31, 2012 would have changed by $20.6 million, and net accounts receivable at March 31, 2012 would have changed by $32.7 million. We also continually review our overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding and the impact of recent acquisitions and dispositions.

Our policy is to write-off gross accounts receivable if the balance is under $10.00 or when such amounts are placed with outside collection agencies. We believe this policy accurately reflects our ongoing collection efforts and is consistent with industry practices.

54

We had approximately $2.3 billion and $2.2 billion at March 31, 2012 and December 31, 2011, respectively, being pursued by various outside collection agencies. We expect to collect less than 3%, net of estimated collection fees, of the amounts being pursued by outside collection agencies. As these amounts have been written-off, they are not included in our gross accounts receivable or our allowance for doubtful accounts. Collections on amounts previously written-off are recognized as a reduction to bad debt expense when received. However, we take into consideration estimated collections of these future amounts written-off in evaluating the reasonableness of our allowance for doubtful accounts.

All of the following information is derived from our hospitals, excluding clinics, unless otherwise noted.

Patient accounts receivable from our hospitals represent approximately 95% of our total consolidated accounts receivable.

Days revenue outstanding was 56 days at both March 31, 2012 and December 31, 2011. Our target range for days revenue outstanding is 53 to 63 days.

Total gross accounts receivable (prior to allowance for contractual adjustments and doubtful accounts) was approximately $9.3 billion and $8.3 billion as of March 31, 2012 and December 31, 2011, respectively.

The approximate percentage of total gross accounts receivable (prior to allowances for contractual adjustments and doubtful accounts) summarized by payor category is as follows:

	March 31, 2012			December 31, 2011
Insured receivables		65.6	%		63.7	%
Self-pay receivables		34.4	%		36.3	%
Total		100.0	%		100.0	%

For the hospital segment, the combined total of the allowance for doubtful accounts for self-pay accounts receivable and related allowances for other self-pay discounts and contractuals, as a percentage of gross self-pay receivables, was approximately 84% at both March 31, 2012 and December 31, 2011. If the receivables that have been written-off, but where collections are still being pursued by outside collection agencies, were included in both the allowances and gross self-pay receivables specified above, the percentage of combined allowances to total self-pay receivables would have been approximately 91% at both March 31, 2012 and December 31, 2011.

Goodwill and Other Intangibles

Goodwill represents the excess of the fair value of the consideration conveyed in the acquisition over the fair value of net assets acquired. Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. We have selected September 30 as our annual testing date. Based on the results of our most recent annual impairment test, we have concluded that we do not have any reporting units that are at risk of failing step one of the goodwill impairment test.

Impairment or Disposal of Long-Lived Assets

Whenever events or changes in circumstances indicate that the carrying values of certain long-lived assets may be impaired, we project the undiscounted cash flows expected to be generated by these assets. If the projections indicate that the reported amounts are not expected to be recovered, such amounts are reduced to their estimated fair value based on a quoted market price, if available, or an estimate based on valuation techniques available in the circumstances.

55

Professional Liability Insurance Claims

As part of our business of owning and operating hospitals, we are subject to legal actions alleging liability on our part. We accrue for losses resulting from such liability claims, as well as loss adjustment expenses that are out-of-pocket and directly related to such liability claims. These direct out-of-pocket expenses include fees of outside counsel and experts. We do not accrue for costs that are part of our corporate overhead, such as the costs of our in-house legal and risk management departments. The losses resulting from professional liability claims primarily consist of estimates for known claims, as well as estimates for incurred but not reported claims. The estimates are based on specific claim facts, our historical claim reporting and payment patterns, the nature and level of our hospital operations, and actuarially determined projections. The actuarially determined projections are based on our actual claim data, including historic reporting and payment patterns which have been gathered over approximately a 20-year period. As discussed below, since we purchase excess insurance on a claims-made basis that transfers risk to third-party insurers, the liability we accrue does include an amount for the losses covered by our excess insurance. We also record a receivable for the expected reimbursement of losses covered by our excess insurance. Since we believe that the amount and timing of our future claims payments are reliably determinable, we discount the amount we accrue for losses resulting from professional liability claims using the risk-free interest rate corresponding to the timing of our expected payments.

The net present value of the projected payments was discounted using a weighted-average risk-free rate of 1.2% and 1.3% in 2011 and 2010, respectively. This liability is adjusted for new claims information in the period such information becomes known to us. Professional malpractice expense includes the losses resulting from professional liability claims and loss adjustment expense, as well as paid excess insurance premiums, and is presented within other operating expenses in the accompanying condensed consolidated statements of income.

Our processes for obtaining and analyzing claims and incident data are standardized across all of our hospitals and have been consistent for many years. We monitor the outcomes of the medical care services that we provide and for each reported claim, we obtain various information concerning the facts and circumstances related to that claim. In addition, we routinely monitor current key statistics and volume indicators in our assessment of utilizing historical trends. The average lag period between claim occurrence and payment of a final settlement is between four and five years, although the facts and circumstances of individual claims could result in the timing of such payments being different from this average. Since claims are paid promptly after settlement with the claimant is reached, settled claims represent less than 1.0% of the total liability at the end of any period.

For purposes of estimating our individual claim accruals, we utilize specific claim information, including the nature of the claim, the expected claim amount, the year in which the claim occurred and the laws of the jurisdiction in which the claim occurred. Once the case accruals for known claims are determined, information is stratified by loss layers and retentions, accident years, reported years, geography, and claims relating to the acquired Triad hospitals versus claims relating to our other hospitals. Several actuarial methods are used against this data to produce estimates of ultimate paid losses and reserves for incurred but not reported claims. Each of these methods uses our company-specific historical claims data and other information. This company-specific data includes information regarding our business, including historical paid losses and loss adjustment expenses, historical and current case loss reserves, actual and projected hospital statistical data, a variety of hospital census information, employed physician information, professional liability retentions for each policy year, geographic information and other data.

Based on these analyses, we determine our estimate of the professional liability claims. The determination of management’s estimate, including the preparation of the reserve analysis that supports such estimate, involves subjective judgment of management. Changes in reserving data or the trends and factors that influence reserving data may signal fundamental shifts in our future claim development patterns or may simply reflect single-period anomalies. Even if a change reflects a fundamental shift, the full extent of the change may not become evident until years later. Moreover, since our methods and models use different types of data and we select our liability from the results of all of these methods, we typically cannot quantify the precise impact of such factors on our estimates of the liability. Due to our standardized and consistent processes for handling claims and the long history and depth of our company-specific data, our methodologies have produced reliably determinable estimates of ultimate paid losses.

We are primarily self-insured for these claims; however, we obtain excess insurance that transfers the risk of loss to a third-party insurer for claims in excess of our self-insured retentions. Our excess insurance is underwritten on a claims-made basis. For claims reported prior to June 1, 2002, substantially all of our professional and general liability risks were subject to a $0.5 million per occurrence self-insured retention and for claims reported from June 1, 2002 through June 1, 2003, these self-insured retentions were $2.0 million per occurrence. Substantially all claims reported after June 1, 2003 and before June 1, 2005 are self-insured up to $4 million per claim. Substantially all claims reported on or after June 1, 2005 are self-insured up to $5 million per claim. Management, on occasion, has selectively increased the insured risk at certain hospitals based upon insurance pricing and other factors and may

56

continue that practice in the future. Excess insurance for all hospitals has been purchased through commercial insurance companies and generally covers us for liabilities in excess of the self-insured retentions. The excess coverage consists of multiple layers of insurance, the sum of which totals up to $95 million per occurrence and in the aggregate for claims reported on or after June 1, 2003, up to $145 million per occurrence and in the aggregate for claims incurred and reported after January 1, 2008 and up to $195 million per occurrence and in the aggregate for claims reported after June 1, 2010. For certain policy years, if the first aggregate layer of excess coverage becomes fully utilized, then the self-insured retention could increase to $10 million per claim for any subsequent claims in that policy year until our total aggregate coverage is met.

Effective January 1, 2008, the former Triad hospitals are insured on a claims-made basis as described above and through commercial insurance companies as described above for substantially all claims occurring on or after January 1, 2002 and reported on or after January 1, 2008. Substantially all losses for the former Triad hospitals in periods prior to May 1, 1999 were insured through a wholly-owned insurance subsidiary of HCA Inc., or HCA, Triad’s owner prior to that time, and excess loss policies maintained by HCA. HCA has agreed to indemnify the former Triad hospitals in respect of claims covered by such insurance policies arising prior to May 1, 1999. From May 1, 1999 through December 31, 2006, the former Triad hospitals obtained insurance coverage on a claims incurred basis from HCA’s wholly-owned insurance subsidiary with excess coverage obtained from other carriers that is subject to certain deductibles. Effective for claims incurred after December 31, 2006, Triad began insuring its claims from $1 million to $5 million through its wholly-owned captive insurance company, replacing the coverage provided by HCA. Substantially all claims occurring during 2007 were self-insured up to $10 million per claim.

There have been no significant changes in our estimate of the reserve for professional liability claims during the three months ended March 31, 2012.

Income Taxes

We must make estimates in recording provision for income taxes, including determination of deferred tax assets and deferred tax liabilities and any valuation allowances that might be required against the deferred tax assets. We believe that future income will enable us to realize certain deferred tax assets, subject to the valuation allowance we have established.

The total amount of unrecognized benefit that would impact the effective tax rate, if recognized, was approximately $2.0 million as of March 31, 2012. During the three months ended March 31, 2012, we increased liabilities for uncertain tax positions by $1.0 million and increased interest and penalties by approximately $0.2 million. A total of approximately $0.5 million of interest and penalties is included in the amount of liability for uncertain tax positions at March 31, 2012. It is our policy to recognize interest and penalties related to unrecognized benefits in our condensed consolidated statements of income as income tax expense.

It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, we do not anticipate the change will have a material impact on our consolidated results of operations or consolidated financial position.

We, or one or more of our subsidiaries, file income tax returns in the United States federal jurisdiction and various state jurisdictions. We have extended the federal statute of limitations for Triad for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The IRS has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. With few exceptions, we are no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. Our federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. We believe the results of this examination will not be material to our consolidated results of operations or consolidated financial position. In connection with our 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of our malpractice expense deductions. Management believes that our deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of our deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.

57

Recent Accounting Pronouncements

In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about our policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and was adopted by us on January 1, 2012. Upon adoption, our provision for bad debts was presented as a reduction of operating revenue after contractual adjustments and discounts.

In September 2011, the FASB issued ASU 2011-08, which modifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. This ASU is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and was adopted by us on January 1, 2012. The adoption of this ASU is not expected to impact our consolidated financial position, results of operations or cash flows.

FORWARD-LOOKING STATEMENTS

Some of the matters discussed in this report include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “thinks,” and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include the following:

• general economic and business conditions, both nationally and in the regions in which we operate,

• implementation and effect of adopted and potential federal and state healthcare legislation,

• risks associated with our substantial indebtedness, leverage and debt service obligations,

• demographic changes,

• changes in, or the failure to comply with, governmental regulations,

• potential adverse impact of known and unknown government investigations, audits, and Federal and State False Claims Act litigation and other legal proceedings,

• our ability, where appropriate, to enter into and maintain managed care provider arrangements and the terms of these arrangements,

• changes in, or the failure to comply with, managed care provider contracts could result in disputes and changes in reimbursement that could be applied retroactively,

• changes in inpatient or outpatient Medicare and Medicaid payment levels,

• increases in the amount and risk of collectability of patient accounts receivable,

• increases in wages as a result of inflation or competition for highly technical positions and rising supply costs due to market pressure from pharmaceutical companies and new product releases,

• liabilities and other claims asserted against us, including self-insured malpractice claims,

58

• competition,

• our ability to attract and retain, at reasonable employment costs, qualified personnel, key management, physicians, nurses and other healthcare workers,

• trends toward treatment of patients in less acute or specialty healthcare settings, including ambulatory surgery centers or specialty hospitals,

• changes in medical or other technology,

• changes in U.S. GAAP,

• the availability and terms of capital to fund additional acquisitions or replacement facilities,

• our ability to successfully acquire additional hospitals or complete divestitures,

• our ability to successfully integrate any acquired hospitals or to recognize expected synergies from such acquisitions,

• our ability to obtain adequate levels of general and professional liability insurance and

• timeliness of reimbursement payments received under government programs.

Although we believe that these statements are based upon reasonable assumptions, we can give no assurance that our goals will be achieved. Given these uncertainties, prospective investors are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are made as of the date of this filing. We assume no obligation to update or revise them or provide reasons why actual results may differ.

Item 3.     Quantitative and Qualitative Disclosures about Market Risk

We are exposed to interest rate changes, primarily as a result of our Credit Facility which bears interest based on floating rates. In order to manage the volatility relating to the market risk, we entered into interest rate swap agreements described under the heading “Liquidity and Capital Resources” in Item 2. We utilize risk management procedures and controls in executing derivative financial instrument transactions. We do not execute transactions or hold derivative financial instruments for trading purposes. Derivative financial instruments related to interest rate sensitivity of debt obligations are used with the goal of mitigating a portion of the exposure when it is cost effective to do so. As interest rate swap agreements expire throughout the year, we will become more subject to variable interest rates during 2012.

A 1% change in interest rates on variable rate debt in excess of that amount covered by interest rate swaps would have resulted in interest expense fluctuating approximately $3.4 million and $1.6 million for the three months ended March 31, 2012 and 2011, respectively.

Item 4.     Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, with the participation of other members of management, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based on such evaluations, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective (at the reasonable assurance level) to ensure that the information required to be included in this report has been recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and to ensure that the information required to be included in this report was accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

There have been no changes in our internal control over financial reporting during the quarter ended March 31, 2012, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

59

PART II OTHER INFORMATION

Item 1.     Legal Proceedings

From time to time, we receive various inquiries or subpoenas from state regulators, fiscal intermediaries, the Centers for Medicare and Medicaid Services and the Department of Justice regarding various Medicare and Medicaid issues. In addition to the subpoenas discussed below, we are currently responding to subpoenas for matters such as: DME vendor relationships and patient choice discharge instructions at our Washington hospitals, operations of a cardiovascular surgery department at our Oregon hospital and lab operations at a New Mexico hospital. In addition, we are subject to other claims and lawsuits arising in the ordinary course of our business. We are not aware of any pending or threatened litigation that is not covered by insurance policies or reserved for in our financial statements or which we believe would have a material adverse impact on us; however, some pending or threatened proceedings against us may involve potentially substantial amounts as well as the possibility of civil, criminal, or administrative fines, penalties, or other sanctions, which could be material. Settlements of suits involving Medicare and Medicaid issues routinely require both monetary payments as well as corporate integrity agreements. Additionally, qui tam or “whistleblower” actions initiated under the civil False Claims Act may be pending but placed under seal by the court to comply with the False Claims Act’s requirements for filing such suits.

Community Health Systems, Inc. Legal Proceedings

On February 10, 2006, we received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on our hospitals in three states: Arkansas, New Mexico and South Carolina. On August 31, 2006, we received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to our three hospitals in that state. Through the beginning of 2009, we provided the Department of Justice with requested documents, met with its personnel on numerous occasions and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified us that it believed that we and these three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. We filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part our motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied our motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, we filed our answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. Motions for Summary Judgment were filed on March 27, 2012 and there is currently no trial date set. On March 30, 2012, the court denied our motion to exclude Plaintiffs’ expert witness testimony, which we believe fails to follow the controlling Medicaid statute and regulations and results in an exaggeration of the damages estimate by fourfold. We will have the opportunity to challenge the methodology employed at trial. We are vigorously defending this action.

On June 12, 2008, two of our hospitals received letters from the United States Attorney’s Office for the Western District of New York requesting documents in an investigation it was conducting into billing practices with respect to kyphoplasty procedures performed during the period January 1, 2002 through June 9, 2008. On September 16, 2008, one of our hospitals in South Carolina also received an inquiry. Kyphoplasty is a surgical spine procedure that returns a compromised vertebrae (either from trauma or osteoporotic disease process) to its previous height, reducing or eliminating severe pain. We have been informed that similar investigations have been initiated at unaffiliated facilities in Alabama, South Carolina, Indiana and other states. We believe that this investigation is related to a qui tam settlement between the same United States Attorney’s office and the manufacturer and distributor of the Kyphon product, which is used in performing the kyphoplasty procedure. We are cooperating with the investigation and we are continuing to evaluate and discuss this matter with the federal government.

60

On April 19, 2009, we were served in Roswell, New Mexico with an answer and counterclaim in the case of Roswell Hospital Corporation d/b/a Eastern New Mexico Medical Center vs. Patrick Sisneros and Tammie McClain (sued as Jane Doe Sisneros). The case was originally filed as a collection matter. The counterclaim was filed as a putative class action and alleged theories of breach of contract, unjust enrichment, misrepresentation, prima facie tort, Fair Trade Practices Act and violation of the New Mexico RICO statute. On May 7, 2009, the hospital filed a notice of removal to federal court. On July 27, 2009, the case was remanded to state court for lack of a federal question. A motion to dismiss and a motion to dismiss misjoined counterclaim plaintiffs were filed on October 20, 2009. These motions were denied. Extensive discovery has been conducted. A motion for class certification for all uninsured patients was heard on March 3 through March 5, 2010 and on April 13, 2010, the state district court judge certified the case as a class action. Numerous hearings have been conducted to assess the sufficiency of the methodology used to determine class damages. On December 5, 2011, the court entered an order approving the suggested damages methodology. The court has now ordered that class notice be sent by April 30, 2012. We are vigorously defending this action.

On December 7, 2009, we received a document subpoena from the United States Department of Health and Human Services, Office of the Inspector General, or OIG, requesting documents related to our hospital in Laredo, Texas. The categories of documents requested included case management, resource management, admission criteria, patient medical records, coding, billing, compliance, the Joint Commission accreditation, physician documentation, payments to referral sources, transactions involving physicians, disproportionate share hospital status and audits by the hospital’s Quality Improvement organization. On January 22, 2010, we received a “request for information or assistance” from the OIG’s Office of Investigation requesting patient medical records from Laredo Medical Center in Laredo, Texas for certain Medicaid patients with an extended length of stay. Additional requests for records have also been received, including a request containing follow-up questions received on January 5, 2011. We continue to cooperate fully with this investigation.

On May 16, 2011, we received a subpoena dated May 10, 2011 from the Houston Office of the United States Department of Health and Human Services, OIG, requesting 71 patient medical records from our hospital in Shelbyville, Tennessee, and directing the return of the records to the Assistant United States Attorney handling the Laredo investigation. We are unaware of any connection between these two facilities other than they are both affiliated with us. We continue to cooperate fully with this investigation.

On September 20, 2010, we received a letter from the United States Department of Justice, Civil Division, advising us that an investigation is being conducted to determine whether certain hospitals have improperly submitted claims for payment for implantable cardioverter defibrillators, or ICD. The period of time covered by the investigation is 2003 to the present. The letter states that the Department of Justice’s data indicates that many of our hospitals have claims that need to be reviewed to determine if Medicare payment was appropriate. We understand that the Department of Justice has submitted similar requests to many other hospitals and hospital systems across the country as well as to the ICD manufacturers themselves. We continue to fully cooperate with the government in this investigation and have provided requested records and documents.

On November 15, 2010, we were served with substantially identical Civil Investigative Demands (CIDs) from the Office of Attorney General, State of Texas for all 18 of our affiliated Texas hospitals. The subject of the requests appears to concern emergency department procedures and billing. We have complied with these requests and are providing all documentation and reports requested. We are continuing to cooperate with the government in this investigation.

On April 8, 2011, we received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, OIG, in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of our hospitals and appears to concern emergency department processes and procedures, including our hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about our relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by our Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010 (described above). This investigation is being led by the Department of Justice. We are continuing to cooperate with the government including detailing a process for a medical necessity review by clinical reviewers and physicians of a sampling of medical records at a small number of hospitals.

On April 11, 2011, Tenet Healthcare Corporation, or Tenet, filed suit against the Company, Wayne T. Smith and W. Larry Cash in the United States District Court for the Northern District of Texas. The suit alleged we committed violations of certain federal securities laws by making certain statements in various proxy materials filed with the Securities and Exchange Commission, or SEC,

61

in connection with our offer to purchase Tenet. Tenet alleged that we engaged in a practice to under-utilize observation status and over-utilize inpatient admission status and asserts that by doing so, we created undisclosed financial and legal liability to federal, state and private payors. The suit seeks declaratory and injunctive relief and Tenet’s costs. On April 19, 2011, we filed a motion to dismiss the complaint. On April 28, 2011, we responded to the allegations during our earnings release conference call (see our Form 8-K furnished on April 28, 2011). On May 16, 2011, Tenet filed an amended complaint. On June 29, 2011, we filed a motion to dismiss the amended complaint. A hearing on our motion to dismiss occurred on September 8, 2011. On March 21, 2012, the court dismissed this case in its entirety, with prejudice.

On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another department in the fall of 2006. This facility was acquired by us as part of the July 25, 2007 merger transaction with Triad Hospitals, Inc. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. We had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services, or HHS, are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of our Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. (Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, we may learn of additional qui tam suits filed against us or our affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests we have received in the past from various governmental agencies are generated from qui tam cases filed under seal.) The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. Our management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. We agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. Our response setting forth our legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. On April 26, 2012, we joined the government and the relator in a motion to extend the stay in this case for an additional 180 days. As noted in that filing, we are working with the government on a probe audit of medical records (described above with respect to the April 2011 subpoena). We are cooperating fully with the government in its investigations.

On May 13, 2011, we received a subpoena from the SEC requesting documents related to or requested in connection with the various inquiries, lawsuits and investigations regarding, generally, emergency room admissions or observation practices at our hospitals. The subpoena also requested documents relied upon by us in responding to the Tenet litigation, as well as other communications about the Tenet litigation. As with all government investigations, we are cooperating fully with the SEC.

Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark

62

Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of our common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for our common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties are in the process of negotiating operative dates for these consolidated shareholder federal securities actions, including dates for the filing of an operative consolidated complaint and related briefing.

Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. The Plaintiffs filed an operative amended derivative complaint in these three consolidated actions on March 15, 2012. A responsive pleading is due May 14, 2012. We believe all of these matters are without merit and will vigorously defend them.

On June 2, 2011, an order was entered unsealing a relator’s qui tam complaint in the matter of U.S. ex. rel Wood M. Deming, MD, individually and on behalf of Regional Cardiology Consultants, PC v. Jackson-Madison County General Hospital, an Affiliate of West Tennessee Healthcare, Regional Hospital of Jackson, a Division of Community Health Systems Professional Services Corporation, James Moss, individually, Timothy Puthoff, individually, Joel Perchik, MD, individually, and Elie H. Korban, MD, individually. The action is pending in the Western District of Tennessee, Jackson Division. Regional Hospital of Jackson is an affiliated hospital and Mr. Puthoff is a former chief executive officer there. The Order recited that the United States had elected to intervene to a limited degree only concerning the claims against Dr. Korban for false and fraudulent billing for allegedly unnecessary stent procedures and for causing the submission of false claims by the hospitals. The United States expressly declined to intervene in all other claims against all other named defendants. On July 28, 2011, we were served by the relator. On September 7, 2011, we filed our answer. On January 26, 2012, the relator was granted unopposed leave to file an amended complaint, but has not yet done so. We believe the claims against our hospital are without merit and we will vigorously defend this case.

On June 13, 2011, our hospital in Easton, Pennsylvania received a document subpoena from the Philadelphia office of the United States Department of Justice. The documents requested included medical records for certain urological procedures performed by a non-employed physician who is no longer on the medical staff and other records concerning the hospital’s relationship with the physician. Certain procedures performed by the physician had been previously reviewed and appropriate repayments had been made. We are cooperating fully with the government in this investigation.

On February 2, 2012, an order was entered unsealing a relator’s qui tam complaint in the matter of Pamela Gronemeyer ex rel. United States of America v. Crossroads Community Hospital. The action is pending in the United States District Court, Southern District of Illinois. Crossroads Community Hospital is an affiliated hospital. The order recited that the United States had declined to intervene in this matter. We had previously disclosed this matter in the context of our response to a subpoena concerning blood administration practices at an affiliated Illinois hospital. We were served in this case on April 18, 2012. We believe the claim against our hospital is without merit and we will vigorously defend this case.

On February 4, 2010, suit was filed in the matter styled Managed Care Solutions, Inc. v. Community Health Systems, Inc., United States District Court for the Southern District of Florida. Plaintiff contracted with two affiliated hospitals to provide services collecting receivables from third-party payors. Plaintiff seeks to extend the contract to additional facilities at which it never provided any services and is claiming $435 million in damages. A motion for summary judgment was filed on February 17, 2012. Trial is currently scheduled for June 4, 2012. We will continue to vigorously defend this action.

On February 23, 2012, our hospital in Hattiesburg, Mississippi received a document subpoena from the United States Department of Health and Human Services, OIG relating to its relationship with Allegiance Health Management, Inc., or Allegiance, a company that provides intensive outpatient psychiatric, or IOP, services to its patients. The subpoena seeks information concerning the hospital’s financial relationship with Allegiance, medical records of patients receiving IOP services, and other documents relating to Allegiance such as agreements, policies and procedures, audits, complaints, budgets, financial analyses and identities of those delivering services. This is our only hospital that received services from this vendor. We are cooperating fully with this investigation.

63

On January 30, 2012, an order was entered unsealing a relator’s qui tam complaint in the matter of U.S. ex rel. Wilson v. Crestwood Healthcare LP d/b/a Crestwood Medical Center, et al., United States District Court for the Northern District of Alabama and originally filed on September 16, 2011. Co-defendant Dr. Pamela Hudson is the chief executive officer there. The matter concerns lease arrangements with the other named physician co-defendants. The government declined to intervene in this case. The hospital was served on February 21, 2012, and a motion to dismiss was filed on April 30, 2012. We are vigorously defending this matter.

On February 29, 2012, Gregg Becker, a former chief financial officer at Rockwood Clinic in Spokane, Washington, sued “Community Health Systems, Inc. d/b/a Community Health Systems Professional Services Corporation d/b/a Community Health Systems d/b/a Community Health Systems PSC, Inc. d/b/a Rockwood Clinic P.S and Rockwood Clinic, PS” in Superior Court, Spokane, Washington. On March 9, 2012, the case was removed to federal court in Spokane. Becker claims he was wrongfully terminated for allegedly refusing to certify a budget for Rockwood Clinic in 2012. On February 29, 2012, he also filed an administrative complaint with the Department of Labor, Occupational Safety and Health Administration alleging that he is a whistleblower under Sarbanes-Oxley. On April 5, 2012, motions to dismiss on the merits and jurisdictional grounds were filed in the civil case. We will vigorously defend this action.

Management of Significant Legal Proceedings

In accordance with our governance documents, including our Governance Guidelines and the charter of the Audit and Compliance Committee, our management of significant legal proceedings is overseen by the independent members of the Board of Directors and, in particular, the Audit and Compliance Committee. The Audit and Compliance Committee is charged with oversight of compliance, regulatory and litigation matters, and enterprise risk management. All significant legal proceedings and allegations of financial statement fraud, error, or misstatement are promptly referred to the Audit and Compliance Committee for its oversight and evaluation. Consistent with New York Stock Exchange and Sarbanes-Oxley independence requirements, the Audit and Compliance Committee is comprised entirely of individuals who are independent of Company management, and all three members of the Audit and Compliance Committee are “audit committee financial experts” as defined in the Exchange Act.

In addition, the Audit and Compliance Committee and the other independent members of the Board of Directors oversee the functions of the voluntary compliance program, including its auditing and monitoring functions and confidential disclosure program. In recent years, the voluntary compliance program has addressed the potential for a variety of billing errors that might be the subject of audits and payment denials by the CMS Recovery Audit Contractors’ permanent project, including MS-DRG coding, outpatient hospital and physician coding and billing, and medical necessity for services (including a focus on hospital stays of very short duration). Efforts by management, through the voluntary compliance program, to identify and limit risk from these government audits included significant policy and guidance revisions, training and education, and auditing. With respect to Medicare inpatient admissions, improvements in case management, including updating of inpatient medical necessity criteria, heightened focus on correct use of observation status, and new policies requiring unambiguous signed physician orders prior to billing, were all adopted in 2009 and 2010. These activities were communicated to and discussed with the Audit and Compliance Committee.

With respect to the various assertions of third parties about the Audit and Compliance Committee’s oversight:

• The September 2010 allegation made by CtW Investment Group (that a high percentage of our hospitals had a high percentage of Medicare short-stay inpatient admissions, which could signal billing improprieties) was promptly referred to the Audit and Compliance Committee and an investigation was authorized and initiated with outside counsel and consultants in December 2010 (on February 15, 2012, we received a follow-up letter from CtW Investment Group that discusses the inherent limitations in using only publicly available data and points out that other factors can affect admission and length of stay patterns; the letter also concludes that CtW Investment Group is now satisfied with the commitment of the Company, its management and its Board of Directors to acting in accordance with their respective duties and obligations);

• Prior to the receipt of the civil investigative demands in Texas in November 2010, no concerns had been raised that the Pro-MED emergency department management system inappropriately caused physicians or hospitals to order tests or admit patients, and we continue to dispute that it does so; and

64

• The purported “observation rate” metric, which served as a basis for allegations contained in Tenet’s lawsuit, is not generally accepted in the industry and fails to account for patients who are treated and discharged promptly (i.e., neither admitted as inpatients nor placed in observation). We continue to dispute the validity of the metric in the manner used by Tenet or that the metric is a meaningful indicator of incorrect billing practices, and on March 21, 2012, Tenet’s lawsuit was dismissed in its entirety.

Since April 2011, our Audit and Compliance Committee and/or Board of Directors has met, on average, monthly to review the status of the lawsuits and investigations relating to allegations of improper billing for inpatient care at our hospitals and to oversee management in connection with our investigation and defense of these matters. At many of those meetings, the independent members of the Board of Directors have met in separate session, first with outside counsel handling the investigations and lawsuits, and then alone, to discuss their duties and oversight of these matters. The independent members of the Board of Directors have determined that (a) the Audit and Compliance Committee is the correct and most capable group of directors to oversee these matters and, given the independence and authority of the Audit and Compliance Committee, there is no need to form a further special committee to oversee these matters, and (b) outside counsel is handling the investigation and defense of these matters in the best interests of us and our stockholders and there is no need to engage separate counsel in connection with the investigation of these matters.

The independent members of our Board of Directors remain fully engaged in the oversight of these matters. We intend to provide additional updates about these matters as we are able to do so (taking into account any potential impact on these matters) through appropriate, widely-disseminated means.

Triad Hospitals, Inc. Legal Proceedings

In a case styled U.S. ex rel. Bartlett vs. Quorum Health Resources, LLC, et al., pending in the Western District of Pennsylvania, Johnstown Division, the relator alleges in his second amended complaint, filed in January 2006 (the first amended complaint having been dismissed), that QHR conspired with an unaffiliated hospital to pay illegal remuneration in violation of the federal anti-kickback statute and the Stark Law, thus causing false claims to be filed. A renewed motion to dismiss was filed in March 2006 asserting that the second amended complaint did not cure the defects contained in the first amended complaint. In September 2006, the hospital and one of the other defendants affiliated with the hospital filed for protection under Chapter 11 of the federal bankruptcy code, which imposed an automatic stay on proceedings in the case. Relators entered into a settlement agreement with the hospital, subject to confirmation of the hospital’s reorganization plan. The District Court conducted a status conference on January 30, 2009 and later convened another conference on March 30, 2009 and heard arguments on whether to proceed with a motion to dismiss, but did not make a ruling. The government and relator have reached a settlement with the hospital. On March 22, 2011, the court denied all other defendants’ motions to dismiss. Initial written discovery is underway. We believe this case is without merit and will continue to vigorously defend it.

Item 1A.     Risk Factors

None

Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds

We have not paid any cash dividends since our inception, and do not anticipate the payment of cash dividends in the foreseeable future. Our Credit Facility limits our ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate plus the aggregate amount of proceeds from the exercise of stock options. The indenture governing our Notes also limits our ability to pay dividends and/or repurchase stock. As of March 31, 2012, under the most restrictive test under these agreements, we have approximately $80.4 million available with which to pay permitted dividends and/or repurchase shares of stock or our Senior Notes.

Item 3.     Defaults Upon Senior Securities

None

Item 4.     Mine Safety Disclosures

None

Item 5.     Other Information

None

65

Item 6.     Exhibits

No.	Description
12	Computation of Ratio of Earnings to Fixed Charges
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document*
101.SCH	XBRL Schema Document*
101.CAL	XBRL Calculation Linkbase Document*
101.DEF	XBRL Definition Linkbase Document*
101.LAB	XBRL Label Linkbase Document*
101.PRE	XBRL Presentation Linkbase Document*

* Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

66

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

COMMUNITY HEALTH SYSTEMS, INC. (Registrant)
By:	/s/ Wayne T. Smith
	Wayne T. Smith Chairman of the Board, President and Chief Executive Officer (principal executive officer)

By:	/s/ W. Larry Cash
	W. Larry Cash Executive Vice President, Chief Financial Officer and Director (principal financial officer)

By:	/s/ Kevin J. Hammons
	Kevin J. Hammons Vice President and Chief Accounting Officer (principal accounting officer)

Date: April 27, 2012

67

Index to Exhibits

No.	Description
12	Computation of Ratio of Earnings to Fixed Charges
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document*
101.SCH	XBRL Schema Document*
101.CAL	XBRL Calculation Linkbase Document*
101.DEF	XBRL Definition Linkbase Document*
101.LAB	XBRL Label Linkbase Document*
101.PRE	XBRL Presentation Linkbase Document*

* Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

68

EX-12

Exhibit 12

STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(DOLLARS IN THOUSANDS)

	Three Months Ended March 31, 2012
Earnings
Income from continuing operations before provision for income taxes	$	145,537
Income from equity investees		(12,013	)
Distributed income from equity investees		2,941
Interest and amortization of deferred finance costs		152,175
Amortization of capitalized interest		3,285
Implicit rental interest expense		16,806
Total Earnings	$	308,731
Fixed Charges
Interest and amortization of deferred finance costs	$	152,175
Capitalized interest		7,199
Implicit rental interest expense		16,806
Total Fixed Charges	$	176,180
Ratio of earnings to fixed charges		1.75x

EX-31.1

Exhibit 31.1

I, Wayne T. Smith, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Community Health Systems, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2012	/s/ Wayne T. Smith
	Wayne T. Smith Chairman of the Board, President and Chief Executive Officer

EX-31.2

Exhibit 31.2

I, W. Larry Cash, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Community Health Systems, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2012	/s/ W. Larry Cash
	W. Larry Cash Executive Vice President, Chief Financial Officer and Director

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Community Health Systems, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wayne T. Smith, Chairman of the Board, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Wayne T. Smith

Wayne T. Smith

Chairman of the Board, President and Chief Executive Officer

April 27, 2012

A signed original of this written statement required by Section 906 has been provided to Community Health Systems, Inc. and will be retained by Community Health Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Community Health Systems, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, W. Larry Cash, Executive Vice President, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ W. Larry Cash

W. Larry Cash

Executive Vice President, Chief Financial Officer and Director

April 27, 2012

A signed original of this written statement required by Section 906 has been provided to Community Health Systems, Inc. and will be retained by Community Health Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Basis of Presentation and Significant Accounting Policies (Details) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	$ 3,783,491,000	$ 3,354,052,000
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Textual) [Abstract]
Percentage reserved of all accounts aging over specified period from the date of discharge	100.00%
Number of days from the date of discharge over which all accounts are reserved 100%	365 days
Electronic health records incentive reimbursement	26,168,000	0
Electronic Health Records Incentive Reimbursement, Cash received	5,800,000	0
Included in net operating revenues on a non-same store basis from an industry-wide reimbursement settlement	101,800,000
Reimbursement settlement and payment Included in net operating revenues	80,800,000
Unfavorable Adjustment Related To Newly Issued Supplemental Security Income Ratios	21,000,000
Medicare [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	1,064,157,000	923,864,000
Medicaid [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	315,092,000	321,525,000
Managed Care and other third-party payors [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	1,906,487,000	1,699,860,000
Self Pay [Member]
Health Care Organization Receivable and Revenue Disclosures [Line Items]
Total	$ 497,755,000	$ 408,803,000

XML

Earnings Per Share (Details 1)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Dilutive securities outstanding not included in computation of earnings per share
Employee stock options	6,869,031	4,395,292

XML

Acquisitions and Divestitures (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Net operating revenues and loss from discontinued operations
Net operating revenues		$ 59,126
Loss from operations of entities sold before income taxes	(729)	(2,673)
Impairment of hospitals sold		(13,095)
Loss on sale, net		(5,061)
Loss from discontinued operations, before taxes	(729)	(20,829)
Income tax benefit	263	7,549
Loss from discontinued operations, net of taxes	$ (466)	$ (13,280)

XML

Fair Value (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	$ 34,354	$ 31,582
Trading securities, fair value disclosure	35,944	30,486
Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	34,354	31,582
Trading securities, fair value disclosure	35,944	30,486
Total assets	70,298	62,068
Fair value of interest rate swap agreements	237,739	254,228
Total liabilities	237,739	254,228
Level 1 [Member] | Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure	34,354	31,582
Trading securities, fair value disclosure	35,944	30,486
Total assets	70,298	62,068
Level 2 [Member] | Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Fair value of interest rate swap agreements	237,739	254,228
Total liabilities	237,739	254,228
Level 3 [Member] | Fair Value, Measurements, Recurring [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale securities, fair value disclosure
Trading securities, fair value disclosure
Total assets
Fair value of interest rate swap agreements
Total liabilities

XML

Stockholders' Equity (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Beginning Balance	$ 2,464,445
Comprehensive income	113,595	116,612
Distributions to noncontrolling interests, net of contributions	(11,019)
Purchase of subsidiary shares from noncontrolling interests	(18,811)
Other reclassifications of noncontrolling interests	(623)
Adjustment to redemption value of redeemable noncontrolling interests	22,236
Repurchases of common stock
Issuance of common stock in connection with the exercise of stock options	308
Cancellation of restricted stock for tax withholdings on vested shares	(9,035)
Excess tax benefit from exercise of stock options	(1,895)
Share-based compensation	10,502
Ending Balance	2,552,104
Redeemable Noncontrolling Interests [Member]
Beginning Balance	395,743
Comprehensive income	17,599
Distributions to noncontrolling interests, net of contributions	(15,904)
Purchase of subsidiary shares from noncontrolling interests	(12,285)
Other reclassifications of noncontrolling interests	623
Adjustment to redemption value of redeemable noncontrolling interests	(22,236)
Repurchases of common stock
Ending Balance	363,540
Common Stock [Member]
Beginning Balance	915
Repurchases of common stock
Cancellation of restricted stock for tax withholdings on vested shares	(3)
Share-based compensation	7
Ending Balance	919
Additional Paid-in Capital [Member]
Beginning Balance	1,086,008
Purchase of subsidiary shares from noncontrolling interests	(18,673)
Adjustment to redemption value of redeemable noncontrolling interests	22,236
Repurchases of common stock
Issuance of common stock in connection with the exercise of stock options	308
Cancellation of restricted stock for tax withholdings on vested shares	(9,032)
Excess tax benefit from exercise of stock options	(1,895)
Share-based compensation	10,495
Ending Balance	1,089,447
Treasury Stock [Member]
Beginning Balance	(6,678)
Repurchases of common stock
Ending Balance	(6,678)
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance	(184,479)
Comprehensive income	14,343
Repurchases of common stock
Ending Balance	(170,136)
Retained Earnings [Member]
Beginning Balance	1,501,330
Comprehensive income	75,474
Repurchases of common stock
Ending Balance	1,576,804
Noncontrolling Interests [Member]
Beginning Balance	67,349
Comprehensive income	6,179
Distributions to noncontrolling interests, net of contributions	(11,019)
Purchase of subsidiary shares from noncontrolling interests	(138)
Other reclassifications of noncontrolling interests	(623)
Repurchases of common stock
Ending Balance	$ 61,748

XML

Supplemental Condensed Consolidating Financial Information (Details 3) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 187,310	$ 187,511
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(248,436)	(45,422)
Purchases of property and equipment	(184,903)	(153,875)
Proceeds from disposition of ancillary operations		14,583
Proceeds from sale of property and equipment	748	7,587
Increase in other investments	(67,708)	(32,277)
Net cash used in investing activities	(500,299)	(209,404)
Cash flows from financing activities:
Proceeds from exercise of stock options	308	18,125
Repurchase of restricted stock shares for payroll tax withholding requirements	(9,032)
Deferred financing costs	(24,787)
Excess tax benefit relating to stock-based compensation	1,004	4,675
Proceeds from noncontrolling investors in joint ventures	0	863
Redemption of noncontrolling investments in joint ventures	(31,096)	(225)
Distributions to noncontrolling investors in joint ventures	(27,038)	(15,333)
Changes in intercompany balances with affiliates, net	0
Borrowings under credit agreements	4,315,011
Issuance of long-term debt	1,025,000
Proceeds from receivables facility	300,000
Repayments of long-term indebtedness	(5,236,948)	(14,665)
Net cash provided by (used in) financing activities	312,422	(6,560)
Net change in cash and cash equivalents	(567)	(28,453)
Cash and cash equivalents at beginning of period	129,865	299,169
Cash and cash equivalents at end of period	129,298	270,716
Parent Guarantor [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(1,230)	(22,195)
Cash flows from investing activities:
Proceeds from disposition of ancillary operations	0
Cash flows from financing activities:
Proceeds from exercise of stock options	308	18,125
Repurchase of restricted stock shares for payroll tax withholding requirements	(9,032)
Excess tax benefit relating to stock-based compensation	1,004	4,675
Changes in intercompany balances with affiliates, net	8,950	(605)
Borrowings under credit agreements		0
Issuance of long-term debt		0
Proceeds from receivables facility		0
Net cash provided by (used in) financing activities	1,230	22,195
Net change in cash and cash equivalents	0
Cash and cash equivalents at beginning of period	0
Cash and cash equivalents at end of period	0
Issuer [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(26,237)	(83,202)
Cash flows from investing activities:
Proceeds from disposition of ancillary operations	0
Increase in other investments	10,000
Net cash used in investing activities	10,000
Cash flows from financing activities:
Deferred financing costs	(24,787)
Changes in intercompany balances with affiliates, net	(58,772)	95,750
Borrowings under credit agreements	4,305,674
Issuance of long-term debt	1,025,000
Proceeds from receivables facility		0
Repayments of long-term indebtedness	(5,230,878)	(12,548)
Net cash provided by (used in) financing activities	16,237	83,202
Net change in cash and cash equivalents	0
Cash and cash equivalents at beginning of period	0
Cash and cash equivalents at end of period	0
Other Guarantors [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	251,923	311,077
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(252,977)	(10,727)
Purchases of property and equipment	(127,796)	(64,312)
Proceeds from disposition of ancillary operations	0	0
Proceeds from sale of property and equipment	688	473
Increase in other investments	(45,612)	(36,201)
Net cash used in investing activities	(425,697)	(110,767)
Cash flows from financing activities:
Changes in intercompany balances with affiliates, net	173,612	(191,179)
Borrowings under credit agreements	9,337
Issuance of long-term debt		0
Proceeds from receivables facility		0
Repayments of long-term indebtedness	(5,307)	(1,472)
Net cash provided by (used in) financing activities	177,642	(192,651)
Net change in cash and cash equivalents	3,868	27,659
Cash and cash equivalents at beginning of period	14,536	212,035
Cash and cash equivalents at end of period	18,404	239,694
Non-Guarantors [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(37,146)	(38,169)
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	4,541	(34,695)
Purchases of property and equipment	(57,107)	(89,563)
Proceeds from disposition of ancillary operations	0	14,583
Proceeds from sale of property and equipment	60	7,114
Increase in other investments	(32,096)	3,924
Net cash used in investing activities	(84,602)	(98,637)
Cash flows from financing activities:
Proceeds from noncontrolling investors in joint ventures		863
Redemption of noncontrolling investments in joint ventures	(31,096)	(225)
Distributions to noncontrolling investors in joint ventures	(27,038)	(15,333)
Changes in intercompany balances with affiliates, net	(123,790)	96,034
Borrowings under credit agreements		0
Issuance of long-term debt		0
Proceeds from receivables facility	300,000
Repayments of long-term indebtedness	(763)	(645)
Net cash provided by (used in) financing activities	117,313	80,694
Net change in cash and cash equivalents	(4,435)	(56,112)
Cash and cash equivalents at beginning of period	115,329	87,134
Cash and cash equivalents at end of period	110,894	31,022
Eliminations [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities
Cash flows from investing activities:
Acquisitions of facilities and other related equipment
Purchases of property and equipment
Proceeds from disposition of ancillary operations
Proceeds from sale of property and equipment
Increase in other investments
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from exercise of stock options
Repurchase of restricted stock shares for payroll tax withholding requirements
Deferred financing costs
Excess tax benefit relating to stock-based compensation
Proceeds from noncontrolling investors in joint ventures
Redemption of noncontrolling investments in joint ventures
Distributions to noncontrolling investors in joint ventures
Changes in intercompany balances with affiliates, net
Borrowings under credit agreements	0	0
Issuance of long-term debt	0	0
Proceeds from receivables facility
Repayments of long-term indebtedness
Net cash provided by (used in) financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

XML

Accounting for Stock-Based Compensation (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended									3 Months Ended
	Mar. 31, 2012 M	Mar. 31, 2011	Mar. 31, 2012 Contractual Term of Option Granted Prior to 2005 [Member]	Mar. 31, 2012 Contractual Term of Option Granted from 2005 Through 2007 [Member]	Mar. 31, 2012 Contractual term of option granted from 2008 through 2012 [Member]	Mar. 31, 2012 Plan 2000 [Member]	Mar. 31, 2012 Plan 2009 [Member]	Mar. 31, 2012 Employee Stock Option [Member]	Mar. 31, 2012 Restricted Stock Restricted Stock Units and Phantom Shares [Member]	Mar. 31, 2012 Phantom Stock and Restricted Stock Units [Member] M	Feb. 24, 2010 Phantom Stock and Restricted Stock Units [Member] Plan 2000 [Member]	May 19, 2009 Phantom Stock and Restricted Stock Units [Member] Plan 2000 [Member]	Feb. 25, 2009 Phantom Stock and Restricted Stock Units [Member] Plan 2000 [Member]	Feb. 16, 2012 Phantom Stock and Restricted Stock Units [Member] Plan 2009 [Member]	Feb. 23, 2011 Phantom Stock and Restricted Stock Units [Member] Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unissued common stock reserved for grants						446,221	1,529,549
Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards	$ 64.9							$ 13.1	$ 51.8
Weighted Average Period in months	23									24
Closing price of Company's common stock	$ 22.24
Number of shares received by Director.											4,130	7,151	7,151	6,645	3,688
Contractual term of option granted			10 years	8 years	10 years
Accounting For Stock Based Compensation (Textual) [Abstract]
Weighted-average grant date fair value of stock options	$ 9.15	$ 10.34
Aggregate fair value, Deferred in plan	0.7
Aggregate intrinsic value of options exercised	$ 0.1	$ 5.9
Share equivalent units, Deferred in the plan	30,012
Valuation method used to estimate the fair value of stock options	Black Scholes option pricing model

XML

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2012

Long-Term Debt [Abstract]

Components of long term debt

Long-term debt consists of the following (in thousands):

	March 31,			December 31,
	2012			2011
Credit Facility:
Term loan A	$	750,000		$	—
Term loan B		5,219,062			5,949,383
Revolving credit loans		—			30,000
8 7/ 8% Senior Notes due 2015		931,016			1,777,617
8% Senior Notes due 2019		2,024,694			1,000,000
Receivables Facility		300,000			—
Capital lease obligations		48,767			48,361
Other		45,465			41,143
Total debt		9,319,004			8,846,504
Less current maturities		(75,388	)		(63,706	)
Total long-term debt	$	9,243,616		$	8,782,798

Redemption Price of 8.875 % Senior Notes in Long Term Debt

After July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the 8  ⁷/8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	Redemption Price
2011		104.438	%
2012		102.219	%
2013 and thereafter		100.000	%

Redemption Price of 8 % Senior Notes in Long Term Debt

On and after November 15, 2015, CHS is entitled, at its option, to redeem all or a portion of the 8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on November 15 of the years set forth below:

Period	Redemption Price
2015		104.000	%
2016		102.000	%
2017 and thereafter		100.000	%

XML

Supplemental Condensed Consolidating Financial Information (Details Textual) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2012	Mar. 31, 2012 Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2011 Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2007 Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Senior Notes 8.875% Due 2015 [Member]	Mar. 31, 2012 8% Senior Notes Due 2019 [Member]	Dec. 31, 2011 8% Senior Notes Due 2019 [Member]	Nov. 22, 2011 8% Senior Notes Due 2019 [Member]	Jul. 25, 2007 8% Senior Notes Due 2019 [Member]	Jul. 25, 2007 Community Health System [Member]	Dec. 31, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]
Supplemental Condensed Consolidating Financial Information (Textual) [Abstract]
Senior secured financing under a new credit facility										$ 7,200,000,000
Principal amount of senior notes issued						1,000,000,000	1,000,000,000	1,000,000,000			3,000,000,000	3,000,000,000
Percentage of owned domestic subsidiaries which guaranteed senior notes	100.00%
Amount used to tender long term debt		$ 850,000,000	$ 1,000,000,000
Percentage of interest rate				8.875%	8.875%	8.00%			8.00%

XML

Contingencies (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012
Pre tax charges in connection with lawsuits
Professional fees and other related costs	$ 1,903

XML

Stockholders' Equity (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended				3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Dec. 31, 2011	Dec. 14, 2011 New open market repurchase program [Member]	Mar. 31, 2012 Open Market Repurchase Program [Member]	Sep. 15, 2010 Open Market Repurchase Program [Member]
Stockholders' Equity (Textual) [Abstract]
Total capital stock, shares authorized	400,000,000
Common stock, shares authorized	300,000,000		300,000,000
Preferred stock, shares authorized	100,000,000		100,000,000
Common stock, par value per share	$ 0.01		$ 0.01
Maximum amount of dividends and or stock repurchases under credit facility	$ 50
Amount Available for Dividend Distribution for Restrictions on Dividends Stock and Notes Repurchases	80.4
Additional Stockholders' Equity (Textual) [Abstract]
Maximum Number of shares authorized for repurchase				4,000,000		4,000,000
Maximum amount of shares authorized under repurchase program				$ 100		$ 100
Condition to conclude repurchase program				Earliest of three years, when the maximum number of shares has been repurchased, or when the maximum dollar amount has been reached.
Number of shares repurchased and retired	0	0
Cumulative number of shares repurchased and retired					3,921,138
Cumulative weighted average price of repurchased and retired shares, per share					$ 25.39

XML

Supplemental Condensed Consolidating Financial Information (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Condensed Consolidated Statements of Income (Unaudited)
Operating revenues (net of contractual allowances and discounts)	$ 3,783,491	$ 3,354,052
Provision for bad debts	486,456	399,969
Net operating revenues	3,297,035	2,954,083
Operating costs and expenses:
Salaries and benefits	1,524,975	1,379,367
Supplies	498,579	457,817
Other operating expenses	708,943	614,793
Electronic health records incentive reimbursement	(26,168)	0
Rent	67,224	63,170
Depreciation and amortization	174,354	158,155
Total operating costs and expenses	2,947,907	2,673,302
Income from operations	349,128	280,781
Interest expense, net	152,175	163,218
Loss from early extinguishment of debt	63,429
Equity in earnings of unconsolidated affiliates	(12,013)	(18,134)
Income from continuing operations before income taxes	145,537	135,697
Provision for (benefit from) income taxes	45,819	44,092
Income from continuing operations	99,718	91,605
Discontinued operations, net of taxes:
Loss from operations of entities sold	(466)	(1,678)
Impairment of hospital sold		(8,368)
Loss on sale, net		(3,234)
Loss from discontinued operations, net of taxes	(466)	(13,280)
Net income	99,252	78,325
Less: Net income attributable to noncontrolling interests	23,778	17,001
Net income attributable to Community Health Systems, Inc.	75,474	61,324
Parent Guarantor [Member]
Operating costs and expenses:
Loss from early extinguishment of debt
Equity in earnings of unconsolidated affiliates	(75,474)	(61,324)
Income from continuing operations before income taxes	75,474	61,324
Provision for (benefit from) income taxes		0
Income from continuing operations	75,474	61,324
Discontinued operations, net of taxes:
Impairment of hospital sold
Loss on sale, net
Net income	75,474	61,324
Less: Net income attributable to noncontrolling interests		0
Net income attributable to Community Health Systems, Inc.	75,474	61,324
Issuer [Member]
Condensed Consolidated Statements of Income (Unaudited)
Operating revenues (net of contractual allowances and discounts)	(1,746)
Net operating revenues	(1,746)
Operating costs and expenses:
Other operating expenses	315
Total operating costs and expenses	315
Income from operations	(2,079)
Interest expense, net	15,737	28,103
Loss from early extinguishment of debt	63,429
Equity in earnings of unconsolidated affiliates	(115,064)	(79,436)
Income from continuing operations before income taxes	33,819	51,333
Provision for (benefit from) income taxes	(41,655)	(9,991)
Income from continuing operations	75,474	61,324
Discontinued operations, net of taxes:
Impairment of hospital sold
Loss on sale, net
Net income	75,474	61,324
Less: Net income attributable to noncontrolling interests		0
Net income attributable to Community Health Systems, Inc.	75,474	61,324
Other Guarantors [Member]
Condensed Consolidated Statements of Income (Unaudited)
Operating revenues (net of contractual allowances and discounts)	2,297,493	1,965,090
Provision for bad debts	323,543	245,533
Net operating revenues	1,973,950	1,719,557
Operating costs and expenses:
Salaries and benefits	851,412	753,989
Supplies	301,328	268,603
Other operating expenses	445,871	350,667
Electronic health records incentive reimbursement	(18,079)	0
Rent	34,805	31,489
Depreciation and amortization	111,133	95,556
Total operating costs and expenses	1,726,470	1,500,304
Income from operations	247,480	219,253
Interest expense, net	123,418	119,358
Loss from early extinguishment of debt
Equity in earnings of unconsolidated affiliates	(51,314)	(21,096)
Income from continuing operations before income taxes	175,376	120,991
Provision for (benefit from) income taxes	63,311	43,678
Income from continuing operations	112,065	77,313
Discontinued operations, net of taxes:
Impairment of hospital sold
Loss on sale, net
Net income	112,065	77,313
Less: Net income attributable to noncontrolling interests		0
Net income attributable to Community Health Systems, Inc.	112,065	77,313
Non-Guarantors [Member]
Condensed Consolidated Statements of Income (Unaudited)
Operating revenues (net of contractual allowances and discounts)	1,487,762	1,388,962
Provision for bad debts	162,913	154,436
Net operating revenues	1,324,849	1,234,526
Operating costs and expenses:
Salaries and benefits	673,563	625,378
Supplies	197,251	189,214
Other operating expenses	262,757	264,126
Electronic health records incentive reimbursement	(8,089)	0
Rent	32,419	31,681
Depreciation and amortization	63,221	62,599
Total operating costs and expenses	1,221,122	1,172,998
Income from operations	103,727	61,528
Interest expense, net	13,020	15,757
Loss from early extinguishment of debt
Equity in earnings of unconsolidated affiliates		0
Income from continuing operations before income taxes	90,707	45,771
Provision for (benefit from) income taxes	24,163	10,405
Income from continuing operations	66,544	35,366
Discontinued operations, net of taxes:
Loss from operations of entities sold	(466)	(1,678)
Impairment of hospital sold		(8,368)
Loss on sale, net		(3,234)
Loss from discontinued operations, net of taxes	(466)	(13,280)
Net income	66,078	22,086
Less: Net income attributable to noncontrolling interests	23,778	17,001
Net income attributable to Community Health Systems, Inc.	42,300	5,085
Eliminations [Member]
Operating costs and expenses:
Loss from early extinguishment of debt
Equity in earnings of unconsolidated affiliates	229,839	143,722
Income from continuing operations before income taxes	(229,839)	(143,722)
Provision for (benefit from) income taxes		0
Income from continuing operations	(229,839)	(143,722)
Discontinued operations, net of taxes:
Impairment of hospital sold
Loss on sale, net
Net income	(229,839)	(143,722)
Less: Net income attributable to noncontrolling interests		0
Net income attributable to Community Health Systems, Inc.	$ (229,839)	$ (143,722)

XML

Supplemental Condensed Consolidating Financial Information (Details 2) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 99,252	$ 78,325
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	10,536	36,446
Net change in fair value of available-for-sale securities	2,667	1,069
Amortization and recognition of unrecognized pension cost components	1,140	772
Other comprehensive income	14,343	38,287
Comprehensive income	113,595	116,612
Less: Comprehensive income attributable to noncontrolling interests	23,778	17,001
Comprehensive income attributable to Community Health Systems, Inc.	89,817	99,611
Parent Guarantor [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	75,474	61,324
Other comprehensive income, net of income taxes:
Comprehensive income	75,474	61,324
Comprehensive income attributable to Community Health Systems, Inc.	75,474	61,324
Issuer [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	75,474	61,324
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	10,536	36,446
Other comprehensive income	10,536	36,446
Comprehensive income	86,010	97,770
Comprehensive income attributable to Community Health Systems, Inc.	86,010	97,770
Other Guarantors [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	112,065	77,313
Other comprehensive income, net of income taxes:
Net change in fair value of available-for-sale securities	2,667	1,069
Amortization and recognition of unrecognized pension cost components	1,140	772
Other comprehensive income	3,807	1,841
Comprehensive income	115,872	79,154
Comprehensive income attributable to Community Health Systems, Inc.	115,872	79,154
Non-Guarantors [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	66,078	22,086
Other comprehensive income, net of income taxes:
Comprehensive income	66,078	22,086
Less: Comprehensive income attributable to noncontrolling interests	23,778	17,001
Comprehensive income attributable to Community Health Systems, Inc.	42,300	5,085
Eliminations [Member]
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	(229,839)	(143,722)
Other comprehensive income, net of income taxes:
Comprehensive income	(229,839)	(143,722)
Comprehensive income attributable to Community Health Systems, Inc.	$ (229,839)	$ (143,722)

XML

Fair Value (Details Textual) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2012	Dec. 31, 2011
Fair Value (Textual) [Abstract]
Decrease in fair value of liability related to interest rate swap agreements	$ 12.6	$ 21.7
After tax adjustment to other comprehensive due to interest rate swap agreement	$ 8.1	$ 13.9

XML

Basis of Presentation and Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2012

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Goodwill and intangible assets goodwill

In September 2011, the FASB issued ASU 2011-08, which modifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. This ASU is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and was adopted by the Company on January 1, 2012. The adoption of this ASU did not impact the Company’s consolidated financial position, results of operations or cash flows.

Incentive reimbursement

Electronic Health Records Incentive Reimbursement. The American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act (“HITECH”). These provisions were designed to increase the use of electronic health records (“EHR”) technology and establish the requirements for a Medicare and Medicaid incentive payments program beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. Eligibility for annual Medicare incentive payments is dependent on providers demonstrating meaningful use of EHR technology in each period over a four-year period. Initial Medicaid incentive payments are available to providers that adopt, implement or upgrade certified EHR technology; but providers must demonstrate meaningful use of such technology in subsequent years to qualify for additional incentive payments. Medicaid EHR incentive payments are fully funded by the federal government and administered by the states; however, the states are not required to offer EHR incentive payments to providers.

During the three months ended March 31, 2012, the Company recognized approximately $26.2 million of incentive reimbursement for HITECH incentives from Medicaid related to certain of the Company’s hospitals and from Medicare and Medicaid for certain of the Company’s employed physicians that have demonstrated meaningful use of certified EHR technology or have completed attestations to their adoption or implementation of certified EHR technology. These incentive reimbursements were presented as a reduction of operating expenses on the condensed consolidated statement of income. The Company received approximately $5.8 million of cash related to the incentive reimbursement for HITECH incentives during the three months ended March 31, 2012. No incentive reimbursements were recognized during the three months ended March 31, 2011.

Reimbursement Settlements. Included in net operating revenues on a non-same store basis is approximately $101.8 million of net operating revenue from an industry-wide settlement with the United States Department of Health and Human Services and Centers for Medicare and Medicaid Services, based on a claim that acute-care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system in federal fiscal years 1999 through 2011. The underpayments resulted from calculations related to the rural floor budget neutrality adjustments implemented in connection with the Balanced Budget Act of 1997. Also included is an unfavorable adjustment of approximately $21.0 million related to the newly issued Supplemental Security Income ratios for federal fiscal years 2006 through 2009 utilized for calculating Medicare Disproportionate Share Hospital reimbursements.

Health care organization, bad debts policy

Allowance for Doubtful Accounts. In July 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU was adopted by the Company on January 1, 2012. Upon adoption, the Company’s provision for bad debts was presented as a reduction of net operating revenue after contractual adjustments and discounts. The condensed consolidated statement of income for the three months ended March 31, 2011 has been restated to present the provision for bad debts as a reduction of net operating revenue for comparative purposes with the March 31, 2012 presentation.

Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.

The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.

XML

Income Taxes (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Income Taxes (Textual) [Abstract]
Unrecognized benefit that would affect the effective tax rate	$ 2,000,000
Increased liabilities	1,000,000
Increased interest and penalties	200,000
Amount of interest and penalties included in liabilities	500,000
Income tax examination period	24 months
Cash paid for income tax	$ 61,000	$ 677,000

XML

Accounting for Stock-Based Compensation (Details 2) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012 Y
Options outstanding and exercisable
Beginning Balance, shares	8,389,142
Granted, Shares	246,500
Exercised, Shares	(17,244)
Forfeited and cancelled, Shares	(130,475)
Ending Balance, shares	8,487,923
Beginning of Period, Weighted Average Exercise Price	$ 32.83
Granted, Weighted Average Exercise Price	$ 21.07
Exercised, Weighted Average Exercise Price	$ 17.88
Forfeited and cancelled, Weighted Average Exercise Price	$ 32.27
End of Period, Weighted Average Exercise Price	$ 32.53
Weighted Average Remaining Contractual Term	5.2
Aggregate Intrinsic Value	$ 5,244
Exercisable, Shares	6,802,639
Exercisable, Weighted Average Exercise Price	$ 32.56
Exercisable, Weighted Average Remaining Contractual Term	4.3
Exercisable, Intrinsic Value	$ 4,329

XML

Supplemental Condensed Consolidating Financial Information (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011	Mar. 31, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 129,298	$ 129,865	$ 270,716	$ 299,169
Patient accounts receivable, net of allowance for doubtful accounts	2,019,537	1,834,167
Supplies	354,074	346,611
Deferred income taxes	89,797	89,797
Prepaid expenses and taxes	178,923	214,002
Other current assets	328,847	231,647
Total current assets	3,100,476	2,846,089
Property and equipment, net	7,001,863	6,855,976
Goodwill	4,367,841	4,264,845
Other assets, net of accumulated amortization	1,376,236	1,241,930
Total assets	15,846,416	15,208,840
Current liabilities:
Current maturities of long-term debt	75,388	63,706
Accounts payable	822,247	748,997
Accrued interest	101,156	110,121
Accrued liabilities	997,618	988,315
Total current liabilities	1,996,409	1,911,139
Long-term debt	9,243,616	8,782,798
Deferred income taxes	704,725	704,725
Other long-term liabilities	986,022	949,990
Total liabilities	12,930,772	12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries	363,540	395,743
Community Health Systems, Inc. stockholders' equity:
Preferred stock
Common stock	919	915
Additional paid-in capital	1,089,447	1,086,008
Treasury stock, at cost, 975,549 shares at March 31,2012 and December 31, 2011	(6,678)	(6,678)
Accumulated other comprehensive (loss) income	(170,136)	(184,479)
Retained earnings	1,576,804	1,501,330
Total Community Health Systems, Inc. stockholders' equity	2,490,356	2,397,096
Noncontrolling interests in equity of consolidated subsidiaries	61,748	67,349
Total equity	2,552,104	2,464,445
Total liabilities and equity	15,846,416	15,208,840
Parent Guarantor [Member]
Current assets:
Cash and cash equivalents	0	0
Deferred income taxes	89,797	89,797
Prepaid expenses and taxes	49,769	101,389
Total current assets	139,566	191,186
Intercompany receivable	1,217,652	1,160,785
Net investment in subsidiaries	1,848,287	1,758,458
Total assets	3,205,505	3,110,429
Current liabilities:
Accrued liabilities	7,580	7,580
Total current liabilities	7,580	7,580
Deferred income taxes	704,725	704,725
Other long-term liabilities	2,844	1,028
Total liabilities	715,149	713,333
Community Health Systems, Inc. stockholders' equity:
Preferred stock
Common stock	919	915
Additional paid-in capital	1,089,447	1,086,008
Treasury stock, at cost, 975,549 shares at March 31,2012 and December 31, 2011	(6,678)	(6,678)
Accumulated other comprehensive (loss) income	(170,136)	(184,479)
Retained earnings	1,576,804	1,501,330
Total Community Health Systems, Inc. stockholders' equity	2,490,356	2,397,096
Total equity	2,490,356	2,397,096
Total liabilities and equity	3,205,505	3,110,429
Issuer [Member]
Current assets:
Cash and cash equivalents	0	0
Prepaid expenses and taxes	67	117
Other current assets		10,235
Total current assets	67	10,352
Intercompany receivable	9,144,874	9,294,295
Other assets, net of accumulated amortization	133,393	99,521
Net investment in subsidiaries	7,131,830	6,413,757
Total assets	16,410,164	15,817,925
Current liabilities:
Current maturities of long-term debt	56,329	49,954
Accounts payable	1,982	345
Accrued interest	100,941	109,984
Accrued liabilities	0	567
Total current liabilities	159,252	160,850
Long-term debt	8,869,202	8,707,805
Intercompany payable	5,295,699	4,936,587
Other long-term liabilities	237,739	254,228
Total liabilities	14,561,892	14,059,470
Community Health Systems, Inc. stockholders' equity:
Preferred stock
Common stock		0
Additional paid-in capital	760,940	701,399
Accumulated other comprehensive (loss) income	(170,136)	(184,479)
Retained earnings	1,257,468	1,241,535
Total Community Health Systems, Inc. stockholders' equity	1,848,272	1,758,455
Total equity	1,848,272	1,758,455
Total liabilities and equity	16,410,164	15,817,925
Other Guarantors [Member]
Current assets:
Cash and cash equivalents	18,404	14,536	239,694	212,035
Patient accounts receivable, net of allowance for doubtful accounts	585,904	1,088,121
Supplies	228,702	215,203
Prepaid expenses and taxes	96,916	83,983
Other current assets	247,017	141,192
Total current assets	1,176,943	1,543,035
Intercompany receivable	2,309,599	1,741,928
Property and equipment, net	4,612,206	4,395,498
Goodwill	2,511,418	2,412,517
Other assets, net of accumulated amortization	1,021,362	523,645
Net investment in subsidiaries	3,054,704	2,450,625
Total assets	14,686,232	13,067,248
Current liabilities:
Current maturities of long-term debt	15,032	9,625
Accounts payable	569,299	511,145
Accrued interest	129	131
Accrued liabilities	673,039	662,746
Total current liabilities	1,257,499	1,183,647
Long-term debt	49,271	49,184
Intercompany payable	10,670,064	9,290,461
Other long-term liabilities	482,689	433,119
Total liabilities	12,459,523	10,956,411
Community Health Systems, Inc. stockholders' equity:
Preferred stock
Common stock	1	1
Additional paid-in capital	846,210	769,841
Accumulated other comprehensive (loss) income	(17,880)	(21,687)
Retained earnings	1,398,378	1,362,682
Total Community Health Systems, Inc. stockholders' equity	2,226,709	2,110,837
Total equity	2,226,709	2,110,837
Total liabilities and equity	14,686,232	13,067,248
Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	110,894	115,329	31,022	87,134
Patient accounts receivable, net of allowance for doubtful accounts	1,433,633	746,046
Supplies	125,372	131,408
Prepaid expenses and taxes	32,171	28,513
Other current assets	81,830	80,220
Total current assets	1,783,900	1,101,516
Intercompany receivable	1,997,851	1,672,003
Property and equipment, net	2,389,657	2,460,478
Goodwill	1,856,423	1,852,328
Other assets, net of accumulated amortization	221,481	618,764
Net investment in subsidiaries		0
Total assets	8,249,312	7,705,089
Current liabilities:
Current maturities of long-term debt	4,027	4,127
Accounts payable	250,966	237,507
Accrued interest	86	6
Accrued liabilities	316,999	317,422
Total current liabilities	572,078	559,062
Long-term debt	325,143	25,809
Intercompany payable	5,875,570	6,229,469
Other long-term liabilities	262,750	261,615
Total liabilities	7,035,541	7,075,955
Redeemable noncontrolling interests in equity of consolidated subsidiaries	363,540	395,743
Community Health Systems, Inc. stockholders' equity:
Preferred stock
Common stock	2	2
Additional paid-in capital	658,685	59,941
Retained earnings	129,796	106,099
Total Community Health Systems, Inc. stockholders' equity	788,483	166,042
Noncontrolling interests in equity of consolidated subsidiaries	61,748	67,349
Total equity	850,231	233,391
Total liabilities and equity	8,249,312	7,705,089
Eliminations [Member]
Current assets:
Cash and cash equivalents
Intercompany receivable	(14,669,976)	(13,869,011)
Net investment in subsidiaries	(12,034,821)	(10,622,840)
Total assets	(26,704,797)	(24,491,851)
Current liabilities:
Intercompany payable	(21,841,333)	(20,456,517)
Total liabilities	(21,841,333)	(20,456,517)
Community Health Systems, Inc. stockholders' equity:
Preferred stock
Common stock	(3)	(3)
Additional paid-in capital	(2,265,835)	(1,531,181)
Accumulated other comprehensive (loss) income	188,016	206,166
Retained earnings	(2,785,642)	(2,710,316)
Total Community Health Systems, Inc. stockholders' equity	(4,863,464)	(4,035,334)
Total equity	(4,863,464)	(4,035,334)
Total liabilities and equity	$ (26,704,797)	$ (24,491,851)

XML

Contingencies (Tables)

3 Months Ended

Mar. 31, 2012

Contingencies [Abstract]

Pre tax charges in connection with lawsuits

The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits of possible improper claims submitted to Medicare and Medicaid during the three months ending March 31, 2012 and 2011 (in thousands):

	Three Months Ended March  31,
	2012		2011
Professional fees and other related costs	$	1,903	$	—

XML

Goodwill and Other Intangible Assets (Details Textual) (USD $)	3 Months Ended		3 Months Ended
	Mar. 31, 2012 Y	Dec. 31, 2011	Mar. 31, 2012 Other Intangible Assets [Member]	Mar. 31, 2011 Other Intangible Assets [Member]	Mar. 31, 2012 Significant system conversions [Member] Y	Mar. 31, 2012 Capitalized Internal Use Software [Member] Y	Mar. 31, 2011 Capitalized Internal Use Software [Member]	Mar. 31, 2012 Hospital Operations Reporting Unit [Member]	Mar. 31, 2012 Home Care Agency Operations Reporting Unit [Member]	Mar. 31, 2012 Hospital Management Services Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	$ 4,367,841,000	$ 4,264,845,000						$ 4,300,000,000	$ 40,500,000	$ 33,300,000
Finite-Lived Intangible Assets [Line Items]
Amortization expense			1,600,000	1,900,000		19,700,000	17,900,000
Amortization expense for remaining 2012			6,200,000			68,600,000
Amortization expense for 2013			5,400,000			85,600,000
Amortization expense for 2014			3,500,000			41,200,000
Amortization expense for 2015			3,100,000			19,100,000
Amortization expense for 2016			2,400,000			16,400,000
Amortization expense for 2017			2,200,000			12,900,000
Amortization expense thereafter			8,700,000			12,500,000
Estimated amortization period					8	3
Expected residual value			0			0
Goodwill and Other Intangibles Assets (Textual) [Abstract]
Gross, intangible asset subject to amortization	62,600,000	60,000,000
Net, intangible asset subject to amortization	31,500,000	30,600,000
Net, intangible asset not subject to amortization	47,300,000	46,900,000
Weighted-average amortization	8
Gross carrying amount of capitalized software	486,300,000	451,000,000
Net carrying amount considering accumulated amortization	256,300,000	241,300,000
Capitalized costs for internal-use software in development stage	$ 152,800,000

XML

Fair Value of Financial Instruments (Details 2) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Interest expense, net [Member]
Effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss ("OCL') into interest expense on the condensed consolidated statements of income
Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)	$ 39,610	$ 52,923
Derivatives in Cash Flow Hedging Relationships [Member] | Interest rate swaps [Member]
Amount of pre-tax loss recognized in the condensed consolidated balance sheets as a component of other comprehensive income
Amount of Pre-Tax Gain (Loss) Recognized in OCI on Derivative (Effective Portion)	$ (23,122)	$ 4,113

XML

Long-Term Debt (Details 1) (8.875% Senior Noted Due 2015 [Member])	3 Months Ended
	Mar. 31, 2012
8.875% Senior Noted Due 2015 [Member]
Redemption Price of Senior Notes in Long Term Debt
2011	104.438%
2012	102.219%
2013 and thereafter	100.00%

XML

Cost of Revenue (Details Textual) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cost of Revenue (Textual) [Abstract]
Corporate office costs	$ 47.6	$ 41.7
Stock-based compensation expense	$ 10.5	$ 9.9

XML

Cost of Revenue

3 Months Ended

Mar. 31, 2012

Cost of Revenue [Abstract]

COST OF REVENUE

3. COST OF REVENUE

Substantially all of the Company’s operating costs and expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $47.6 million and $41.7 million for the three months ended March 31, 2012 and 2011, respectively. Included in these amounts is stock-based compensation expense of $10.5 million and $9.9 million for the three months ended March 31, 2012 and 2011, respectively.

XML

Long-Term Debt (Details 2) (8% Senior Notes Due 2019 [Member])	3 Months Ended
	Mar. 31, 2012
8% Senior Notes Due 2019 [Member]
Redemption Price of Senior Notes in Long Term Debt
2015	104.00%
2016	102.00%
2017 and thereafter	100.00%

XML

Accounting for Stock-Based Compensation (Details 3) (Restricted Stock Units [Member], USD $)	3 Months Ended
	Mar. 31, 2012
Restricted Stock Units [Member]
Restricted stock outstanding
Beginning Balance, Shares	2,207,612
Granted, Shares	660,500
Vested, Shares	(1,082,821)
Forfeited, Shares	(1,000)
Ending Balance, Shares	1,784,291
Beginning of Period, Weighted Average Grant Date Fair Value	$ 32.95
Granted, Weighted Average Grant Date Fair Value	$ 21.07
Vested, Weighted Average Grant Date Fair Value	$ 29.67
Forfeited, Weighted Average Grant Date Fair Value	$ 37.96
End of Period, Weighted Average Grant Date Fair Value	$ 30.54

XML

Goodwill and Other Intangibles Assets (Tables)

3 Months Ended

Mar. 31, 2012

Goodwill and Other Intangible Assets [Abstract]

Carrying amount of goodwill

The changes in the carrying amount of goodwill for the three months ended March 31, 2012, are as follows (in thousands):

Balance as of December 31, 2011	$	4,264,845
Goodwill acquired as part of acquisitions during 2012		101,097
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		1,899
Balance as of March 31, 2012	$	4,367,841

XML

Acquisitions and Divestitures (Tables)

3 Months Ended

Mar. 31, 2012

Acquisitions and Divestitures [Abstract]

Net operating revenues and loss from discontinued operations

Net operating revenues and loss from discontinued operations for the respective periods are as follows (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Net operating revenues	$	—		$	59,126
Loss from operations of entities sold before income taxes		(729	)		(2,673	)
Impairment of hospitals sold		—			(13,095	)
Loss on sale, net		—			(5,061	)
Loss from discontinued operations, before taxes		(729	)		(20,829	)
Income tax benefit		263			7,549
Loss from discontinued operations, net of taxes	$	(466	)	$	(13,280	)

XML

Stockholders Equity (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Effects of changes in the ownership interest in less-than-wholly-owned subsidiaries
Net income attributable to Community Health Systems, Inc.	$ 75,474	$ 61,324
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests	(18,673)
Net transfers to the noncontrolling interests	(18,673)
Change to Community Health Systems, Inc. stockholders equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	$ 56,801

XML

Accounting For Stock Based Compensation (Details 4) (Phantom Stock and Restricted Stock Units [Member], USD $)	3 Months Ended
	Mar. 31, 2012
Phantom Stock and Restricted Stock Units [Member]
Phantom stock and restricted stock
Beginning Balance, Shares	52,956
Granted, Shares	39,870
Vested, Shares	(27,556)
Forfeited, Shares
Ending Balance, Shares	65,270
Beginning of Period, Weighted Average Grant Date Fair Value	$ 31.67
Granted, Weighted Average Grant Date Fair Value	$ 21.07
Vested, Weighted Average Grant Date Fair Value	$ 28.19
Forfeited, Weighted Average Grant Date Fair Value
End of Period, Weighted Average Grant Date Fair Value	$ 26.67

XML

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2012

Earnings per Share [Abstract]

Components for computation of basic and diluted earnings per share

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Three Months Ended
	March 31,
	2012			2011
Numerator:
Income from continuing operations, net of taxes	$	99,718		$	91,605
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		23,778			17,001
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	75,940		$	74,604
Loss from discontinued operations, net of taxes	$	(466	)	$	(13,280	)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes		—			—
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	(466	)	$	(13,280	)
Denominator:
Weighted-average number of shares outstanding — basic		88,674,779			91,008,405
Effect of dilutive securities:
Restricted stock awards		21,233			253,866
Employee stock options		147,440			865,691
Other equity-based awards		9,252			8,857
Weighted-average number of shares outstanding — diluted		88,852,704			92,136,819

Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive

Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options	6,869,031	4,395,292

XML

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2012

Stockholders' Equity [Abstract]

Reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests

The following schedule presents the reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests for the three-month period ended March 31, 2012 (in thousands):

				Community Health Systems, Inc. Stockholders
													Accumulated
	Redeemable						Additional						Other								Total
	Noncontrolling			Common			Paid-in			Treasury			Comprehensive			Retained		Noncontrolling			Stockholders’
	Interests			Stock			Capital			Stock			Income (Loss)			Earnings		Interests			Equity
Balance, December 31, 2011	$	395,743		$	915		$	1,086,008		$	(6,678	)	$	(184,479	)	$	1,501,330	$	67,349		$	2,464,445
Comprehensive income		17,599			—			—			—			14,343			75,474		6,179			95,996
Distributions to noncontrolling interests, net of contributions		(15,904	)		—			—			—			—			—		(11,019	)		(11,019	)
Purchase of subsidiary shares from noncontrolling interests		(12,285	)		—			(18,673	)		—			—			—		(138	)		(18,811	)
Other reclassifications of noncontrolling interests		623			—			—			—			—			—		(623	)		(623	)
Adjustment to redemption value of redeemable noncontrolling interests		(22,236	)		—			22,236			—			—			—		—			22,236
Repurchase of common stock		—			—			—			—			—			—		—			—
Issuance of common stock in connection with the exercise of stock options		—			—			308			—			—			—		—			308
Cancellation of restricted stock for tax withholdings on vested shares		—			(3	)		(9,032	)		—			—			—		—			(9,035	)
Excess tax benefit from exercise of stock options		—			—			(1,895	)		—			—			—		—			(1,895	)
Share-based compensation		—			7			10,495			—			—			—		—			10,502
Balance, March 31, 2012	$	363,540		$	919		$	1,089,447		$	(6,678	)	$	(170,136	)	$	1,576,804	$	61,748		$	2,552,104

Effects of changes in the ownership interest in less-than-wholly-owned subsidiaries

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Three Months Ended March 31, 2012
Net income attributable to Community Health Systems, Inc.	$	75,474
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(18,673	)
Net transfers to the noncontrolling interests		(18,673	)
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	$	56,801

XML

Accounting for Stock-Based Compensation

3 Months Ended

Mar. 31, 2012

Accounting for Stock-Based Compensation [Abstract]

ACCOUNTING FOR STOCK-BASED COMPENSATION

2. ACCOUNTING FOR STOCK-BASED COMPENSATION

Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and Restated 2000 Stock Option and Award Plan, amended and restated as of March 24, 2009 (the “2000 Plan”), and the Community Health Systems, Inc. 2009 Stock Option and Award Plan, amended and restated as of March 18, 2011 (the “2009 Plan”).

The 2000 Plan allows for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code (the “IRC”), as well as stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Prior to being amended in 2009, the 2000 Plan also allowed for the grant of phantom stock. Persons eligible to receive grants under the 2000 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2000 Plan have been “nonqualified” stock options for tax purposes. Generally, vesting of these granted options occurs in one-third increments on each of the first three anniversaries of the award date. Options granted prior to 2005 have a 10-year contractual term, options granted in 2005 through 2007 have an eight-year contractual term and options granted in 2008 or later have a 10-year contractual term. As of March 31, 2012, 446,221 shares of unissued common stock were reserved for future grants under the 2000 Plan.

The 2009 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the IRC and for the grant of stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Persons eligible to receive grants under the 2009 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2009 Plan have been “nonqualified” stock options for tax purposes. Options granted in 2011 have a 10-year contractual term. As of March 31, 2012, 1,529,549 shares of unissued common stock were reserved for future grants under the 2009 Plan.

The exercise price of all options granted is equal to the fair value of the Company’s common stock on the option grant date.

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Effect on income from continuing operations before income taxes	$	(10,495	)	$	(9,918	)
Effect on net income	$	(6,664	)	$	(6,298	)

At March 31, 2012, $64.9 million of unrecognized stock-based compensation expense was expected to be recognized over a weighted-average period of 23 months. Of that amount, $13.1 million related to outstanding unvested stock options was expected to be recognized over a weighted-average period of 23 months and $51.8 million related to outstanding unvested restricted stock, restricted stock units and phantom shares was expected to be recognized over a weighted-average period of 24 months. There were no modifications to awards during the three months ended March 31, 2012.

The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three months ended March 31, 2012 and 2011:

	Three Months Ended
	March 31,
	2012			2011
Expected volatility		57.7	%		31.2	%
Expected dividends		—			—
Expected term		4.1 years			4 years
Risk-free interest rate		0.7	%		1.7	%

In determining the expected term, the Company examined concentrations of option holdings and historical patterns of option exercises and forfeitures, as well as forward-looking factors, in an effort to determine if there were any discernable employee populations. From this analysis, the Company identified two primary employee populations, one consisting of certain senior executives and the other consisting of substantially all other recipients.

The expected volatility rate was estimated based on historical volatility. In determining expected volatility, the Company also reviewed the market-based implied volatility of actively traded options of its common stock and determined that historical volatility utilized to estimate the expected volatility rate did not differ significantly from the implied volatility.

The expected term computation is based on historical exercise and cancellation patterns and forward-looking factors, where present, for each population identified. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting forfeiture rate is based on historical rates and forward-looking factors for each population identified. The Company adjusts the estimated forfeiture rate to its actual experience.

Options outstanding and exercisable under the 2000 Plan and the 2009 Plan as of March 31, 2012, and changes during the three-month period following December 31, 2011, were as follows (in thousands, except share and per share data):

						Weighted - Average
				Weighted -				Aggregate
				Average		Remaining		Intrinsic
				Exercise		Contractual		Value as of
	Shares			Price		Term		March 31, 2012
Outstanding at December 31, 2011		8,389,142		$	32.83
Granted		246,500			21.07
Exercised		(17,244	)		17.88
Forfeited and cancelled		(130,475	)		32.27
Outstanding at March 31, 2012		8,487,923		$	32.53		5.2 years	$	5,244
Exercisable at March 31, 2012		6,802,639		$	32.56		4.3 years	$	4,329

The weighted-average grant date fair value of stock options granted during the three months ended March 31, 2012 and 2011 was $9.15 and $10.34, respectively. The aggregate intrinsic value (the number of in-the-money stock options multiplied by the difference between the Company’s closing stock price on the last trading day of the reporting period ($22.24) and the exercise price of the respective stock options) in the table above represents the amount that would have been received by the option holders had all option holders exercised their options on March 31, 2012. This amount changes based on the market value of the Company’s common stock. The aggregate intrinsic value of options exercised during the three months ended March 31, 2012 and 2011 was $0.1 million and $5.9 million, respectively. The aggregate intrinsic value of options vested and expected to vest approximates that of the outstanding options.

The Company has also awarded restricted stock under the 2000 Plan and the 2009 Plan to its directors and employees of certain subsidiaries. The restrictions on these shares generally lapse in one-third increments on each of the first three anniversaries of the award date. Certain of the restricted stock awards granted to the Company’s senior executives contain a performance objective that must be met in addition to any vesting requirements. If the performance objective is not attained, the awards will be forfeited in their entirety. Once the performance objective has been attained, restrictions will lapse in one-third increments on each of the first three anniversaries of the award date. Notwithstanding the above-mentioned performance objectives and vesting requirements, the restrictions will lapse earlier in the event of death, disability or termination of employment by the Company for any reason other than for cause of the holder of the restricted stock, or change in control of the Company. Restricted stock awards subject to performance standards are not considered outstanding for purposes of determining earnings per share until the performance objectives have been satisfied.

Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of March 31, 2012, and changes during the three-month period following December 31, 2011, were as follows:

				Weighted -
				Average
				Grant Date
	Shares			Fair Value
Unvested at December 31, 2011		2,207,612		$	32.95
Granted		660,500			21.07
Vested		(1,082,821	)		29.67
Forfeited		(1,000	)		37.96
Unvested at March 31, 2012		1,784,291			30.54

Phantom stock and restricted stock units (“RSUs”) have been granted to the Company’s outside directors under the 2000 Plan and the 2009 Plan. On February 25, 2009, each of the Company’s outside directors received a grant under the 2000 Plan of 7,151 shares of phantom stock. On May 19, 2009, the newly elected outside director received a grant under the 2000 Plan of 7,151 RSUs. On February 24, 2010, six of the Company’s seven outside directors each received a grant under the 2000 Plan of 4,130 RSUs and one outside director, who did not stand for reelection in 2010, did not receive such a grant. On February 23, 2011, each of the Company’s outside directors received a grant under the 2009 Plan of 3,688 RSUs. On February 16, 2012, each of the Company’s outside directors received a grant under the 2009 Plan of 6,645 RSUs. Vesting of these shares of phantom stock and RSUs occurs in one-third increments on each of the first three anniversaries of the award date.

				Weighted -
				Average
				Grant Date
				Fair
	Shares			Value
Unvested at December 31, 2011		52,956		$	31.67
RSUs Granted February 16, 2012		39,870			21.07
Vested		(27,556	)		28.19
Forfeited		—			—
Unvested at March 31, 2012		65,270			26.67

Under the Directors’ Fees Deferral Plan, the Company’s outside directors may elect to receive share equivalent units in lieu of cash for their directors’ fees. These share equivalent units are held in the plan until the director electing to receive the share equivalent units retires or otherwise terminates his/her directorship with the Company. Share equivalent units are converted to shares of common stock of the Company at the time of distribution based on the closing market price of the Company’s common stock on that date. The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

	Three Months Ended
	March 31,
	2012		2011
Directors’ fees earned and deferred into plan	$	28	$	55
Share equivalent units		1,237		1,375

At March 31, 2012, a total of 30,012 share equivalent units were deferred in the plan with an aggregate fair value of $0.7 million, based on the closing market price of the Company’s common stock at March 31, 2012 of $22.24.

XML

Equity Investments (Tables)

3 Months Ended

Mar. 31, 2012

Equity Investments [Abstract]

Summarized combined financial information of entities in which Company owns equity interest

Summarized combined financial information for the three months ended March 31, 2012 and 2011, for these unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	Three Months Ended
	March 31
	2012		2011
Revenues	$	317,317	$	320,840
Operating costs and expenses	$	277,256	$	266,236
Income from continuing operations before taxes	$	40,035	$	54,584

XML

Accounting for Stock-Based Compensation (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Impact of Total Compensation Expense
Effect on income from continuing operations before income taxes	$ (10,495)	$ (9,918)
Effect on net income	$ (6,664)	$ (6,298)

XML

Earnings per Share (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Numerator:
Income from continuing operations, net of taxes	$ 99,718	$ 91,605
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes	23,778	17,001
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	75,940	74,604
Loss from discontinued operations, net of taxes	(466)	(13,280)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	$ (466)	$ (13,280)
Denominator:
Weighted-average number of shares outstanding - basic	88,674,779	91,008,405
Effect of dilutive securities:
Restricted stock awards	21,233	253,866
Employee stock options	147,440	865,691
Other equity-based awards	9,252	8,857
Weighted-average number of shares outstanding - diluted	88,852,704	92,136,819

XML

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenues:
Revenues	$ 3,297,035	$ 2,954,083
Income from continuing operations before income taxes:
Income from continuing operations before income taxes	145,537	135,697
Hospital operations [Member]
Revenues:
Revenues	3,223,098	2,884,330
Income from continuing operations before income taxes:
Income from continuing operations before income taxes	200,308	178,113
Corporate and all other [Member]
Revenues:
Revenues	73,937	69,753
Income from continuing operations before income taxes:
Income from continuing operations before income taxes	$ (54,771)	$ (42,416)

XML

Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Current assets
Cash and cash equivalents	$ 129,298	$ 129,865
Patient accounts receivable, net of allowance for doubtful accounts of $1,996,090 and $1,891,334 at March 31, 2012 and December 31, 2011, respectively	2,019,537	1,834,167
Supplies	354,074	346,611
Prepaid income taxes	49,769	101,389
Deferred income taxes	89,797	89,797
Prepaid expenses and taxes	129,154	112,613
Other current assets	328,847	231,647
Total current assets	3,100,476	2,846,089
Property and equipment	9,640,636	9,369,528
Less accumulated depreciation and amortization	(2,638,773)	(2,513,552)
Property and equipment, net	7,001,863	6,855,976
Goodwill	4,367,841	4,264,845
Other assets, net	1,376,236	1,241,930
Total assets	15,846,416	15,208,840
Current liabilities
Current maturities of long-term debt	75,388	63,706
Accounts payable	822,247	748,997
Accrued interest	101,156	110,121
Accrued liabilities	997,618	988,315
Total current liabilities	1,996,409	1,911,139
Long-term debt	9,243,616	8,782,798
Deferred income taxes	704,725	704,725
Other long-term liabilities	986,022	949,990
Total liabilities	12,930,772	12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries	363,540	395,743
Community Health Systems, Inc. stockholders' equity
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued
Common stock, $.01 par value per share, 300,000,000 shares authorized; 91,858,778 shares issued and 90,883,229 shares outstanding at March 31, 2012, and 91,547,079 shares issued and 90,571,530 shares outstanding at December 31, 2011	919	915
Additional paid-in capital	1,089,447	1,086,008
Treasury stock, at cost, 975,549 shares at March 31,2012 and December 31, 2011	(6,678)	(6,678)
Accumulated other comprehensive loss	(170,136)	(184,479)
Retained earnings	1,576,804	1,501,330
Total Community Health Systems, Inc. stockholders' equity	2,490,356	2,397,096
Noncontrolling interests in equity of consolidated subsidiaries	61,748	67,349
Total equity	2,552,104	2,464,445
Total liabilities and equity	$ 15,846,416	$ 15,208,840

XML

Accounting for Stock-Based Compensation (Details 5) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Deferred Director's Fee
Directors' fees earned and deferred into plan	$ 28	$ 55
Share equivalent units	1,237	1,375

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities
Net income	$ 99,252	$ 78,325
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	174,354	161,318
Stock-based compensation expense	10,495	9,918
Loss on sale, net		3,234
Impairment of hospitals sold		8,368
Loss from early extinguishment of debt	63,429
Excess tax benefit relating to stock-based compensation	(1,004)	(4,675)
Other non-cash expenses, net	2,569	(11,173)
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable	(163,484)	(56,454)
Supplies, prepaid expenses and other current assets	(125,111)	14,336
Accounts payable, accrued liabilities and income taxes	96,109	(14,938)
Other	30,701	(748)
Net cash provided by operating activities	187,310	187,511
Cash flows from investing activities
Acquisitions of facilities and other related equipment	(248,436)	(45,422)
Purchases of property and equipment	(184,903)	(153,875)
Proceeds from disposition of ancillary operations		14,583
Proceeds from sale of property and equipment	748	7,587
Increase in other investments	(67,708)	(32,277)
Net cash used in investing activities	(500,299)	(209,404)
Cash flows from financing activities
Proceeds from exercise of stock options	308	18,125
Repurchase of restricted stock shares for payroll tax withholding requirements	(9,032)
Deferred financing costs	(24,787)
Excess tax benefit relating to stock-based compensation	1,004	4,675
Proceeds from noncontrolling investors in joint ventures	0	863
Redemption of noncontrolling investments in joint ventures	(31,096)	(225)
Distributions to noncontrolling investors in joint ventures	(27,038)	(15,333)
Borrowings under credit agreements	4,315,011
Issuance of long-term debt	1,025,000
Proceeds from receivables facility	300,000
Repayments of long-term indebtedness	(5,236,948)	(14,665)
Net cash provided by (used in) financing activities	312,422	(6,560)
Net change in cash and cash equivalents	(567)	(28,453)
Cash and cash equivalents at beginning of period	129,865	299,169
Cash and cash equivalents at end of period	129,298	270,716
Supplemental disclosure of cash flow information:
Interest payments	161,140	226,124
Income tax refunds received, net	$ (61)	$ (677)

XML

Equity Investments (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Dec. 31, 2011
Additional Equity Investments (Textual) [Abstract]
Total company's investment	$ 431,900,000		$ 422,200,000
Income from equity methods investments	$ 12,013,000	$ 18,134,000
Four Hospitals in Las Vegas, Nevada [Member]
Equity Investments (Textual) [Abstract]
Company owned equity interests	27.50%
One Hospital in Las Vegas, Nevada [Member]
Equity Investments (Textual) [Abstract]
Company owned equity interests	26.10%
Three Hospitals in Macon Georgia, [Member]
Equity Investments (Textual) [Abstract]
Company owned equity interests	38.00%

XML

Fair Value (Tables)

3 Months Ended

Mar. 31, 2012

Fair Value [Abstract]

Financial assets and liabilities recorded at fair value on a recurring basis

The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of March 31, 2012 and December 31, 2011 (in thousands):

		000000000		000000000		000000000		000000000
	March 31,
	2012		Level 1		Level 2		Level 3
Available-for-sale securities	$	34,354	$	34,354	$	—	$	—
Trading securities		35,944		35,944		—		—
Total assets	$	70,298	$	70,298	$	—	$	—
Fair value of interest rate swap agreements	$	237,739	$	—	$	237,739	$	—
Total liabilities	$	237,739	$	—	$	237,739	$	—
	December 31, 2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,582	$	31,582	$	—	$	—
Trading securities		30,486		30,486		—		—
Total assets	$	62,068	$	62,068	$	—	$	—
Fair value of interest rate swap agreements	$	254,228	$	—	$	254,228	$	—
Total liabilities	$	254,228	$	—	$	254,228	$	—

XML

Fair Value of Financial Instruments (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011	Mar. 31, 2011	Dec. 31, 2010
Assets:
Cash and cash equivalents	$ 129,298	$ 129,865	$ 270,716	$ 299,169
Cash and cash equivalents, fair value disclosure	129,298	129,865
Available-for-sale securities	34,354	31,582
Available-for-sale securities, fair value disclosure	34,354	31,582
Trading securities	35,944	30,486
Trading securities, fair value disclosure	35,944	30,486
Liabilities:
Credit facilities	5,969,062	5,979,383
Credit facilities, fair value disclosure	5,894,354	5,780,877
Other debt	345,465	41,143
Other debt, fair value disclosure	345,465	41,143
8.875% Senior Notes [Member]
Liabilities:
Senior notes	931,016	1,777,617
Senior notes, fair value disclosure	968,200	1,842,322
8% Senior Notes [Member]
Liabilities:
Senior notes	2,024,694	1,000,000
Senior notes, fair value disclosure	$ 2,067,500	$ 995,000

XML

Contingencies

3 Months Ended

Mar. 31, 2012

Contingencies [Abstract]

CONTINGENCIES

16. CONTINGENCIES

The Company is a party to various legal proceedings incidental to its business. In the opinion of management, any ultimate liability with respect to these actions will not have a material adverse effect on the Company’s consolidated financial position, cash flows or results of operations. With respect to all litigation matters, the Company considers the likelihood of a negative outcome. If the Company determines the likelihood of a negative outcome is probable and the amount of the loss can be reasonably estimated, the Company records an estimated loss for the expected outcome of the litigation and discloses that fact together with the amount accrued, if it was estimable. If the likelihood of a negative outcome is reasonably possible and the Company is able to determine an estimate of the possible loss or a range of loss, the Company discloses that fact together with the estimate of the possible loss or range of loss. However, it is difficult to predict the outcome or estimate a possible loss or range of loss in some instances because litigation is subject to significant uncertainties.

Reasonably Possible Contingencies

For all of the legal matters below, the Company believes that a negative outcome is reasonably possible, but the Company is unable to determine an estimate of the possible loss or a range of loss.

On February 10, 2006, the Company received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on the Company’s hospitals in three states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, the Company received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to the Company’s three hospitals in that state. Through the beginning of 2009, the Company provided the Department of Justice with requested documents, met with its personnel on numerous occasions, and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified the Company that it believed that the Company and its three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. The Company filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part the Company’s motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied the Company’s motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, the Company filed its answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. Motions for Summary Judgment were filed on March 27, 2012 and there is currently no trial date set. On March 30, 2012, the court denied the Company’s motion to exclude Plaintiffs’ expert witness testimony, which the Company believes fails to follow the controlling Medicaid statute and regulations and results in an exaggeration of the damages estimate by fourfold. The Company has the opportunity to challenge the methodology employed at trial. The Company is vigorously defending this action.

Matters for which an Outcome Cannot be Assessed

For all of the legal matters below, the Company cannot at this time assess what the outcome may be and is further unable to determine any estimate of loss or range of loss. Because the investigations are at a very preliminary stage, there are not sufficient facts available to make these assessments.

On April 8, 2011, the Company received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, Office of Inspector General (the “OIG”), in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of the Company’s hospitals and appears to concern emergency department processes and procedures, including the Company’s hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about the Company’s relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by the Company’s Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010. This investigation is being led by the Department of Justice. The Company is continuing to cooperate with the government including detailing a process for a medical necessity review by clinical reviewers and physicians of a sampling of medical records at a small number of hospitals.

On April 11, 2011, Tenet Healthcare Corporation (“Tenet”) filed suit against the Company, Wayne T. Smith and W. Larry Cash in the United States District Court for the Northern District of Texas. The suit alleged the Company committed violations of certain federal securities laws by making certain statements in various proxy materials filed with the SEC in connection with the Company’s offer to purchase Tenet. Tenet alleged that the Company engaged in a practice to under-utilize observation status and over-utilize inpatient admission status and asserts that by doing so, the Company created undisclosed financial and legal liability to federal, state and private payors. The suit seeks declaratory and injunctive relief and Tenet’s costs. On April 19, 2011, the Company filed a motion to dismiss the complaint. On April 28, 2011, the Company responded to the allegations during its earnings release conference call as discussed in the Company’s Form 8-K furnished on April 28, 2011. On May 16, 2011, Tenet filed an amended complaint. On June 29, 2011, the Company filed a motion to dismiss the amended complaint. A hearing on the Company’s motion to dismiss occurred on September 8, 2011. On March 21, 2012, the court dismissed this case in its entirety, with prejudice.

On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another department in the fall of 2006. This facility was acquired by the Company as part of the July 25, 2007 merger transaction with Triad. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. The Company had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services (the “HHS”) are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of the Company’s Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. (Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, the Company may learn of additional qui tam suits filed against the Company or its affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests the Company has received in the past from various governmental agencies are generated from qui tam cases filed under seal.) The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. The Company’s management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. The Company agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. The Company’s response setting forth the Company’s legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. On April 26, 2012, the Company joined the government and the relator in a motion to extend the stay in this case for an additional 180 days. As noted in that filing, the Company is working with the government on a probe audit of medical records (described above with respect to the April 2011 subpoena). The Company is cooperating fully with the government in its investigations.

Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of the Company’s common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for the Company’s common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties are in the process of negotiating operative dates for these consolidated shareholder federal securities actions, including dates for the filing of an operative consolidated complaint and related briefing.

Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. The Plaintiffs filed an operative amended derivative complaint in these three consolidated actions on March 15, 2012. A responsive pleading is due May 14, 2012. The Company believes all of these matters are without merit and will vigorously defend them.

The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits of possible improper claims submitted to Medicare and Medicaid during the three months ending March 31, 2012 and 2011 (in thousands):

	Three Months Ended March  31,
	2012		2011
Professional fees and other related costs	$	1,903	$	—

Probable Contingencies

In addition to the cases described above, there are a number of legal matters for which, based on information currently available, the Company believes that a negative outcome is known or is probable. In the aggregate, an estimate of these losses has been accrued in the amount of $21.3 million at March 31, 2012. Due to the uncertainties and difficulty in predicting the ultimate resolution of these contingencies, the actual amount could differ from the estimated amount; however, the Company does not believe the ultimate outcome of any of these matters would be material.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2012

Segment Information [Abstract]

Revenues and Income from continuing operations before income taxes

The distribution between reportable segments of the Company’s revenues and income from continuing operations before income taxes is summarized in the following tables (in thousands):

	Three Months Ended March 31,
	2012			2011
Revenues:
Hospital operations	$	3,223,098		$	2,884,330
Corporate and all other		73,937			69,753
Total	$	3,297,035		$	2,954,083
Income from continuing operations before income taxes:
Hospital operations	$	200,308		$	178,113
Corporate and all other		(54,771	)		(42,416	)
Total	$	145,537		$	135,697

XML

Supplemental Condensed Consolidating Financial Information

3 Months Ended

Mar. 31, 2012

Supplemental Financial Information [Abstract]

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

18. SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

In 2007, CHS issued the 8  ⁷/8% Senior Notes in the aggregate principal amount of approximately $3.0 billion. In 2011, CHS issued the 8% Senior Notes in the aggregate principal amount of $1.0 billion, the proceeds from which were used to purchase $1.0 billion of the 8  ⁷/8% Senior Notes. In addition, CHS issued an additional $1.0 billion of 8% Senior Notes in March 2012, which were used to purchase $850 million of 8 ⁷/8 % Senior Notes. These 8 ⁷/8 % Senior Notes and 8% Senior Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.

Both the 8  ⁷/8% Senior Notes and the 8% Senior Notes are guaranteed on a joint and several basis, with limited exceptions considered customary for such guarantees, including the release of the guarantee when a subsidiary’s assets used in operations are sold. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental condensed consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. This activity also includes the intercompany transactions between consolidated entities as part of the Receivables Facility that is further discussed in Note 11. The Company’s subsidiaries generally do not purchase services from one another; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of March 31, 2012.

Condensed Consolidating Balance Sheet

March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	18,404		$	110,894	$	—		$	129,298
Patient accounts receivable, net of allowance for doubtful accounts		—			—			585,904			1,433,633		—			2,019,537
Supplies		—			—			228,702			125,372		—			354,074
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		49,769			67			96,916			32,171		—			178,923
Other current assets		—			—			247,017			81,830		—			328,847
Total current assets		139,566			67			1,176,943			1,783,900		—			3,100,476
Intercompany receivable		1,217,652			9,144,874			2,309,599			1,997,851		(14,669,976	)		—
Property and equipment, net		—			—			4,612,206			2,389,657		—			7,001,863
Goodwill		—			—			2,511,418			1,856,423		—			4,367,841
Other assets, net of accumulated amortization		—			133,393			606,887			635,956		—			1,376,236
Net investment in subsidiaries		1,848,287			7,131,830			3,469,179			—		(12,449,296	)		—
Total assets	$	3,205,505		$	16,410,164		$	14,686,232		$	8,663,787	$	(27,119,272	)	$	15,846,416
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	56,329		$	15,032		$	4,027	$	—		$	75,388
Accounts payable		—			1,982			569,299			250,966		—			822,247
Accrued interest		—			100,941			129			86		—			101,156
Accrued liabilities		7,580			—			673,039			316,999		—			997,618
Total current liabilities		7,580			159,252			1,257,499			572,078		—			1,996,409
Long-term debt		—			8,869,202			49,271			325,143		—			9,243,616
Intercompany payable		—			5,295,699			10,670,064			6,290,045		(22,255,808	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		2,844			237,739			482,689			262,750		—			986,022
Total liabilities		715,149			14,561,892			12,459,523			7,450,016		(22,255,808	)		12,930,772
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			363,540		—			363,540
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		919			—			1			2		(3	)		919
Additional paid-in capital		1,089,447			760,940			846,210			658,685		(2,265,835	)		1,089,447
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(170,136	)		(170,136	)		(17,880	)		—		188,016			(170,136	)
Retained earnings		1,576,804			1,257,468			1,398,378			129,796		(2,785,642	)		1,576,804
Total Community Health Systems, Inc. stockholders’ equity		2,490,356			1,848,272			2,226,709			788,483		(4,863,464	)		2,490,356
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			61,748		—			61,748
Total equity		2,490,356			1,848,272			2,226,709			850,231		(4,863,464	)		2,552,104
Total liabilities and equity	$	3,205,505		$	16,410,164		$	14,686,232		$	8,663,787	$	(27,119,272	)	$	15,846,416

Condensed Consolidating Balance Sheet

December 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

Condensed Consolidating Statement of Income

Three Months Ended March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	(1,764	)	$	2,297,493		$	1,487,762		$	—		$	3,783,491
Provision for bad debts		—			—			323,543			162,913			—			486,456
Net operating revenues		—			(1,764	)		1,973,950			1,324,849			—			3,297,035
Operating costs and expenses:
Salaries and benefits		—			—			851,412			673,563			—			1,524,975
Supplies		—			—			301,328			197,251			—			498,579
Other operating expenses		—			315			445,871			262,757			—			708,943
Electronic health records incentive reimbursement		—			—			(18,079	)		(8,089	)		—			(26,168	)
Rent		—			—			34,805			32,419			—			67,224
Depreciation and amortization		—			—			111,133			63,221			—			174,354
Total operating costs and expenses		—			315			1,726,470			1,221,122			—			2,947,907
Income from operations		—			(2,079	)		247,480			103,727			—			349,128
Interest expense, net		—			15,737			123,418			13,020			—			152,175
Loss from early extinguishment of debt		—			63,429			—			—			—			63,429
Equity in earnings of unconsolidated affiliates		(75,474	)		(115,064	)		(51,314	)		—			229,839			(12,013	)
Income from continuing operations before income taxes		75,474			33,819			175,376			90,707			(229,839	)		145,537
Provision for (benefit from) income taxes		—			(41,655	)		63,311			24,163			—			45,819
Income from continuing operations		75,474			75,474			112,065			66,544			(229,839	)		99,718
Discontinued operations, net of taxes:
Loss from operations of entities sold		—			—			—			(466	)		—			(466	)
Impairment of hospital sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			—			(466	)		—			(466	)
Net income		75,474			75,474			112,065			66,078			(229,839	)		99,252
Less: Net income attributable to noncontrolling interests		—			—			—			23,778			—			23,778
Net income attributable to Community Health Systems, Inc.	$	75,474		$	75,474		$	112,065		$	42,300		$	(229,839	)	$	75,474

Condensed Consolidating Statement of Income

Three Months Ended March 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	1,965,090		$	1,388,962		$	—		$	3,354,052
Provision for bad debts		—			—			245,533			154,436			—			399,969
Net operating revenues		—			—			1,719,557			1,234,526			—			2,954,083
Operating costs and expenses:
Salaries and benefits		—			—			753,989			625,378			—			1,379,367
Supplies		—			—			268,603			189,214			—			457,817
Other operating expenses		—			—			350,667			264,126			—			614,793
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			31,489			31,681			—			63,170
Depreciation and amortization		—			—			95,556			62,599			—			158,155
Total operating costs and expenses		—			—			1,500,304			1,172,998			—			2,673,302
Income from operations		—			—			219,253			61,528			—			280,781
Interest expense, net		—			28,103			119,358			15,757			—			163,218
Loss from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(61,324	)		(79,436	)		(21,096	)		—			143,722			(18,134	)
Income from continuing operations before income taxes		61,324			51,333			120,991			45,771			(143,722	)		135,697
Provision for (benefit from) income taxes		—			(9,991	)		43,678			10,405			—			44,092
Income from continuing operations		61,324			61,324			77,313			35,366			(143,722	)		91,605
Discontinued operations, net of taxes:
Loss from operations of entities sold		—			—			—			(1,678	)		—			(1,678	)
Impairment of hospital sold		—			—			—			(8,368	)		—			(8,368	)
Loss on sale, net		—			—			—			(3,234	)		—			(3,234	)
Loss from discontinued operations, net of taxes		—			—			—			(13,280	)		—			(13,280	)
Net income		61,324			61,324			77,313			22,086			(143,722	)		78,325
Less: Net income attributable to noncontrolling interests		—			—			—			17,001			—			17,001
Net income attributable to Community Health Systems, Inc.	$	61,324		$	61,324		$	77,313		$	5,085		$	(143,722	)	$	61,324

Condensed Consolidating Statement of Comprehensive Income

Three Months Ended March 31, 2012

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	75,474	$	75,474	$	112,065	$	66,078	$	(229,839	)	$	99,252
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		10,536		10,536		—		—		(10,536	)		10,536
Net change in fair value of available-for-sale securities		2,667		2,667		2,667		—		(5,334	)		2,667
Amortization and recognition of unrecognized pension cost components		1,140		1,140		1,140		—		(2,280	)		1,140
Other comprehensive income		14,343		14,343		3,807		—		(18,150	)		14,343
Comprehensive income		89,817		89,817		115,872		66,078		(247,989	)		113,595
Less: Comprehensive income attributable to noncontrolling interests		—		—		—		23,778		—			23,778
Comprehensive income attributable to Community Health Systems, Inc.	$	89,817	$	89,817	$	115,872	$	42,300	$	(247,989	)	$	89,817

Condensed Consolidating Statement of Comprehensive Income

Three Months Ended March 31, 2011

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	61,324	$	61,324	$	77,313	$	22,086	$	(143,722	)	$	78,325
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		36,446		36,446		—		—		(36,446	)		36,446
Net change in fair value of available-for-sale securities		1,069		1,069		1,069		—		(2,138	)		1,069
Amortization and recognition of unrecognized pension cost components		772		772		772		—		(1,544	)		772
Other comprehensive income		38,287		38,287		1,841		—		(40,128	)		38,287
Comprehensive income		99,611		99,611		79,154		22,086		(183,850	)		116,612
Less: Comprehensive income attributable to noncontrolling interests		—		—		—		17,001		—			17,001
Comprehensive income attributable to Community Health Systems, Inc.	$	99,611	$	99,611	$	79,154	$	5,085	$	(183,850	)	$	99,611

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(1,230	)	$	(26,237	)	$	(64,108	)	$	278,885		$	—	$	187,310
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(242,977	)		(5,459	)		—		(248,436	)
Purchases of property and equipment		—			—			(127,796	)		(57,107	)		—		(184,903	)
Proceeds from disposition of ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			688			60			—		748
Increase in other investments		—			10,000			(45,612	)		(32,096	)		—		(67,708	)
Net cash used in investing activities		—			10,000			(415,697	)		(94,602	)		—		(500,299	)
Cash flows from financing activities:
Proceeds from exercise of stock options		308			—			—			—			—		308
Repurchase of restricted stock shares for payroll tax withholding requirements		(9,032	)		—			—			—			—		(9,032	)
Deferred financing costs		—			(24,787	)		—			—			—		(24,787	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		1,004			—			—			—			—		1,004
Proceeds from noncontrolling investors in joint ventures		—			—			—			—			—		—
Redemption of noncontrolling investments in joint ventures		—			—			—			(31,096	)		—		(31,096	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(27,038	)		—		(27,038	)
Changes in intercompany balances with affiliates, net		8,950			(58,772	)		479,643			(429,821	)		—		—
Borrowings under credit agreement		—			4,305,674			9,337			—			—		4,315,011
Issuance of long-term debt		—			1,025,000			—			—			—		1,025,000
Proceeds from receivables facility		—			—			—			300,000			—		300,000
Repayments of long-term indebtedness		—			(5,230,878	)		(5,307	)		(763	)		—		(5,236,948	)
Net cash provided by (used in) financing activities		1,230			16,237			483,673			(188,718	)		—		312,422
Net change in cash and cash equivalents		—			—			3,868			(4,435	)		—		(567	)
Cash and cash equivalents at beginning of period		—			—			14,536			115,329			—		129,865
Cash and cash equivalents at end of period	$	—		$	—		$	18,404		$	110,894		$	—	$	129,298

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(22,195	)	$	(83,202	)	$	331,077		$	(38,169	)	$	—	$	187,511
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(10,727	)		(34,695	)		—		(45,422	)
Purchases of property and equipment		—			—			(64,312	)		(89,563	)		—		(153,875	)
Proceeds from disposition of ancillary operations		—			—			—			14,583			—		14,583
Proceeds from sale of property and equipment		—			—			473			7,114			—		7,587
Increase in other investments		—			—			(36,201	)		3,924			—		(32,277	)
Net cash used in investing activities		—			—			(110,767	)		(98,637	)		—		(209,404	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,125			—			—			—			—		18,125
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			—			—			—			—		—
Excess tax benefit (income tax payable increase) relating to stock-based compensation		4,675			—			—			—			—		4,675
Proceeds from noncontrolling investors in joint ventures		—			—			—			863			—		863
Redemption of noncontrolling investments in joint ventures		—			—			—			(225	)		—		(225	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(15,333	)		—		(15,333	)
Changes in intercompany balances with affiliates, net		(605	)		95,750			(191,179	)		96,034			—		—
Borrowings under credit agreement		—			—			—			—			—		—
Proceeds from receivables facility		—			—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(12,548	)		(1,472	)		(645	)		—		(14,665	)
Net cash provided by (used in) financing activities		22,195			83,202			(192,651	)		80,694			—		(6,560	)
Net change in cash and cash equivalents		—			—			27,659			(56,112	)		—		(28,453	)
Cash and cash equivalents at beginning of period		—			—			212,035			87,134			—		299,169
Cash and cash equivalents at end of period	$	—		$	—		$	239,694		$	31,022		$	—	$	270,716

XML

Fair Value of Financial Instruments (Details 3) (Derivatives designated as hedging instruments [Member], USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Other assets, net [Member]
Fair value of derivative instruments in the condensed consolidated balance sheets
Derivatives assets designated as hedging instruments	$ 0	$ 0
Other long-term liabilities [Member]
Fair value of derivative instruments in the condensed consolidated balance sheets
Derivatives liabilities designated as hedging instruments	$ 237,739	$ 254,228

XML

Basis of Presentation and Significant Accounting Policies

3 Months Ended

Mar. 31, 2012

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]

BASIS OF PRESENTATION

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The unaudited condensed consolidated financial statements of Community Health Systems, Inc. and its subsidiaries (the “Company”) as of March 31, 2012 and December 31, 2011 and for the three-month period ended March 31, 2012 and March 31, 2011, have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, such information contains all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for such periods. All intercompany transactions and balances have been eliminated. The results of operations for the three months ended March 31, 2012, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2012. Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted as permitted by the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company believes the disclosures are adequate to make the information presented not misleading. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2011, contained in the Company’s Annual Report on Form 10-K.

Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the parent are presented as a component of total equity on the condensed consolidated balance sheets to distinguish between the interests of the parent company and the interests of the noncontrolling owners. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the condensed consolidated balance sheets.

Allowance for Doubtful Accounts. In July 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU was adopted by the Company on January 1, 2012. Upon adoption, the Company’s provision for bad debts was presented as a reduction of net operating revenue after contractual adjustments and discounts. The condensed consolidated statement of income for the three months ended March 31, 2011 has been restated to present the provision for bad debts as a reduction of net operating revenue for comparative purposes with the March 31, 2012 presentation.

Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.

The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.

Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.

Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the three months ended March 31, 2012 and 2011, is as follows (in thousands):

	Three Months Ended
	March 31,
	2012		2011
Medicare	$	1,064,157	$	923,864
Medicaid		315,092		321,525
Managed Care and other third-party payors		1,906,487		1,699,860
Self-pay		497,755		408,803
Total	$	3,783,491	$	3,354,052

Electronic Health Records Incentive Reimbursement. The American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act (“HITECH”). These provisions were designed to increase the use of electronic health records (“EHR”) technology and establish the requirements for a Medicare and Medicaid incentive payments program beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. Eligibility for annual Medicare incentive payments is dependent on providers demonstrating meaningful use of EHR technology in each period over a four-year period. Initial Medicaid incentive payments are available to providers that adopt, implement or upgrade certified EHR technology; but providers must demonstrate meaningful use of such technology in subsequent years to qualify for additional incentive payments. Medicaid EHR incentive payments are fully funded by the federal government and administered by the states; however, the states are not required to offer EHR incentive payments to providers.

During the three months ended March 31, 2012, the Company recognized approximately $26.2 million of incentive reimbursement for HITECH incentives from Medicaid related to certain of the Company’s hospitals and from Medicare and Medicaid for certain of the Company’s employed physicians that have demonstrated meaningful use of certified EHR technology or have completed attestations to their adoption or implementation of certified EHR technology. These incentive reimbursements were presented as a reduction of operating expenses on the condensed consolidated statement of income. The Company received approximately $5.8 million of cash related to the incentive reimbursement for HITECH incentives during the three months ended March 31, 2012. No incentive reimbursements were recognized during the three months ended March 31, 2011.

Reimbursement Settlements. Included in net operating revenues on a non-same store basis is approximately $101.8 million of net operating revenue from an industry-wide settlement with the United States Department of Health and Human Services and Centers for Medicare and Medicaid Services, based on a claim that acute-care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system in federal fiscal years 1999 through 2011. The underpayments resulted from calculations related to the rural floor budget neutrality adjustments implemented in connection with the Balanced Budget Act of 1997. Also included is an unfavorable adjustment of approximately $21.0 million related to the newly issued Supplemental Security Income ratios for federal fiscal years 2006 through 2009 utilized for calculating Medicare Disproportionate Share Hospital reimbursements.

Throughout these notes to the condensed consolidated financial statements, Community Health Systems, Inc. (the “Parent”), and its consolidated subsidiaries are referred to on a collective basis as the “Company.” This drafting style is not meant to indicate that the publicly-traded Parent or any subsidiary of the Parent owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Condensed Consolidated Balance Sheets [Abstract]
Allowance for doubtful patient accounts	$ 1,996,090	$ 1,891,334
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	91,858,778	91,547,079
Common stock, shares outstanding	90,883,229	90,571,530
Treasury stock, shares	975,549	975,549

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2012

Long-Term Debt [Abstract]

LONG-TERM DEBT

11. LONG-TERM DEBT

Long-term debt consists of the following (in thousands):

	March 31,			December 31,
	2012			2011
Credit Facility:
Term loan A	$	750,000		$	—
Term loan B		5,219,062			5,949,383
Revolving credit loans		—			30,000
8 7/ 8% Senior Notes due 2015		931,016			1,777,617
8% Senior Notes due 2019		2,024,694			1,000,000
Receivables Facility		300,000			—
Capital lease obligations		48,767			48,361
Other		45,465			41,143
Total debt		9,319,004			8,846,504
Less current maturities		(75,388	)		(63,706	)
Total long-term debt	$	9,243,616		$	8,782,798

Credit Facility

In connection with the consummation of the acquisition of Triad in July 2007, the Company’s wholly-owned subsidiary CHS/Community Health Systems, Inc. (“CHS”) obtained approximately $7.2 billion of senior secured financing under a new credit facility (the “Credit Facility”) with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent, and issued approximately $3.0 billion aggregate principal amount of 8 ⁷/8% senior notes due 2015 (the “ 8  ⁷/8% Senior Notes”). The Company used the net proceeds of $3.0 billion from the 8 ⁷/8% Senior Notes offering and the net proceeds of approximately $6.1 billion of term loans under the Credit Facility to acquire the outstanding shares of Triad, to refinance certain of Triad’s indebtedness and the Company’s indebtedness, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. Specifically, the Company repaid its outstanding debt under the previously outstanding credit facility, the 6.50% senior subordinated notes due 2012 and certain of Triad’s existing indebtedness.

The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $400 million delayed draw term loan facility with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million delayed draw term loan facility had been reduced to $300 million at the request of CHS. During the fourth quarter of 2008, $100 million of the delayed draw term loan was drawn by CHS, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, CHS drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans.

On November 5, 2010, CHS entered into an amendment and restatement of the Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of the existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of the 8 ⁷/8% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increased CHS’s ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permitted CHS to issue term loan A loans under the incremental facility, and provided up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which $1.7 billion would be required to be used for repayment of existing term loans. In addition, effective February 2, 2012, the Company completed the second amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.

Effective March 6, 2012, the Company obtained a new $750 million senior secured revolving credit facility (the “Replacement Revolver Facility”) and a new $750 million incremental term loan A facility (the “Incremental Term Loan”) subject to the terms and conditions set forth in the Credit Facility. The Replacement Revolver Facility replaced in full the existing revolving credit facility under the Credit Facility. The net proceeds of the Incremental Term Loan were used to repay the same amount of the existing term loans under the Credit Facility. The execution of these agreements resulted in a loss from early extinguishment of debt of $8.5 million with an after-tax impact of $5.3 million recorded in continuing operations for the three months ended March 31, 2012. Both the Replacement Revolver Facility and the Incremental Term Loan have a maturity date of October 25, 2016, subject to customary acceleration events and to the repayment, extension or refinancing with longer maturity debt of substantially all of the Company’s outstanding term loans maturing July 25, 2014, and 8  ⁷/8% Senior Notes due 2015. The pricing on each of the Replacement Revolver Facility and the Incremental Term Loan initially is LIBOR plus a margin of 250 basis points, subject to adjustment based on the Company’s leverage ratio. The Incremental Term Loan amortizes at 5% in year one, 10% in years two and three, 15% in year four and 60% in year five.

The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

The obligor under the Credit Facility is CHS. All of the obligations under the Credit Facility are unconditionally guaranteed by the Company and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of the Company, CHS and each subsidiary guarantor, including equity interests held by the Company, CHS or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for revolving loans is 1.50% for Alternate Base Rate revolving loans and 2.50% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

CHS has agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. CHS is obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon the Company’s leverage ratio) on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, CHS was also obligated to pay commitment fees of 0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum. In each case, the commitment fee was paid on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, CHS no longer pays any commitment fees for the delayed draw term loan facility. CHS paid arrangement fees on the closing of the 2007 Credit Facility and pays an annual administrative agent fee.

The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting the Company’s and its subsidiaries’ ability, subject to certain exceptions, to, among other things (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the Company’s businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the Company’s fiscal year. The Company is also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

Events of default under the Credit Facility include, but are not limited to, (1) CHS’s failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

As of March 31, 2012, the availability for additional borrowings under the Credit Facility was $750 million pursuant to the Replacement Revolver Facility, of which $37.7 million was set aside for outstanding letters of credit. CHS has the ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, which CHS has not yet accessed. As of March 31, 2012, the weighted-average interest rate under the Credit Facility, excluding swaps, was 3.4%.

8  ⁷/8% Senior Notes due 2015

The 8 ⁷ /8% Senior Notes were issued by CHS in connection with the Triad acquisition in the principal amount of approximately $3.0 billion. The 8  ⁷/8% Senior Notes will mature on July 15, 2015. The 8 ⁷/8% Senior Notes bear interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July 15, commencing January 15, 2008. Interest on the 8 ⁷ /8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

On December 7, 2011, CHS completed the cash tender offer for $1.0 billion of the then $2.8 billion aggregate outstanding principal amount of 8 ⁷/8 % Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $66.0 million with an after-tax impact of $42.0 million recorded in continuing operations for the year ended December 31, 2011.

On March 21, 2012, CHS completed the cash tender offer for $850 million of the then $1.8 billion aggregate outstanding principal amount of 8 ⁷/8 % Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $54.9 million with an after-tax impact of $34.3 million recorded in continuing operations for the three months ended March 31, 2012.

After July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the 8  ⁷/8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	Redemption Price
2011		104.438	%
2012		102.219	%
2013 and thereafter		100.000	%

Pursuant to a registration rights agreement entered into at the time of the issuance of the 8  ⁷/8% Senior Notes, as a result of an exchange offer made by CHS, substantially all of the 8 ⁷/8% Senior Notes issued in July 2007 were exchanged in November 2007 for new notes (the “Exchange Notes”) having terms substantially identical in all material respects to the 8  ⁷/8% Senior Notes (except that the Exchange Notes were issued under a registration statement pursuant to the 1933 Act). References to the 8 ⁷/8 % Senior Notes shall also be deemed to include the Exchange Notes unless the context provides otherwise.

8% Senior Notes due 2019

On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 (the “8% Senior Notes”), which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of $1.0 billion aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015 and related fees and expenses. On March 21, 2012, CHS completed the secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019, which were issued in a private placement (at a premium of 102.5%). The net proceeds from this issuance were used to finance the purchase of $850 million aggregate principal amount of CHS’ outstanding 8 ⁷/8% Senior Notes due 2015, to pay related fees and expenses and for general corporate purposes. The 8% Senior Notes bear interest at 8% per annum, payable semiannually in arrears on May 15 and November 15, commencing May 15, 2012. Interest on the 8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

Except as set forth below, CHS is not entitled to redeem the 8% Senior Notes prior to November 15, 2015.

On and after November 15, 2015, CHS is entitled, at its option, to redeem all or a portion of the 8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on November 15 of the years set forth below:

Period	Redemption Price
2015		104.000	%
2016		102.000	%
2017 and thereafter		100.000	%

Receivables Facility

On March 21, 2012, the Company and certain of its subsidiaries entered into an accounts receivables loan agreement (the “Receivables Facility”) with a group of conduit lenders and liquidity banks, Credit Agricolé Corporate and Investment Bank, as a managing agent and as the administrative agent, and The Bank of Nova Scotia, as a managing agent. The existing and future patient-related accounts receivable (the “Receivables”) for certain of the Company’s hospitals serve as collateral for the outstanding borrowings under the Receivables Facility. The interest rate on the borrowings is based on the commercial paper rate plus an applicable interest rate spread. Unless earlier terminated or subsequently extended pursuant to its terms, the Receivables Facility will expire on March 21, 2014, subject to customary termination events that could cause an early termination date. The Company maintains effective control over the Receivables because, pursuant to the terms of the Receivables Facility, the Receivables are sold from certain of the Company’s subsidiaries to the Company, which then sells or contributes the Receivables to a special-purpose entity that is wholly-owned by the Company. The wholly-owned special-purpose entity in turn grants security interests in the Receivables in exchange for borrowings obtained from the group of third-party conduit lenders and liquidity banks of up to $300 million outstanding from time to time based on the availability of eligible Receivables and other customary factors. The group of third-party conduit lenders and liquidity banks do not have recourse to the Company or its subsidiaries beyond the assets of the wholly-owned special-purpose entity that collateralizes the loan. The Receivables and other assets of the wholly-owned special-purpose entity will be available first and foremost to satisfy the claims of the creditors of such entity. The outstanding borrowings pursuant to the Receivables Facility at March 31, 2012 totaled $300.0 million and are classified as long-term debt on the condensed consolidated balance sheet. At March 31, 2012, the carrying amount of Receivables included in the Receivables Facility totaled approximately $881.9 million and are included in patient accounts receivable on the condensed consolidated balance sheet.

The Company paid interest of $161.1 million and $226.1 million on borrowings during the three months ended March 31, 2012 and 2011, respectively.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2012	Apr. 19, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	COMMUNITY HEALTH SYSTEMS INC
Entity Central Index Key	0001108109
Document Type	10-Q
Document Period End Date	Mar. 31, 2012
Amendment Flag	false
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		91,888,334

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2012

Fair Value of Financial Instruments [Abstract]

FAIR VALUE OF FINANCIAL INSTRUMENTS

12. FAIR VALUE OF FINANCIAL INSTRUMENTS

The fair value of financial instruments has been estimated by the Company using available market information as of March 31, 2012 and December 31, 2011, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

	March 31, 2012				December 31, 2011
	Carrying		Estimated Fair		Carrying		Estimated Fair
	Amount		Value		Amount		Value
Assets:
Cash and cash equivalents	$	129,298	$	129,298	$	129,865	$	129,865
Available-for-sale securities		34,354		34,354		31,582		31,582
Trading securities		35,944		35,944		30,486		30,486
Liabilities:
Credit Facility		5,969,062		5,894,354		5,979,383		5,780,877
8 7/ 8% Senior Notes		931,016		968,200		1,777,617		1,842,322
8% Senior Notes		2,024,694		2,067,500		1,000,000		995,000
Other debt		345,465		345,465		41,143		41,143

The estimated fair value is determined using the methodologies discussed below in accordance with accounting standards related to the determination of fair value based on the U.S. GAAP fair value hierarchy as discussed in Note 13. The estimated fair value for financial instruments with a fair value that does not equal its carrying value is considered a Level 2 valuation. The Company utilizes the market approach and obtains indicative pricing from the administrative agent to our Credit Facility to determine fair values, which are validated through subscription services such as Bloomberg where relevant.

Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

Trading securities. Estimated fair value is based on closing price as quoted in public markets.

Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

8 ⁷ /8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

8% Senior Notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.

Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the three months ended March 31, 2012 and 2011, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at March 31, 2012, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

Interest rate swaps consisted of the following at March 31, 2012:

								Fair Value
	Notional Amount		Fixed Interest			Termination		of Liability
Swap #	(in 000’s)		Rate			Date		(in 000’s)
1	$	250,000		5.0185	%		May 30, 2012	$	1,845
2		150,000		5.0250	%		May 30, 2012		1,108
3		200,000		4.6845	%		September 11, 2012		3,750
4		100,000		3.3520	%		October 23, 2012		1,607
5		125,000		4.3745	%		November 23, 2012		3,140
6		75,000		4.3800	%		November 23, 2012		1,886
7		150,000		5.0200	%		November 30, 2012		4,524
8		200,000		2.2420	%		February 28, 2013		3,170
9		100,000		5.0230	%		May 30, 2013		5,218
10		300,000		5.2420	%		August 6, 2013		18,940
11		100,000		5.0380	%		August 30, 2013		6,320
12		50,000		3.5860	%		October 23, 2013		2,350
13		50,000		3.5240	%		October 23, 2013		2,303
14		100,000		5.0500	%		November 30, 2013		7,377
15		200,000		2.0700	%		December 19, 2013		5,130
16		100,000		5.2310	%		July 25, 2014		10,301
17		100,000		5.2310	%		July 25, 2014		10,302
18		200,000		5.1600	%		July 25, 2014		20,287
19		75,000		5.0405	%		July 25, 2014		7,405
20		125,000		5.0215	%		July 25, 2014		12,289
21		100,000		2.6210	%		July 25, 2014		4,453
22		100,000		3.1100	%		July 25, 2014		5,550
23		100,000		3.2580	%		July 25, 2014		5,881
24		200,000		2.6930	%		October 26, 2014		9,962
25		300,000		3.4470	%		August 8, 2016		27,989
26		200,000		3.4285	%		August 19, 2016		18,576
27		100,000		3.4010	%		August 19, 2016		9,185
28		200,000		3.5000	%		August 30, 2016		19,200
29		100,000		3.0050	%		November 30, 2016		7,691

The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the condensed consolidated statement of financial position. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.

Assuming no change in March 31, 2012 interest rates, approximately $111.0 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings.

The following tabular disclosure provides the amount of pre-tax (loss) gain recognized in the condensed consolidated balance sheets as a component of OCI during the three months ended March 31, 2012 and 2011 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Amount of Pre-Tax (Loss) Gain Recognized in OCI on Derivative (Effective Portion)
	Three Months Ended March 31,
	2012			2011
Interest rate swaps	$	(23,122	)	$	4,113

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the condensed consolidated statements of income during the three months ended March 31, 2012 and 2011 (in thousands):

Location of Loss Reclassified from AOCL into Income (Effective Portion)	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)
	Three Months Ended March 31,
	2012		2011
Interest expense, net	$	39,610	$	52,923

The fair values of derivative instruments in the condensed consolidated balance sheets as of March 31, 2012 and December 31, 2011 were as follows (in thousands):

	0000000		0000000	0000000		0000000	0000000		0000000	0000000		0000000
	Asset Derivatives						Liability Derivatives
	March 31, 2012			December 31, 2011			March 31, 2012			December 31, 2011
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments	Other assets, net	$	—	Other assets, net	$	—	Other long- term liabilities	$	237,739	Other long- term liabilities	$	254,228

XML

Condensed Consolidated Statements of Income (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012		Mar. 31, 2011
Condensed Consolidated Statements of Income [Abstract]
Operating revenues (net of contractual allowances and discounts)	$ 3,783,491		$ 3,354,052
Provision for bad debts	486,456		399,969
Net operating revenues	3,297,035		2,954,083
Operating costs and expenses:
Salaries and benefits	1,524,975		1,379,367
Supplies	498,579		457,817
Other operating expenses	708,943		614,793
Electronic health records incentive reimbursement	(26,168)		0
Rent	67,224		63,170
Depreciation and amortization	174,354		158,155
Total operating costs and expenses	2,947,907		2,673,302
Income from operations	349,128		280,781
Interest expense, net	152,175		163,218
Loss from early extinguishment of debt	63,429
Equity in earnings of unconsolidated affiliates	(12,013)		(18,134)
Income from continuing operations before income taxes	145,537		135,697
Provision for income taxes	45,819		44,092
Income from continuing operations	99,718		91,605
Discontinued operations, net of taxes:
Loss from operations of entities sold	(466)		(1,678)
Impairment of hospital sold			(8,368)
Loss on sale, net			(3,234)
Loss from discontinued operations, net of taxes	(466)		(13,280)
Net income	99,252		78,325
Less: Net income attributable to noncontrolling interests	23,778		17,001
Net income attributable to Community Health Systems, Inc.	$ 75,474		$ 61,324
Basic earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders:
Continuing operations	$ 0.86		$ 0.82
Discontinued operations	$ (0.01)		$ (0.15)
Net income	$ 0.85		$ 0.67
Diluted earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders (1):
Continuing operations	$ 0.85	[1]	$ 0.81	[1]
Discontinued operations	$ (0.01)	[1]	$ (0.14)	[1]
Net income	$ 0.85	[1]	$ 0.67	[1]
Weighted-average number of shares outstanding:
Basic	88,674,779		91,008,405
Diluted	88,852,704		92,136,819

[1] [1] Total per share amounts may not add due to rounding.

XML

Income Taxes

3 Months Ended

Mar. 31, 2012

Income Taxes [Abstract]

INCOME TAXES

6. INCOME TAXES

The total amount of unrecognized benefit that would affect the effective tax rate, if recognized, was approximately $2.0 million as of March 31, 2012. During the three months ended March 31, 2012, the Company increased liabilities for uncertain tax positions by $1.0 million and increased interest and penalties by approximately $0.2 million. A total of approximately $0.5 million of interest and penalties is included in the amount of the liability for uncertain tax positions at March 31, 2012. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its condensed consolidated statements of income as income tax expense.

It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, the Company does not anticipate the change will have a material impact on its consolidated results of operations or consolidated financial position.

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction and various state jurisdictions. The Company has extended the federal statute of limitations for Triad Hospitals, Inc. (“Triad”) for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The Internal Revenue Service (the “IRS”) has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. With few exceptions, the Company is no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. The Company’s federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position. In connection with the Company’s 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of the Company’s malpractice expense deductions. Management believes that the Company’s deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of the Company’s deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.

Cash paid for income taxes, net of refunds received, resulted in a net cash refund of $0.1 million and $0.7 million for the three months ended March 31, 2012 and 2011, respectively.

XML

Acquisitions and Divestitures

3 Months Ended

Mar. 31, 2012

Acquisitions and Divestitures [Abstract]

ACQUISITIONS AND DIVESTITURES

5. ACQUISITIONS AND DIVESTITURES

Acquisitions

The Company accounts for all transactions that represent business combinations after January 1, 2009 using the acquisition method of accounting, where the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquired entity are recognized and measured at their fair values on the date the Company obtains control in the acquiree. Such fair values that are not finalized for reporting periods following the acquisition date are estimated and recorded as provisional amounts. Adjustments to these provisional amounts during the measurement period (defined as the date through which all information required to identify and measure the consideration transferred, the assets acquired, the liabilities assumed and any noncontrolling interests has been obtained, limited to one year from the acquisition date) are recorded as of the date of acquisition. Any material impact to comparative information for periods after acquisition, but before the period in which adjustments are identified, is reflected in those prior periods as if the adjustments were considered as of the acquisition date. Goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired.

Effective March 5, 2012, one or more subsidiaries of the Company completed a merger with Diagnostic Clinic of Longview, P.A., which is a multi-specialty clinic serving residents of Longview, Texas and surrounding East Texas communities. This merger was accounted for as a purchase business combination. The total cash consideration paid for the business, including net working capital, was approximately $52.3 million, with additional consideration of $12.0 million assumed in liabilities, for a total consideration of $64.3 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, approximately $41.8 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective March 1, 2012, one or more subsidiaries of the Company completed the acquisition of MetroSouth Medical Center (330 licensed beds) located in Blue Island, Illinois. The total cash consideration paid for fixed assets was approximately $39.3 million with additional consideration of $12.1 million assumed in liabilities as well as a credit applied at closing of $0.9 million for negative acquired working capital, for a total consideration of $50.5 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, no goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective January 1, 2012, one or more subsidiaries of the Company completed the acquisition of Moses Taylor Healthcare System based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals and other healthcare providers. This healthcare system includes Moses Taylor Hospital (217 licensed beds) located in Scranton, Pennsylvania, and Mid-Valley Hospital (25 licensed beds) located in Peckville, Pennsylvania. The total cash consideration paid for fixed assets and working capital was approximately $151.1 million and $9.2 million, respectively, with additional consideration of $12.1 million assumed in liabilities, for a total consideration of $172.4 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, approximately $55.2 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective October 1, 2011, one or more subsidiaries of the Company completed the acquisition of Tomball Regional Hospital (358 licensed beds) located in Tomball, Texas. The total cash consideration paid for fixed assets and working capital was approximately $192.0 million and $17.5 million, respectively, with additional consideration of $15.9 million assumed in liabilities, for a total consideration of $225.4 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of March 31, 2012, approximately $32.4 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

Effective May 1, 2011, one or more subsidiaries of the Company completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.8 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $161.0 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of March 31, 2012, approximately $43.1 million of goodwill has been recorded.

Additionally, during the three months ended March 31, 2012, the Company paid approximately $5.9 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $1.5 million of the consideration paid to property and equipment, $0.3 million to net working capital, and the remainder, approximately $4.1 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.

Approximately $4.3 million and $3.3 million of acquisition costs related to prospective and closed acquisitions were expensed during the three months ended March 31, 2012 and 2011, respectively.

Discontinued Operations

Effective February 1, 2011, the Company sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group, located in Springfield, Oregon, to Oregon Healthcare Resources, LLC, for $14.6 million in cash; this business had a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million.

Effective September 1, 2011, the Company sold SouthCrest Hospital, located in Tulsa, Oklahoma, Claremore Regional Hospital, located in Claremore, Oklahoma, and other related healthcare assets affiliated with those hospitals to Hillcrest Healthcare System, part of Ardent Health Services, for approximately $154.2 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $193.0 million.

Effective October 22, 2011, the Company sold Cleveland Regional Medical Center, located in Cleveland, Texas, and other related healthcare assets affiliated with the hospital to New Directions Health Systems, LLC for approximately $0.9 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $14.2 million.

The Company has classified the results of operations for Oregon Medical Group, SouthCrest Hospital, Claremore Regional Hospital and Cleveland Regional Hospital as discontinued operations in the accompanying condensed consolidated statements of income for the three months ended March 31, 2012 and 2011.

Net operating revenues and loss from discontinued operations for the respective periods are as follows (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Net operating revenues	$	—		$	59,126
Loss from operations of entities sold before income taxes		(729	)		(2,673	)
Impairment of hospitals sold		—			(13,095	)
Loss on sale, net		—			(5,061	)
Loss from discontinued operations, before taxes		(729	)		(20,829	)
Income tax benefit		263			7,549
Loss from discontinued operations, net of taxes	$	(466	)	$	(13,280	)

Interest expense was allocated to discontinued operations based on sale proceeds available for debt repayment.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2012

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

17. SUBSEQUENT EVENTS

The Company evaluated all material events occurring subsequent to the balance sheet date for events requiring disclosure or recognition in the condensed consolidated financial statements.

XML

Fair Value

3 Months Ended

Mar. 31, 2012

Fair Value [Abstract]

FAIR VALUE

13. FAIR VALUE

Fair Value Hierarchy

Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, the Company utilizes the U.S. GAAP fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumption about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The inputs used to measure fair value are classified into the following fair value hierarchy:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes values determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions.

In instances where the determination of the fair value hierarchy measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment of factors specific to the asset or liability.

The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of March 31, 2012 and December 31, 2011 (in thousands):

		000000000		000000000		000000000		000000000
	March 31,
	2012		Level 1		Level 2		Level 3
Available-for-sale securities	$	34,354	$	34,354	$	—	$	—
Trading securities		35,944		35,944		—		—
Total assets	$	70,298	$	70,298	$	—	$	—
Fair value of interest rate swap agreements	$	237,739	$	—	$	237,739	$	—
Total liabilities	$	237,739	$	—	$	237,739	$	—
	December 31, 2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,582	$	31,582	$	—	$	—
Trading securities		30,486		30,486		—		—
Total assets	$	62,068	$	62,068	$	—	$	—
Fair value of interest rate swap agreements	$	254,228	$	—	$	254,228	$	—
Total liabilities	$	254,228	$	—	$	254,228	$	—

Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices.

The valuation of the Company’s interest rate swap agreements is determined using market valuation techniques, including discounted cash flow analysis on the expected cash flows of each agreement. This analysis reflects the contractual terms of the agreement, including the period to maturity, and uses observable market-based inputs, including forward interest rate curves. The fair value of interest rate swap agreements are determined by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates based on observable market forward interest rate curves and the notional amount being hedged.

The Company incorporates CVAs to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. The CVA on the Company’s interest rate swap agreements at March 31, 2012 resulted in a decrease in the fair value of the related liability of $12.6 million and an after-tax adjustment of $8.1 million to OCI. The CVA on the Company’s interest rate swap agreements at December 31, 2011 resulted in a decrease in the fair value of the related liability of $21.7 million and an after-tax adjustment of $13.9 million to OCI.

The majority of the inputs used to value its interest rate swap agreements, including the forward interest rate curves and market perceptions of the Company’s credit risk used in the CVAs, are observable inputs available to a market participant. As a result, the Company has determined that the interest rate swap valuations are classified in Level 2 of the fair value hierarchy.

XML

Stockholders Equity

3 Months Ended

Mar. 31, 2012

Stockholders' Equity [Abstract]

STOCKHOLDERS EQUITY

9. STOCKHOLDERS’ EQUITY

Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of 300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the aforementioned classes of capital stock has a par value of $0.01 per share. Shares of preferred stock, none of which were outstanding as of March 31, 2012, may be issued in one or more series having such rights, preferences and other provisions as determined by the Board of Directors without approval by the holders of common stock.

On December 14, 2011, the Company adopted a new open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. The new repurchase program will conclude at the earliest of three years, when the maximum number of shares has been repurchased, or when the maximum dollar amount of repurchases has been expended. Through March 31, 2012, no shares have been purchased and retired under this program.

On September 15, 2010, the Company commenced an open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount of repurchases has been expended. During the three months ended March 31, 2012 and 2011, the Company did not repurchase any shares under this program. The cumulative number of shares that have been repurchased and retired under this program through March 31, 2012 is 3,921,138 shares at a weighted-average price of $25.39 per share.

The Company’s Credit Facility (as discussed below) limits the Company’s ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate plus the aggregate amount of proceeds from the exercise of stock options. The indentures governing the 8  ⁷/8% Senior Notes due 2015 and the 8% Senior Notes due 2019 (collectively, the “Senior Notes”) also limit the Company’s ability to pay dividends and/or repurchase stock. As of March 31, 2012, under the most restrictive test under these agreements, the Company has approximately $80.4 million remaining available with which to pay permitted dividends and/or repurchase shares of stock or its Senior Notes.

The following schedule presents the reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests for the three-month period ended March 31, 2012 (in thousands):

				Community Health Systems, Inc. Stockholders
													Accumulated
	Redeemable						Additional						Other								Total
	Noncontrolling			Common			Paid-in			Treasury			Comprehensive			Retained		Noncontrolling			Stockholders’
	Interests			Stock			Capital			Stock			Income (Loss)			Earnings		Interests			Equity
Balance, December 31, 2011	$	395,743		$	915		$	1,086,008		$	(6,678	)	$	(184,479	)	$	1,501,330	$	67,349		$	2,464,445
Comprehensive income		17,599			—			—			—			14,343			75,474		6,179			95,996
Distributions to noncontrolling interests, net of contributions		(15,904	)		—			—			—			—			—		(11,019	)		(11,019	)
Purchase of subsidiary shares from noncontrolling interests		(12,285	)		—			(18,673	)		—			—			—		(138	)		(18,811	)
Other reclassifications of noncontrolling interests		623			—			—			—			—			—		(623	)		(623	)
Adjustment to redemption value of redeemable noncontrolling interests		(22,236	)		—			22,236			—			—			—		—			22,236
Repurchase of common stock		—			—			—			—			—			—		—			—
Issuance of common stock in connection with the exercise of stock options		—			—			308			—			—			—		—			308
Cancellation of restricted stock for tax withholdings on vested shares		—			(3	)		(9,032	)		—			—			—		—			(9,035	)
Excess tax benefit from exercise of stock options		—			—			(1,895	)		—			—			—		—			(1,895	)
Share-based compensation		—			7			10,495			—			—			—		—			10,502
Balance, March 31, 2012	$	363,540		$	919		$	1,089,447		$	(6,678	)	$	(170,136	)	$	1,576,804	$	61,748		$	2,552,104

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Three Months Ended March 31, 2012
Net income attributable to Community Health Systems, Inc.	$	75,474
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(18,673	)
Net transfers to the noncontrolling interests		(18,673	)
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	$	56,801

XML

Long-Term Debt (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Long Term Debt
Total debt	$ 9,319,004	$ 8,846,504
Less current maturities	(75,388)	(63,706)
Total long-term debt	9,243,616	8,782,798
8.875% Senior Noted Due 2015 [Member]
Long Term Debt
Total debt	931,016	1,777,617
8% Senior Notes Due 2019 [Member]
Long Term Debt
Total debt	2,024,694	1,000,000
Term Loan A [Member]
Long Term Debt
Total debt	750,000
Term Loan B [Member]
Long Term Debt
Total debt	5,219,062	5,949,383
Revolving Credit Facility [Member]
Long Term Debt
Total debt		30,000
Receivables Facility [Member]
Long Term Debt
Total debt	300,000
Capital Lease Obligations [Member]
Long Term Debt
Total debt	48,767	48,361
Other [Member]
Long Term Debt
Total debt	$ 45,465	$ 41,143

XML

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2012

Goodwill and Other Intangible Assets [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

7. GOODWILL AND OTHER INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for the three months ended March 31, 2012, are as follows (in thousands):

Balance as of December 31, 2011	$	4,264,845
Goodwill acquired as part of acquisitions during 2012		101,097
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		1,899
Balance as of March 31, 2012	$	4,367,841

Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At March 31, 2012, the hospital operations reporting unit, the home care agency operations reporting unit, and the hospital management services reporting unit had approximately $4.3 billion, $40.5 million and $33.3 million, respectively, of goodwill.

Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2011, which evaluation took place during the fourth quarter of 2011. No impairment was indicated by this evaluation.

The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.

The gross carrying amount of the Company’s other intangible assets subject to amortization was $62.6 million at March 31, 2012 and $60.0 million at December 31, 2011, and the net carrying amount was $31.5 million at March 31, 2012 and $30.6 million at December 31, 2011. The carrying amount of the Company’s other intangible assets not subject to amortization was $47.3 million at March 31, 2012 and $46.9 million at December 31, 2011. Other intangible assets are included in other assets, net on the Company’s condensed consolidated balance sheets. Substantially all of the Company’s intangible assets are contract-based intangible assets related to operating licenses, management contracts, or non-compete agreements entered into in connection with prior acquisitions.

The weighted-average amortization period for the intangible assets subject to amortization is approximately eight years. There are no expected residual values related to these intangible assets. Amortization expense on these intangible assets was $1.6 million and $1.9 million during the three months ended March 31, 2012 and 2011, respectively. Amortization expense on intangible assets is estimated to be $6.2 million for the remainder of 2012, $5.4 million in 2013, $3.5 million in 2014, $3.1 million in 2015, $2.4 million in 2016, $2.2 million in 2017 and $8.7 million thereafter.

The gross carrying amount of capitalized software for internal use was approximately $486.3 million and $451.0 million at March 31, 2012 and December 31, 2011, respectively, and the net carrying amount considering accumulated amortization was approximately $256.3 million and $241.3 million at March 31, 2012 and December 31, 2011, respectively. The estimated amortization period for capitalized internal-use software is generally three years, except for capitalized costs related to significant system conversions, which is generally eight years. There is no expected residual value for capitalized internal-use software. At March 31, 2012, there was approximately $152.8 million of capitalized costs for internal-use software that is currently in the development stage and will begin amortization once the software project is complete and ready for its intended use. Amortization expense on capitalized internal-use software was $19.7 million and $17.9 million during the three months ended March 31, 2012 and 2011, respectively. Amortization expense on capitalized internal-use software is estimated to be $68.6 million for the remainder of 2012, $85.6 million in 2013, $41.2 million in 2014, $19.1 million in 2015, $16.4 million in 2016, $12.9 million in 2017 and $12.5 million thereafter.

XML

Earnings per Share

3 Months Ended

Mar. 31, 2012

Earnings per Share [Abstract]

EARNINGS PER SHARE

8. EARNINGS PER SHARE

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Three Months Ended
	March 31,
	2012			2011
Numerator:
Income from continuing operations, net of taxes	$	99,718		$	91,605
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		23,778			17,001
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	75,940		$	74,604
Loss from discontinued operations, net of taxes	$	(466	)	$	(13,280	)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes		—			—
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	(466	)	$	(13,280	)
Denominator:
Weighted-average number of shares outstanding — basic		88,674,779			91,008,405
Effect of dilutive securities:
Restricted stock awards		21,233			253,866
Employee stock options		147,440			865,691
Other equity-based awards		9,252			8,857
Weighted-average number of shares outstanding — diluted		88,852,704			92,136,819
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options		6,869,031			4,395,292

XML

Equity Investments

3 Months Ended

Mar. 31, 2012

Equity Investments [Abstract]

EQUITY INVESTMENTS

10. EQUITY INVESTMENTS

As of March 31, 2012, the Company owned equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one hospital in Las Vegas, Nevada, in which Universal Health Systems, Inc. owns the majority interest, and an equity interest of 38.0% in three hospitals in Macon, Georgia, in which HCA Inc. owns the majority interest.

Summarized combined financial information for the three months ended March 31, 2012 and 2011, for these unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	Three Months Ended
	March 31
	2012		2011
Revenues	$	317,317	$	320,840
Operating costs and expenses	$	277,256	$	266,236
Income from continuing operations before taxes	$	40,035	$	54,584

The summarized financial information for the three months ended March 31, 2012 and 2011 was derived from the unaudited financial information provided to the Company by those unconsolidated entities.

The Company’s investment in all of its unconsolidated affiliates was $431.9 million and $422.2 million at March 31, 2012 and December 31, 2011, respectively, and is included in other assets, net in the accompanying condensed consolidated balance sheets. Included in the Company’s results of operations is the Company’s equity in pre-tax earnings from all of its investments in unconsolidated affiliates, which was $12.0 million and $18.1 million for the three months ended March 31, 2012 and 2011, respectively.

XML

Long-Term Debt (Details Textual 1) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 06, 2012
Community Health System [Member]
Additional Long-Term Debt (Textual) [Abstract]
Extended period of amendment for existing Credit Facility	2 years 6 months
Revolving Credit Facility [Member] | Community Health System [Member]
Additional Long-Term Debt (Textual) [Abstract]
Revolving credit facility	750
Maturity period of revolving credit facility	6 years
Maturity date of existing term loans under Credit Facility	Jan. 25, 2017
Line of Credit [Member]
Additional Long-Term Debt (Textual) [Abstract]
Letters of Credit outstanding	37.7
Line of Credit [Member] | Community Health System [Member]
Additional Long-Term Debt (Textual) [Abstract]
Debt instrument unused borrowing capacity amount	750
Weighted-average interest rate under the Credit Facility, excluding swaps	3.40%
Senior Secured Revolving Credit Facility [Member]
Additional Long-Term Debt (Textual) [Abstract]
Revolving credit facility		$ 750
Maturity date of existing term loans under Credit Facility	Oct. 25, 2016

XML

Fair Value of Financial Instruments (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012
Interest Rate Swaps 1 [Member]
Interest rate swaps
Notional Amount	$ 250,000
Fixed Interest Rate	5.0185%
Termination Date	May 30, 2012
Fair Value of Liability	1,845
Interest Rate Swaps 2 [Member]
Interest rate swaps
Notional Amount	150,000
Fixed Interest Rate	5.025%
Termination Date	May 30, 2012
Fair Value of Liability	1,108
Interest Rate Swaps 3 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	4.6845%
Termination Date	Sep. 11, 2012
Fair Value of Liability	3,750
Interest Rate Swaps 4 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.352%
Termination Date	Oct. 23, 2012
Fair Value of Liability	1,607
Interest Rate Swaps 5 [Member]
Interest rate swaps
Notional Amount	125,000
Fixed Interest Rate	4.3745%
Termination Date	Nov. 23, 2012
Fair Value of Liability	3,140
Interest Rate Swaps 6 [Member]
Interest rate swaps
Notional Amount	75,000
Fixed Interest Rate	4.38%
Termination Date	Nov. 23, 2012
Fair Value of Liability	1,886
Interest Rate Swaps 7 [Member]
Interest rate swaps
Notional Amount	150,000
Fixed Interest Rate	5.02%
Termination Date	Nov. 30, 2012
Fair Value of Liability	4,524
Interest Rate Swaps 8 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.242%
Termination Date	Feb. 28, 2013
Fair Value of Liability	3,170
Interest Rate Swaps 9 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.023%
Termination Date	May 30, 2013
Fair Value of Liability	5,218
Interest Rate Swaps 10 [Member]
Interest rate swaps
Notional Amount	300,000
Fixed Interest Rate	5.242%
Termination Date	Aug. 06, 2013
Fair Value of Liability	18,940
Interest Rate Swaps 11 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.038%
Termination Date	Aug. 30, 2013
Fair Value of Liability	6,320
Interest Rate Swaps 12 [Member]
Interest rate swaps
Notional Amount	50,000
Fixed Interest Rate	3.586%
Termination Date	Oct. 23, 2013
Fair Value of Liability	2,350
Interest Rate Swaps 13 [Member]
Interest rate swaps
Notional Amount	50,000
Fixed Interest Rate	3.524%
Termination Date	Oct. 23, 2013
Fair Value of Liability	2,303
Interest Rate Swaps 14 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.05%
Termination Date	Nov. 30, 2013
Fair Value of Liability	7,377
Interest Rate Swaps 15 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.07%
Termination Date	Dec. 19, 2013
Fair Value of Liability	5,130
Interest Rate Swaps 16 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.231%
Termination Date	Jul. 25, 2014
Fair Value of Liability	10,301
Interest Rate Swaps 17 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.231%
Termination Date	Jul. 25, 2014
Fair Value of Liability	10,302
Interest Rate Swaps 18 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	5.16%
Termination Date	Jul. 25, 2014
Fair Value of Liability	20,287
Interest Rate Swaps 19 [Member]
Interest rate swaps
Notional Amount	75,000
Fixed Interest Rate	5.0405%
Termination Date	Jul. 25, 2014
Fair Value of Liability	7,405
Interest Rate Swaps 20 [Member]
Interest rate swaps
Notional Amount	125,000
Fixed Interest Rate	5.0215%
Termination Date	Jul. 25, 2014
Fair Value of Liability	12,289
Interest Rate Swaps 21 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	2.621%
Termination Date	Jul. 25, 2014
Fair Value of Liability	4,453
Interest Rate Swaps 22 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.11%
Termination Date	Jul. 25, 2014
Fair Value of Liability	5,550
Interest Rate Swaps 23 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.258%
Termination Date	Jul. 25, 2014
Fair Value of Liability	5,881
Interest Rate Swaps 24 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.693%
Termination Date	Oct. 26, 2014
Fair Value of Liability	9,962
Interest Rate Swaps 25 [Member]
Interest rate swaps
Notional Amount	300,000
Fixed Interest Rate	3.447%
Termination Date	Aug. 08, 2016
Fair Value of Liability	27,989
Interest Rate Swaps 26 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.4285%
Termination Date	Aug. 19, 2016
Fair Value of Liability	18,576
Interest Rate Swaps 27 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.401%
Termination Date	Aug. 19, 2016
Fair Value of Liability	9,185
Interest Rate Swaps 28 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.50%
Termination Date	Aug. 30, 2016
Fair Value of Liability	19,200
Interest Rate Swaps 29 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.005%
Termination Date	Nov. 30, 2016
Fair Value of Liability	$ 7,691

XML

Long-Term Debt (Details Textual) (USD $)	3 Months Ended					3 Months Ended			3 Months Ended	12 Months Ended									3 Months Ended					3 Months Ended				1 Months Ended	3 Months Ended		3 Months Ended		3 Months Ended			12 Months Ended			3 Months Ended		1 Months Ended	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 06, 2012	Dec. 31, 2011	Nov. 05, 2010	Mar. 31, 2012 Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2007 Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Senior Notes 8.875% Due 2015 [Member]	Mar. 31, 2012 8% Senior Notes Due 2019 [Member]	Dec. 31, 2011 8% Senior Notes Due 2019 [Member]	Nov. 22, 2011 8% Senior Notes Due 2019 [Member]	Jul. 25, 2007 8% Senior Notes Due 2019 [Member]	Mar. 31, 2012 1.25% term loan due 2014 [Member]	Mar. 31, 2012 2.25% term loan due 2014 [Member]	Mar. 31, 2012 2.25% term loan due 2017 [Member]	Mar. 31, 2012 3.5% term loan due 2017 [Member]	Mar. 31, 2012 Alternate Base Rate Revolving Loan [Member]	Mar. 31, 2012 Eurodollar Revolving Loan [Member]	Mar. 31, 2012 First Nine Months [Member]	Mar. 31, 2012 Next Three Months [Member]	Mar. 31, 2012 One Year Onward [Member]	Feb. 02, 2012 July 25, 2014 maturity term loans [Member]	Feb. 02, 2012 Amended credit agreement [Member]	Mar. 31, 2012 Incremental Term Loan [Member]	Mar. 31, 2012 Incremental Term Loan and Revolver Facility [Member] Senior Notes 8.875% Due 2015 [Member]	Mar. 31, 2012 Term Loan [Member]	Mar. 31, 2012 Receivables Facility [Member]	Jan. 31, 2009 Community Health System [Member]	Mar. 31, 2012 Community Health System [Member]	Jul. 25, 2007 Community Health System [Member]	Mar. 31, 2012 Community Health System [Member] Senior 6.50% Subordinated Notes Due 2012 [Member]	Jul. 25, 2007 Community Health System [Member] Senior 6.50% Subordinated Notes Due 2012 [Member]	Mar. 31, 2012 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Mar. 31, 2011 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Sep. 30, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2011 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Dec. 31, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Sep. 30, 2007 Community Health System [Member] Funded Term Loan Facility [Member]	Mar. 31, 2012 Community Health System [Member] Funded Term Loan Facility [Member]	Jan. 31, 2009 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Mar. 31, 2012 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2008 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2007 Community Health System [Member] Delayed Draw Term Loan Facility [Member]
Long-Term Debt (Textual) [Abstract]
Senior secured financing under a new credit facility																														$ 7,200,000,000
Principal amount of senior notes issued									1,000,000,000	1,000,000,000	1,000,000,000																										3,000,000,000	3,000,000,000
Increase pricing of term loans	LIBOR plus 350 basis points
Applicable percentage for rate loan													1.25%	2.25%	2.25%	3.50%	1.50%	2.50%
Percentage of interest rate							8.875%	8.875%	8.00%			8.00%																				6.50%
Net proceeds from the notes offering	4,315,011,000																																		3,000,000,000
Issuance of long-term debt																																							6,100,000,000
Debt instrument maximum borrowing capacity																																								6,100,000,000		400,000,000		300,000,000
Maturity period of debt instrument																																								7 years		7 years
Drawn of delayed draw term loan																																									200,000,000	200,000,000	100,000,000
Amortization term loan facility as percentage of outstanding term loan																												0.25%
Quarterly amortization payments of each term loan facility																												0.25% of the outstanding amount of the term loans
Condition for amended maturity date	If more than $50 million of the 8.875% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015
Amended maximum borrowing capacity under uncommitted incremental facility	1,000,000,000
Original maximum borrowing capacity under uncommitted incremental facility	600,000,000
Amended borrowing capacity from receivable transactions	2,000,000,000
Increase in borrowing capacity from receivable transactions	500,000,000
Amount of borrowing from receivable transactions to be used for repayment of existing term loans	1,700,000,000
Prepaid amount of term loan																													equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions.
Loans under the Credit Facility interest rate description																													Rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) The Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for revolving loans is 1.50% for Alternate Base Rate revolving loans and 2.50% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio.
Maturity period of senior notes						2015/07/15																									2012
Aggregate principal amount																																	1,800,000,000			2,800,000,000
Percentage payment of commitment fees per annum																													0.50%
Percentage payment of commitment fees Description																																										0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum.
Maturity date of existing term loans under Credit Facility																								Oct. 25, 2016		Jul. 25, 2014
Frequency of payment						semiannually			semiannually
Percentage at which that Issued at Premium under Private Placement									102.50%
Date of commencing interest payment						2008/01/15				2012/05/15
Base for calculation of Interest						360-day year comprised of twelve 30-day months				360-day year comprised of twelve 30-day months
Payments made for term loan under Credit Facility	5,236,948,000	14,665,000
Principle amount of term loans to tranches																																								1,000,000,000
Interest paid on borrowings	161,140,000	226,124,000
Extended maturity date for term loans with minimum specified amount						Apr. 15, 2015
Obligation to pay commitment fees																			0.50%	0.75%	1.00%
Period for calculation of interest rate						360 days				360 days
Frequency of interest						30 days				30 days
Minimum period for redemption of notes						30 days				30 days
Maximum period for redemption of notes						60 days				60 days
Period of redemption commencing on scheduled date						12 months				12 months
Minimum amount of notes without having been refinanced outstanding on specified date						50,000,000
Extinguishment of Debt									1,000,000,000																									850,000,000		1,000,000,000
Net loss from early extinguishment of debt net of tax																									(5,300,000)								(34,300,000)			(42,000,000)
Loss from early extinguishment of debt	63,429,000																								(8,500,000)								(54,900,000)			(66,000,000)
Balance of term loans	9,243,616,000			8,782,798,000																		2,900,000,000
Non-extended term loans under the Credit Facility																							1,600,000,000
Receivables facility expiration date.																											2014/03/21
outstanding borrowings	300,000,000																										300,000,000
Maximum amount of receivables facility outstanding																											300,000,000
Carrying amount of receivables included in receivables facility																											881,900,000
Long Term Debt (Additional) (Textual) [Abstract]
Equivalent percentage of term loan facility related to net cash proceeds of certain asset sales and dispositions by Company and its subsidiaries	100.00%
Equivalent percentage of term loan facility related to net cash proceeds of Issuances of certain debt obligations or receivables based financing by Company and its subsidiaries	100.00%
Equivalent percentage of term loan facility related to reduction to lower percentage based on company's leverage ratio	50.00%
Addition to federal effective rate under credit facility	0.50%
Percentage above LIBOR Rate	1.00%
Amended maximum borrowing capacity under uncommitted incremental facility	1,000,000,000
Original maximum borrowing capacity under uncommitted incremental facility	600,000,000
Amended borrowing capacity from receivable transactions	2,000,000,000
Increase in borrowing capacity from receivable transactions	500,000,000
Amount of borrowing from receivable transactions to be used for repayment of existing term loans	1,700,000,000
Applicable percentage for rate loan													1.25%	2.25%	2.25%	3.50%	1.50%	2.50%
Incremental term loan facility			750,000,000
Incremental term loan amortization rate for year one	5.00%
Incremental term loan amortization rate for year two	10.00%
Incremental term loan amortization rate for year three	10.00%
Incremental term loan amortization rate for year four	15.00%
Incremental term loan amortization rate for year five	60.00%
Pricing on replacement revolver facility	LIBOR plus a margin of 250 basis points
Pricing on Incremental term loan	LIBOR plus a margin of 250 basis points
Condition for amended maturity date	If more than $50 million of the 8.875% Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015
Existing term loans under the Credit Facility					$ 1,500,000,000

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2012

Fair Value of Financial Instruments [Abstract]

Estimated fair value of financial instruments

The fair value of financial instruments has been estimated by the Company using available market information as of March 31, 2012 and December 31, 2011, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

	March 31, 2012				December 31, 2011
	Carrying		Estimated Fair		Carrying		Estimated Fair
	Amount		Value		Amount		Value
Assets:
Cash and cash equivalents	$	129,298	$	129,298	$	129,865	$	129,865
Available-for-sale securities		34,354		34,354		31,582		31,582
Trading securities		35,944		35,944		30,486		30,486
Liabilities:
Credit Facility		5,969,062		5,894,354		5,979,383		5,780,877
8 7/ 8% Senior Notes		931,016		968,200		1,777,617		1,842,322
8% Senior Notes		2,024,694		2,067,500		1,000,000		995,000
Other debt		345,465		345,465		41,143		41,143

Interest rate swaps

Interest rate swaps consisted of the following at March 31, 2012:

								Fair Value
	Notional Amount		Fixed Interest			Termination		of Liability
Swap #	(in 000’s)		Rate			Date		(in 000’s)
1	$	250,000		5.0185	%		May 30, 2012	$	1,845
2		150,000		5.0250	%		May 30, 2012		1,108
3		200,000		4.6845	%		September 11, 2012		3,750
4		100,000		3.3520	%		October 23, 2012		1,607
5		125,000		4.3745	%		November 23, 2012		3,140
6		75,000		4.3800	%		November 23, 2012		1,886
7		150,000		5.0200	%		November 30, 2012		4,524
8		200,000		2.2420	%		February 28, 2013		3,170
9		100,000		5.0230	%		May 30, 2013		5,218
10		300,000		5.2420	%		August 6, 2013		18,940
11		100,000		5.0380	%		August 30, 2013		6,320
12		50,000		3.5860	%		October 23, 2013		2,350
13		50,000		3.5240	%		October 23, 2013		2,303
14		100,000		5.0500	%		November 30, 2013		7,377
15		200,000		2.0700	%		December 19, 2013		5,130
16		100,000		5.2310	%		July 25, 2014		10,301
17		100,000		5.2310	%		July 25, 2014		10,302
18		200,000		5.1600	%		July 25, 2014		20,287
19		75,000		5.0405	%		July 25, 2014		7,405
20		125,000		5.0215	%		July 25, 2014		12,289
21		100,000		2.6210	%		July 25, 2014		4,453
22		100,000		3.1100	%		July 25, 2014		5,550
23		100,000		3.2580	%		July 25, 2014		5,881
24		200,000		2.6930	%		October 26, 2014		9,962
25		300,000		3.4470	%		August 8, 2016		27,989
26		200,000		3.4285	%		August 19, 2016		18,576
27		100,000		3.4010	%		August 19, 2016		9,185
28		200,000		3.5000	%		August 30, 2016		19,200
29		100,000		3.0050	%		November 30, 2016		7,691

Amount of pre-tax loss recognized in the consolidated balance sheets as a component of other comprehensive income

The following tabular disclosure provides the amount of pre-tax (loss) gain recognized in the condensed consolidated balance sheets as a component of OCI during the three months ended March 31, 2012 and 2011 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Amount of Pre-Tax (Loss) Gain Recognized in OCI on Derivative (Effective Portion)
	Three Months Ended March 31,
	2012			2011
Interest rate swaps	$	(23,122	)	$	4,113

Effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss ("OCL") into interest expense on the consolidated statements of income

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the condensed consolidated statements of income during the three months ended March 31, 2012 and 2011 (in thousands):

Location of Loss Reclassified from AOCL into Income (Effective Portion)	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)
	Three Months Ended March 31,
	2012		2011
Interest expense, net	$	39,610	$	52,923

Fair value of derivative instruments in the consolidated balance sheets

The fair values of derivative instruments in the condensed consolidated balance sheets as of March 31, 2012 and December 31, 2011 were as follows (in thousands):

	0000000		0000000	0000000		0000000	0000000		0000000	0000000		0000000
	Asset Derivatives						Liability Derivatives
	March 31, 2012			December 31, 2011			March 31, 2012			December 31, 2011
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments	Other assets, net	$	—	Other assets, net	$	—	Other long- term liabilities	$	237,739	Other long- term liabilities	$	254,228

XML

Goodwill and Other Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012
Carrying amount of goodwill
Beginning Balance	$ 4,264,845
Goodwill acquired as part of acquisitions during 2012	101,097
Consideration adjustments and purchase price allocation adjustments for prior year's acquisitions	1,899
Ending Balance	$ 4,367,841

XML

Segment Information

3 Months Ended

Mar. 31, 2012

Segment Information [Abstract]

SEGMENT INFORMATION

15. SEGMENT INFORMATION

The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.

The distribution between reportable segments of the Company’s revenues and income from continuing operations before income taxes is summarized in the following tables (in thousands):

	Three Months Ended March 31,
	2012			2011
Revenues:
Hospital operations	$	3,223,098		$	2,884,330
Corporate and all other		73,937			69,753
Total	$	3,297,035		$	2,954,083
Income from continuing operations before income taxes:
Hospital operations	$	200,308		$	178,113
Corporate and all other		(54,771	)		(42,416	)
Total	$	145,537		$	135,697

XML

Basis of Presentation and Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2012

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Operating revenue, net of contractual allowances and discounts (but before the provision for bad debts),

Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the three months ended March 31, 2012 and 2011, is as follows (in thousands):

	Three Months Ended
	March 31,
	2012		2011
Medicare	$	1,064,157	$	923,864
Medicaid		315,092		321,525
Managed Care and other third-party payors		1,906,487		1,699,860
Self-pay		497,755		408,803
Total	$	3,783,491	$	3,354,052

XML

Acquisitions and Divestitures (Details Textual) (USD $)	3 Months Ended								1 Months Ended		1 Months Ended		1 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012 Diagnostic Clinic of Longview [Member]	Mar. 31, 2012 Metro South Medical Center [Member]	Mar. 31, 2012 Moses Taylor Healthcare [Member]	Mar. 31, 2012 Mercy health partners [Member]	Mar. 31, 2012 Physician practices, clinics and other ancillary businesses [Member]	Mar. 31, 2012 Tomball Regional Hospital [Member]	Feb. 28, 2011 Oregon Healthcare Resources LLC [Member]	Jan. 31, 2011 Oregon Healthcare Resources LLC [Member]	Sep. 30, 2011 Southcrest and Claremore Hospital [Member]	Aug. 31, 2011 Southcrest and Claremore Hospital [Member]	Oct. 31, 2011 New Directions Health Systems LLC [Member]	Oct. 22, 2011 New Directions Health Systems LLC [Member]
Acquisitions and Divestitures (Textual) [Abstract]
Total cash consideration paid for business including net working capital			$ 52,300,000
Total Consideration of Assets for Business combination				39,300,000	151,100,000	150,800,000		192,000,000
Purchase price allocation to property and equipment							1,500,000
Cash consideration paid including working capital							5,900,000
Cash paid for working capital				(900,000)	9,200,000	(2,100,000)		17,500,000
Purchase price to net working capital							300,000
Assumed liabilities in business combination			12,000,000	12,100,000	12,100,000	12,300,000		15,900,000
Total Consideration			64,300,000	50,500,000	172,400,000	161,000,000		225,400,000
Purchase price allocation to Goodwill			41,800,000		55,200,000	43,100,000	4,100,000	32,400,000
Carrying amount of net assets including allocation of reporting unit goodwill										19,700,000		193,000,000		14,200,000
Cash consideration		14,583,000							14,600,000		154,200,000		900,000
Acquisitions and Divestitures (Additional) (Textual) [Abstract]
Acquisition costs related to prospective and closed acquisitions expensed	$ 4,300,000	$ 3,300,000

XML

Accounting for Stock-Based Compensation (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2012 Y	Mar. 31, 2011 Y
Fair value of stock options
Expected volatility	57.70%	31.20%
Expected dividends
Expected term	4.1	4
Risk-free interest rate	0.70%	1.70%

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Condensed Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 99,252	$ 78,325
Other comprehensive income, net of income taxes:
Net change in fair value of interest rate swaps	10,536	36,446
Net change in fair value of available-for-sale securities	2,667	1,069
Amortization and recognition of unrecognized pension cost components	1,140	772
Other comprehensive income	14,343	38,287
Comprehensive income	113,595	116,612
Less: Comprehensive income attributable to noncontrolling interests	23,778	17,001
Comprehensive income attributable to Community Health Systems, Inc.	$ 89,817	$ 99,611

XML

Use of Estimates

3 Months Ended

Mar. 31, 2012

Use of Estimates [Abstract]

USE OF ESTIMATES

4. USE OF ESTIMATES

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Actual results could differ from these estimates under different assumptions or conditions.

XML

Equity Investments (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Summarized combined financial information of entities in which Company owns equity interest
Revenues	$ 317,317	$ 320,840
Operating costs and expenses	277,256	266,236
Income from continuing operations before taxes	$ 40,035	$ 54,584

XML

Fair Value of Financial Instruments (Details Textual) (USD $) In Millions, unless otherwise specified	Mar. 31, 2012
Fair Value of Financial Instruments (Textual) [Abstract]
Interest expenses due to spread between fixed and floating rates	$ 111.0

XML

Accounting for Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2012

Accounting for Stock-Based Compensation [Abstract]

Impact of Total Compensation Expense

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Effect on income from continuing operations before income taxes	$	(10,495	)	$	(9,918	)
Effect on net income	$	(6,664	)	$	(6,298	)

Fair value of stock options

The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three months ended March 31, 2012 and 2011:

	Three Months Ended
	March 31,
	2012			2011
Expected volatility		57.7	%		31.2	%
Expected dividends		—			—
Expected term		4.1 years			4 years
Risk-free interest rate		0.7	%		1.7	%

Options outstanding and exercisable

Options outstanding and exercisable under the 2000 Plan and the 2009 Plan as of March 31, 2012, and changes during the three-month period following December 31, 2011, were as follows (in thousands, except share and per share data):

						Weighted - Average
				Weighted -				Aggregate
				Average		Remaining		Intrinsic
				Exercise		Contractual		Value as of
	Shares			Price		Term		March 31, 2012
Outstanding at December 31, 2011		8,389,142		$	32.83
Granted		246,500			21.07
Exercised		(17,244	)		17.88
Forfeited and cancelled		(130,475	)		32.27
Outstanding at March 31, 2012		8,487,923		$	32.53		5.2 years	$	5,244
Exercisable at March 31, 2012		6,802,639		$	32.56		4.3 years	$	4,329

Restricted stock outstanding

Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of March 31, 2012, and changes during the three-month period following December 31, 2011, were as follows:

				Weighted -
				Average
				Grant Date
	Shares			Fair Value
Unvested at December 31, 2011		2,207,612		$	32.95
Granted		660,500			21.07
Vested		(1,082,821	)		29.67
Forfeited		(1,000	)		37.96
Unvested at March 31, 2012		1,784,291			30.54

Phantom stock and restricted stock

				Weighted -
				Average
				Grant Date
				Fair
	Shares			Value
Unvested at December 31, 2011		52,956		$	31.67
RSUs Granted February 16, 2012		39,870			21.07
Vested		(27,556	)		28.19
Forfeited		—			—
Unvested at March 31, 2012		65,270			26.67

Deferred Director's Fee

The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

	Three Months Ended
	March 31,
	2012		2011
Directors’ fees earned and deferred into plan	$	28	$	55
Share equivalent units		1,237		1,375

XML

Contingencies (Details Textual) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Jan. 22, 2008	Oct. 04, 2007 Hospital
Contingencies Additional (Textual) [Abstract]
Number of New Mexico hospitals violated the norms under Federal False Claims Act			3
Civil Division notified that hospitals received ineligible federal participation payments		$ 27.5
Period to intervene and to act as plaintiff by government	60 days
Requested shorter period of time	90 days
Accrued estimated losses of legal matters	$ 21.3
Reuille [Member]
Contingencies (Textual) [Abstract]
Period of stay in litigation	180 days
Additional period of stay in litigation	180 days

XML

Supplemental Condensed Consolidating Financial Information (Tables)

3 Months Ended

Mar. 31, 2012

Supplemental Financial Information [Abstract]

Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet

March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	18,404		$	110,894	$	—		$	129,298
Patient accounts receivable, net of allowance for doubtful accounts		—			—			585,904			1,433,633		—			2,019,537
Supplies		—			—			228,702			125,372		—			354,074
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		49,769			67			96,916			32,171		—			178,923
Other current assets		—			—			247,017			81,830		—			328,847
Total current assets		139,566			67			1,176,943			1,783,900		—			3,100,476
Intercompany receivable		1,217,652			9,144,874			2,309,599			1,997,851		(14,669,976	)		—
Property and equipment, net		—			—			4,612,206			2,389,657		—			7,001,863
Goodwill		—			—			2,511,418			1,856,423		—			4,367,841
Other assets, net of accumulated amortization		—			133,393			606,887			635,956		—			1,376,236
Net investment in subsidiaries		1,848,287			7,131,830			3,469,179			—		(12,449,296	)		—
Total assets	$	3,205,505		$	16,410,164		$	14,686,232		$	8,663,787	$	(27,119,272	)	$	15,846,416
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	56,329		$	15,032		$	4,027	$	—		$	75,388
Accounts payable		—			1,982			569,299			250,966		—			822,247
Accrued interest		—			100,941			129			86		—			101,156
Accrued liabilities		7,580			—			673,039			316,999		—			997,618
Total current liabilities		7,580			159,252			1,257,499			572,078		—			1,996,409
Long-term debt		—			8,869,202			49,271			325,143		—			9,243,616
Intercompany payable		—			5,295,699			10,670,064			6,290,045		(22,255,808	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		2,844			237,739			482,689			262,750		—			986,022
Total liabilities		715,149			14,561,892			12,459,523			7,450,016		(22,255,808	)		12,930,772
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			363,540		—			363,540
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		919			—			1			2		(3	)		919
Additional paid-in capital		1,089,447			760,940			846,210			658,685		(2,265,835	)		1,089,447
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(170,136	)		(170,136	)		(17,880	)		—		188,016			(170,136	)
Retained earnings		1,576,804			1,257,468			1,398,378			129,796		(2,785,642	)		1,576,804
Total Community Health Systems, Inc. stockholders’ equity		2,490,356			1,848,272			2,226,709			788,483		(4,863,464	)		2,490,356
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			61,748		—			61,748
Total equity		2,490,356			1,848,272			2,226,709			850,231		(4,863,464	)		2,552,104
Total liabilities and equity	$	3,205,505		$	16,410,164		$	14,686,232		$	8,663,787	$	(27,119,272	)	$	15,846,416

Condensed Consolidating Balance Sheet

December 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

Condensed consolidating statement of income

Condensed Consolidating Statement of Income

Three Months Ended March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	(1,764	)	$	2,297,493		$	1,487,762		$	—		$	3,783,491
Provision for bad debts		—			—			323,543			162,913			—			486,456
Net operating revenues		—			(1,764	)		1,973,950			1,324,849			—			3,297,035
Operating costs and expenses:
Salaries and benefits		—			—			851,412			673,563			—			1,524,975
Supplies		—			—			301,328			197,251			—			498,579
Other operating expenses		—			315			445,871			262,757			—			708,943
Electronic health records incentive reimbursement		—			—			(18,079	)		(8,089	)		—			(26,168	)
Rent		—			—			34,805			32,419			—			67,224
Depreciation and amortization		—			—			111,133			63,221			—			174,354
Total operating costs and expenses		—			315			1,726,470			1,221,122			—			2,947,907
Income from operations		—			(2,079	)		247,480			103,727			—			349,128
Interest expense, net		—			15,737			123,418			13,020			—			152,175
Loss from early extinguishment of debt		—			63,429			—			—			—			63,429
Equity in earnings of unconsolidated affiliates		(75,474	)		(115,064	)		(51,314	)		—			229,839			(12,013	)
Income from continuing operations before income taxes		75,474			33,819			175,376			90,707			(229,839	)		145,537
Provision for (benefit from) income taxes		—			(41,655	)		63,311			24,163			—			45,819
Income from continuing operations		75,474			75,474			112,065			66,544			(229,839	)		99,718
Discontinued operations, net of taxes:
Loss from operations of entities sold		—			—			—			(466	)		—			(466	)
Impairment of hospital sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			—			(466	)		—			(466	)
Net income		75,474			75,474			112,065			66,078			(229,839	)		99,252
Less: Net income attributable to noncontrolling interests		—			—			—			23,778			—			23,778
Net income attributable to Community Health Systems, Inc.	$	75,474		$	75,474		$	112,065		$	42,300		$	(229,839	)	$	75,474

Condensed Consolidating Statement of Income

Three Months Ended March 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Operating revenues (net of contractual allowances and discounts)	$	—		$	—		$	1,965,090		$	1,388,962		$	—		$	3,354,052
Provision for bad debts		—			—			245,533			154,436			—			399,969
Net operating revenues		—			—			1,719,557			1,234,526			—			2,954,083
Operating costs and expenses:
Salaries and benefits		—			—			753,989			625,378			—			1,379,367
Supplies		—			—			268,603			189,214			—			457,817
Other operating expenses		—			—			350,667			264,126			—			614,793
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			31,489			31,681			—			63,170
Depreciation and amortization		—			—			95,556			62,599			—			158,155
Total operating costs and expenses		—			—			1,500,304			1,172,998			—			2,673,302
Income from operations		—			—			219,253			61,528			—			280,781
Interest expense, net		—			28,103			119,358			15,757			—			163,218
Loss from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(61,324	)		(79,436	)		(21,096	)		—			143,722			(18,134	)
Income from continuing operations before income taxes		61,324			51,333			120,991			45,771			(143,722	)		135,697
Provision for (benefit from) income taxes		—			(9,991	)		43,678			10,405			—			44,092
Income from continuing operations		61,324			61,324			77,313			35,366			(143,722	)		91,605
Discontinued operations, net of taxes:
Loss from operations of entities sold		—			—			—			(1,678	)		—			(1,678	)
Impairment of hospital sold		—			—			—			(8,368	)		—			(8,368	)
Loss on sale, net		—			—			—			(3,234	)		—			(3,234	)
Loss from discontinued operations, net of taxes		—			—			—			(13,280	)		—			(13,280	)
Net income		61,324			61,324			77,313			22,086			(143,722	)		78,325
Less: Net income attributable to noncontrolling interests		—			—			—			17,001			—			17,001
Net income attributable to Community Health Systems, Inc.	$	61,324		$	61,324		$	77,313		$	5,085		$	(143,722	)	$	61,324

Condensed Consolidating Statement of Comprehensive Income

Condensed Consolidating Statement of Comprehensive Income

Three Months Ended March 31, 2012

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	75,474	$	75,474	$	112,065	$	66,078	$	(229,839	)	$	99,252
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		10,536		10,536		—		—		(10,536	)		10,536
Net change in fair value of available-for-sale securities		2,667		2,667		2,667		—		(5,334	)		2,667
Amortization and recognition of unrecognized pension cost components		1,140		1,140		1,140		—		(2,280	)		1,140
Other comprehensive income		14,343		14,343		3,807		—		(18,150	)		14,343
Comprehensive income		89,817		89,817		115,872		66,078		(247,989	)		113,595
Less: Comprehensive income attributable to noncontrolling interests		—		—		—		23,778		—			23,778
Comprehensive income attributable to Community Health Systems, Inc.	$	89,817	$	89,817	$	115,872	$	42,300	$	(247,989	)	$	89,817

Condensed Consolidating Statement of Comprehensive Income

Three Months Ended March 31, 2011

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
	(In thousands)
Net income	$	61,324	$	61,324	$	77,313	$	22,086	$	(143,722	)	$	78,325
Other comprehensive income, net of taxes
Net change in fair value of interest rate swaps		36,446		36,446		—		—		(36,446	)		36,446
Net change in fair value of available-for-sale securities		1,069		1,069		1,069		—		(2,138	)		1,069
Amortization and recognition of unrecognized pension cost components		772		772		772		—		(1,544	)		772
Other comprehensive income		38,287		38,287		1,841		—		(40,128	)		38,287
Comprehensive income		99,611		99,611		79,154		22,086		(183,850	)		116,612
Less: Comprehensive income attributable to noncontrolling interests		—		—		—		17,001		—			17,001
Comprehensive income attributable to Community Health Systems, Inc.	$	99,611	$	99,611	$	79,154	$	5,085	$	(183,850	)	$	99,611

Condensed consolidating statement of cash flows

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2012

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(1,230	)	$	(26,237	)	$	(64,108	)	$	278,885		$	—	$	187,310
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(242,977	)		(5,459	)		—		(248,436	)
Purchases of property and equipment		—			—			(127,796	)		(57,107	)		—		(184,903	)
Proceeds from disposition of ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			688			60			—		748
Increase in other investments		—			10,000			(45,612	)		(32,096	)		—		(67,708	)
Net cash used in investing activities		—			10,000			(415,697	)		(94,602	)		—		(500,299	)
Cash flows from financing activities:
Proceeds from exercise of stock options		308			—			—			—			—		308
Repurchase of restricted stock shares for payroll tax withholding requirements		(9,032	)		—			—			—			—		(9,032	)
Deferred financing costs		—			(24,787	)		—			—			—		(24,787	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		1,004			—			—			—			—		1,004
Proceeds from noncontrolling investors in joint ventures		—			—			—			—			—		—
Redemption of noncontrolling investments in joint ventures		—			—			—			(31,096	)		—		(31,096	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(27,038	)		—		(27,038	)
Changes in intercompany balances with affiliates, net		8,950			(58,772	)		479,643			(429,821	)		—		—
Borrowings under credit agreement		—			4,305,674			9,337			—			—		4,315,011
Issuance of long-term debt		—			1,025,000			—			—			—		1,025,000
Proceeds from receivables facility		—			—			—			300,000			—		300,000
Repayments of long-term indebtedness		—			(5,230,878	)		(5,307	)		(763	)		—		(5,236,948	)
Net cash provided by (used in) financing activities		1,230			16,237			483,673			(188,718	)		—		312,422
Net change in cash and cash equivalents		—			—			3,868			(4,435	)		—		(567	)
Cash and cash equivalents at beginning of period		—			—			14,536			115,329			—		129,865
Cash and cash equivalents at end of period	$	—		$	—		$	18,404		$	110,894		$	—	$	129,298

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2011

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(22,195	)	$	(83,202	)	$	331,077		$	(38,169	)	$	—	$	187,511
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(10,727	)		(34,695	)		—		(45,422	)
Purchases of property and equipment		—			—			(64,312	)		(89,563	)		—		(153,875	)
Proceeds from disposition of ancillary operations		—			—			—			14,583			—		14,583
Proceeds from sale of property and equipment		—			—			473			7,114			—		7,587
Increase in other investments		—			—			(36,201	)		3,924			—		(32,277	)
Net cash used in investing activities		—			—			(110,767	)		(98,637	)		—		(209,404	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,125			—			—			—			—		18,125
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			—			—			—			—		—
Excess tax benefit (income tax payable increase) relating to stock-based compensation		4,675			—			—			—			—		4,675
Proceeds from noncontrolling investors in joint ventures		—			—			—			863			—		863
Redemption of noncontrolling investments in joint ventures		—			—			—			(225	)		—		(225	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(15,333	)		—		(15,333	)
Changes in intercompany balances with affiliates, net		(605	)		95,750			(191,179	)		96,034			—		—
Borrowings under credit agreement		—			—			—			—			—		—
Proceeds from receivables facility		—			—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(12,548	)		(1,472	)		(645	)		—		(14,665	)
Net cash provided by (used in) financing activities		22,195			83,202			(192,651	)		80,694			—		(6,560	)
Net change in cash and cash equivalents		—			—			27,659			(56,112	)		—		(28,453	)
Cash and cash equivalents at beginning of period		—			—			212,035			87,134			—		299,169
Cash and cash equivalents at end of period	$	—		$	—		$	239,694		$	31,022		$	—	$	270,716

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2012

Recent Accounting Pronouncements [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

14. RECENT ACCOUNTING PRONOUNCEMENTS

In September 2011, the FASB issued ASU 2011-08, which modifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. This ASU is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and was adopted by the Company on January 1, 2012. The adoption of this ASU did not impact the Company’s consolidated financial position, results of operations or cash flows.